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ABSTRACT:
It has been well-documented that ultraviolet B (UVB) irradiation results in
suppression of the delayed hypersensitivity response to various antigens encountered
in the epidermis, although the mechanism for this is unknown. UVB also causes
depletion of Langerhans cells (LCs) and alterations in their morphology, but the role
of the LC, which is the principal epidermal antigen-presenting cell, in UVB-evoked
immunosuppression is not clear. There is controversy as to whether the apparent
depletion of LCs which follows UVB exposure reflects a genuine decrease in cell
numbers or simply a reduced expression of the cell-surface antigens used to
demonstrate them. Most previous studies were undertaken in vitro, used experimental
animals or UVB doses which differ greatly from normal environmental or therapeutic
levels. The aim of this work was to study the relationship between UVB and the LC
by examining the influence of moderate, suberythemal doses of UVB, such as are
used to treat psoriasis, on epidermal LC morphology, numbers and surface expression
of CD la and major histocompatibility class II (MHC II) antigens in human skin.
A six week course of UVB irradiation, using our standard therapeutic regimen for the
treatment of psoriasis (total doses of UVB ranged from 2.58-5.58 J/cm^), was
administered to nine healthy subjects. The morphology and number of LCs, and the
distribution and expression of certain LC surface antigens were studied in control and
in UVB-irradiated epidermis. The study of LC morphology prior to UVB irradiation,
using the technique of confocal laser scanning microscopy, revealed that their
dendrites extended mainly in the horizontal plane of the epidermis and dendrite
numbers ranged between two and nine per cell. Adjacent LCs were in close
apposition, but there was little contact between them. The majority of normal
unirradiated epidermal LCs expressed HLA-DP, HLA-DQ and HLA-DR antigens,
which were demonstrated by a quantitative ultrastructural immunogold method using
image analysis, although a small proportion either did not express these antigens or
expressed them at high surface densities. This indicates that phenotypic
heterogeneity may exist with respect to the surface expression of MHC II antigens on
LCs. There was a uniform distribution of these antigens on the surface of LCs
derived from both control and UVB-irradiated epidermis.
LCs from UVB-irradiated epidermis, examined using confocal laser scanning
microscopy, possessed fewer dendrites than non-irradiated cells. The mean dendrite
length was unaltered, but the median dendrite length was reduced after UVB
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exposure. This appeared to be due to the retention of fewer dendrites, most of which
were short, but some of which were extremely long. UVB irradiation caused
significant reduction in the number of epidermal LCs detected by surface expression
of CD la, pan MHC II, HLA-DP, HLA-DQ, HLA-DR antigens using light
microscopical immunoperoxidase and immunofluorescence labelling techniques.
However, the expression of CD la and MHC II antigens, detected by immunogold
labelling, was increased on the surface of residual LCs after UVB irradiation.
In conclusion, a true reduction in the number of LCs occurs after UVB exposure
which cannot be explained simply by the loss of LC surface antigen expression.
These studies have defined the UVB-induced changes in LC morphology, numbers
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1.1 General introduction
Human responses to sunlight are complex. Although sunlight is necessary for a wide
range ofmetabolic and other physiological processes, it has harmful as well as
beneficial effects. Sunlight can cause photodermatoses, cataracts, inflammation of the
eyes, wrinkling and ageing of the skin, sunburn, suppression of cutaneous immune
responses and skin malignancy.
The solar spectrum that reaches the Earth's surface includes ultraviolet (wavelength 290-
400nm), visible (400-700nm), and infrared radiation (fig. 1.1). Ultraviolet radiation
(UVR) is arbitrarily subdivided into 3 wavebands (Coblentz, 1932 cited by Parrish et al.,
1978).
Ultraviolet C (UVC) is radiation with wavelengths from 200-280nm which are the
shortest to be transmitted through air. All radiation with a wavelength less than 290nm
is absorbed by the ozone layer in the upper atmosphere. Therefore, UVC does not
normally reach ground level. Radiation in the UVC range is, however, biologically
active. UVC is lethal to micro-organisms, and has been shown to cause skin erythema
(Hausser, 1928 cited by Rottier, 1953) and immunosuppression (Baadsgaard etal.,
1987a).
Mid-range UVR or ultraviolet B (UVB), with wavelengths from 280-320nm, reaches the
Earth in relatively small quantities. These wavelengths are biologically very active and
are the most effective for production of sunburn in man, as well as immunosuppression
and the induction of skin cancers in laboratory animals (Blum, 1959; Baadsgaard,
1991). Moreover, there is strong epidemiological evidence to suggest that solar UVB
causes skin cancer in man (Blum, 1959).
The UVR wavelengths from 320-400nm are termed ultraviolet A (UVA). Although
UVA is not readily absorbed by protein or nucleic acids and is only mildly
erythemogenic, much greater amounts reach the ground than either UVC or UVB. The
oncogenicity ofUVA has not yet been established, despite the suggestion that it can
promote tumours at very high doses and be co-carcinogenic when administered in
conjunction with UVB (Sterenborg etal., 1990; Talve, Sterback and Jansen, 1990). The
demonstration that UVA can eliminate Langerhans cells (LCs) from exposed skin
without reducing the contact hypersensitivity (CH) response suggests that it might have
immunosuppressive effects (Morison et al., 1984).
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Figure 1.1: The solar spectrum
Relative intensity
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1.2 UV therapy for skin diseases
At the turn of the century, the Danish physician Niels Finsen won the third Nobel prize
for his early work on phototherapy of cutaneous tuberculosis (Finsen, 1901). Today
UV therapy is used to treat many different types of skin disease: the most common
treatments being UVB phototherapy and psoralen photochemotherapy (PUVA)(Table
1).
UVB phototherapy is primarily used to treat inflammatory dermatoses such as psoriasis,
acne, eczema and polymorphic light eruption. Phototherapy regimens are very variable
with respect to the irradiation schedules and the equipment used. However, a typical
conventional regimen might consist of 3 treatments per week for 4-6 weeks until the
disease is cleared, which may then be reduced to 1 or 2 times per week for a short
period of maintenance. The whole body may be exposed to irradiation within a cabinet
lined with fluorescent bulbs. The beneficial effects of UVB in the treatment of such
conditions may rely on the alteration or suppression of immune mechanisms which
mediate the diseases.
The use of psoralens as photosensitizers is an ancient practice. Written documentation
of the use of chemical substances in the environment combined with sun exposure to
treat vitiligo dates to 1400BC (Fitzpatrick and Pathak, 1959). In the past 50 years, there
has been much progress in the scientific study of psoralens and photochemotherapy.
PUVA was introduced in 1974 as an alternative treatment for psoriasis and other
dermatological diseases (Parrish et al., 1974). During photochemotherapy, the patient
ingests a psoralen photosensitizer such as 5- or 8-methoxypsoralen and then receives
UVA radiation two hours later. An alternative to ingesting the psoralen is to bathe in a
dilute solution of psoralen immediately (usually 15-30 mins.) prior to irradiation. UVA
is administered to the whole body in a cabinet lined with UVA tubes. Clearance of
psoriasis usually requires approximately 20 sessions over 4-10 weeks. Maintainance
treatment following clearance can be given, although most dermatologists prefer to give
short courses of PUVA without maintenance therapy to reduce the cumulative dose of
radiation. In controlled studies PUVA has also been an effective treatment for several
other skin diseases (Green et al., 1992).
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Table 1.1. Efficacy of phototherapy and photochemotherapv in the treatment of
skin diseases.
SKIN DISEASE UVB PUVA
psoriasis V V
atopic eczema V V
polymorphic light eruption V V
mycosis fungoides +/- V 1
lichen planus V
vitiligo V
solar urticaria +/- V
photosensitive eczema V
actinic reticuloid V
pityriasis lichenoides chronica V V
Despite enormous research efforts to examine the animal response to UVR, there is still
relatively little work concerning the human response. The few investigations into the
effects ofUVR on humans have generally employed unusually low or high doses in
vivo or have used in vitro techniques which may have little relevance to solar UVR doses
commonly encountered or those used therapeutically.
Decreases in stratospheric ozone over the Northern Hemisphere reached a record low in
January and February 1992, and ozone depletion at 40°N was estimated to be
approximately 6% per decade (Stolarski et al., 1992). The ozone layer shields the
surface of the earth against all UVC and some UVB radiation. Therefore an increasing
proportion of sunlight which reaches the earth will consist of UVB radiation. Thus, it
will become increasingly important to investigate the influence ofUVB on human health
in doses relevant to solar UVB exposure.
The following sections review work concerning the skin immune system, antigen
processing and presentation, and the effects of both chronic and acute UVR exposure
on the skin.
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1.3 The skin immune system
In 1978 Streilein proposed a novel theory in which the skin encompassed a separate
branch of the immune system, the skin-associated lymphoid tissue (SALT), specialized
to cope with the antigenic demands imposed upon it by the external environment. SALT
was reported to be similar to other putative specialized branches of the immune system,
such as the gut-associated lymphoid tissue. He postulated that the surveillance of skin
for alterations or abnormalities is a continuous process performed by a pool of
recirculating epidermotropic T lymphocytes. Evidence in favour of this hypothesis was
drawn from the fact that large numbers of Cluster of Differentiation (CD) 4+ve T cells
may migrate into the epidermis in lesions of cutaneous T cell lymphoma (Streilein,
1978; Haynes etal., 1982). According to this theory, LCs would process antigens
which penetrate the skin and present the antigens to recirculating T cells, either in the
epidermis, dermis or within draining lymph nodes. Keratinocytes and endothelial cells
were also considered to be integral parts of SALT (Streilein, 1978).
It is now clear that the skin is an active immunological organ and that many other cell
types are participants in SALT (examples are given in table 1.2). This larger and more
complex system is now more commonly known as the "skin immune system" (SIS)
(Bos and Kapsenberg, 1986). Some of the principal cells of the SIS are discussed
below and shown in fig. 1.2.
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Table 1.2 Cellular constituents of the SIS
CELLULAR CONSTITUENTS OF THE SIS
Langerhans cells (Indeterminate cells)
keratinocytes
T lymphocytes
Thy-1 positive dendritic cells (present in murine epidermis only)









LANGERHANS CELLS were originally identified by Paul Langerhans in 1868,
using a gold stain thought to be specific for neural tissue. They were initially believed
to be of neural origin, but are now considered to be bone marrow-derived, dendritic
antigen-presenting cells (APCs) that express many surface-bound molecules including
surface adenosine triphosphatase (ATPase) activity, CDla,c, and CD4 (Katz et al., 1979;
De Panfilis et al., 1988). Surface major histocompatibility class II (MHC II) molecules
(Human leukocyte-associated, HLA-DP,-DQ,-DR) are constitutively expressed by LCs
in approximately equal amounts (Sontheimer et al., 1986). Receptors for the Fc portion
of IgG, receptors for the Fc portion of IgE (Torresani etal., 1991), the type 3
complement receptor (De Panfilis et al., 1990a), and certain integrin molecules are also
expressed on LC surfaces. The main type of cell necessary for presentation of antigen
encountered in the epidermis for cell-mediated immune responses belongs to the family
of bone marrow-derived dendritic cells which may be ontogenically related. They are all
cells with a dendritic morphology and include LCs, indeterminate cells, veiled cells,
dendritic cells (DCs) of peripheral blood, perivascular dermal MHC Il+ve cells and
interdigitating cells of the lymph node paracortex (Knight et al., 1992). DCs are bone
marrow-derived cells which are present in peripheral blood, become distributed in small
numbers throughout all tissues
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(e.g. LCs in epidermis) and move via afferent lymphatics to the paracortex of lymph
nodes (MacPherson, 1989).
LCs make up approximately 2-8% of the total epidermal cell (EC) population (Hunter,
1983; Bjercke et al., 1987; Hanau et al., 1988). They mainly occupy a suprabasal
epidermal position, with their dendrites lying in close proximity to those of
neighbouring LCs (fig. 1.3), to give rise to a discontinuous network (Shelley and Juhlin,
1976). Their position within the epidermis suggests that they are one of the first lines
of immunological defence against pathological organisms penetrating the skin.
Precursors of LCs have been identified in peripheral blood and appear to be increased in
the peripheral blood of subjects who have lost skin through burns (Gothelf et al.,
1988). LCs appear to reside within murine epidermis for around 3 weeks (Katz et al.,
1979; Toews et al., 1980a). Phototherapy, photochemotherapy and natural sunlight
deplete the skin of LCs (Zelickson and Mottaz, 1970; Aberer et al., 1986) and after
PUVA, the time required for repopulation of human epidermis by LCs is also
approximately 3 weeks (Friedmann et al., 1983). Further discussion of UV-induced
depletion of LCs is given in section 1.9. Intra-epidermal LCs occasionally undergo
mitosis in situ (de Fraissinette et al., 1988; Miyauchi and Hashimoto, 1989) and may be
lost by exfoliation (Davis, Mackenzie and Hart, 1988). LC proliferation may occur
during the recovery of LC numbers after UV irradiation (Miyauchi and Hashimoto,
1987; Bos, Teunissen and Kapsenberg, 1988).
Distinguishing ultrastructural features of LCs (figs. 1.4 and 1.5), include an indented
nucleus, prominent Golgi apparatus and the unique cytoplasmic organelle, the Birbeck
granule (BG; Birbeck et al., 1961). The BG is the most reliable means of identifying
LC. It is a rod-shaped organelle that is sometimes associated with a vacuole, giving it an
appearance similar to a tennis racket (fig. 1.5). Usually BGs are situated close to the
Golgi apparatus, but they are sometimes continuous with the cell membrane. Recently a
BG-specific monoclonal antibody has been raised, called LAG (Kashihara etal., 1986).
BGs associated with cell surfaces have been shown to take up lanthanum and
peroxidase from the extracellular space (Hunter, 1983; Gawkrodger etal., 1989;
Bartosik, 1992). The function of these granules may be secretory or endocytic (Wolff
and Schreiner, 1970; Takigawa etal., 1985; Takahashi and Hashimoto, 1985). Lending
support to the latter view, the receptor-mediated endocytosis of both CD la and HLA-
DR antigens has been shown to involve BGs. Therefore, the granules are a possible
means for intracellular transport of both CDla and HLA-DR molecules (Hanau et al.,
1987,1989). Furthermore, the uptake of peroxidase by LCs involves the
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formation of BGs at the cytomembrane which are able to transport the substance to the
endosomal compartment (Bartosik, 1992).
An immunological role for LCs was first suggested in 1973 when Silberberg noted
direct contact between LCs and lymphocytes at sites of CH reactions (Silberberg, 1973).
The CH response is a form of delayed type hypersensitivity (DH) reaction in which the
antigen penetrates into skin and is first encountered there. Presentation of antigen by
LCs to naive T cells is believed to occur within the epidermis or draining lymph node
and results in the clonal proliferation of an antigen-specific T cell subpopulation in the
draining lymph node (Turk, 1971; Shelley and Juhlin, 1977; Jones etal., 1989). These
T cells form a long-lived clone of circulating memory and effector T cells which can
recognize and rapidly respond to a second exposure to the antigen (Turk and Oort,
1963). The typical inflammatory reaction (associated with a dermal T cell and
macrophage infiltrate) becomes apparent in skin a number of hours after the second
contact has occurred, and is maximal at 24-48 hours.
LCs have been identified in dermal lymphatics draining the site of CH reactions
(Silberberg et al., 1976; Macatonia et al., 1987). Furthermore, DCs isolated from
draining lymph nodes may be derived from epidermal LCs. The observation that both
LCs and DCs express the cell surface antigen recognised by the antibody, NLDC-145,
supports this hypothesis (Kraal et al., 1986). Moreover, the short-term culture of
murine LCs alters their function, phenotype and morphology such that they resemble
lymphoid DCs, a process which may be similar to in vivo maturation of LCs after they
migrate to dermal lymphatics. These alterations may be mediated by the cytokines,
granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-l
(Schuler and Steinman, 1985; Heufler, Koch and Schuler, 1988; Koch etal., 1990).
Whether the alterations to murine LCs induced in vitro bear any resemblance to events
in vivo is currently being investigated. It has been argued that the phenotypic and
functional changes induced in human LCs in vitro might be simply attributed to
recovery from the trypsinization process used to isolate the cells (Teunissen et al.,
1991a). Others have shown a sharp rise in the number of antigen-bearing DCs in
draining lymph nodes following the skin painting of mice with contact sensitizers, and a
proportion of DCs bear high levels of antigen. Such antigen-bearing DCs are MHC II
+ve, intercellular adhesion molecule (ICAM)-l+ve, readily form clusters with T cells
both in situ and in vitro, and are potent stimulators of in vitro primary and secondary T
cell proliferative responses (Knight et al., 1985; Macatonia et al., 1987; Cumberbatch
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Figure 1.3: Langerhans cells in a sheet of human
epidermis, viewed 'en face' and labelled using




Figure 1.4: Human Langerhans cell within the
epidermis, showing indented nucleus (asterisk),
centriole (arrow) and cytoplasmic Birbeck granules
(arrowheads).
Magnification 9,300 x
Figure 1.5: Birbeck granules (arrowheads) within




and Kimber, 1990; Kimber etal., 1990; Cumberbatch, Illingworth and Kimber, 1991).
The number of antigen-bearing cells in lymph nodes is maximal at 48 hours and returns
to normal by 4 days, a time course that is similar to that of the loss of LCs from the skin
after antigen sensitization. Therefore, the application of antigen on mouse skin appears
to stimulate LC migration to draining lymph nodes where these antigen-bearing cells are
detected as DCs. The migration of LCs to draining lymph nodes in mice may be
induced by the cytokines, tumour necrosis factor (TNF)-a and IL-1 (Cumberbatch and
Kimber, 1992a).
Much information, albeit circumstantial, has accumulated to support the hypothesis that
LCs can present antigen to T lymphocytes (Stingl et al., 1978; Ptak et al., 1980; Wolff
and Stingl, 1983). LCs are the only cell type in normal human skin, with the exception
of acrosyringeal keratinocytes, to express membrane-associated MHC II molecules
(Carr et al., 1986; McGregor et al., 1991). This implies that they can process and
present antigen. LCs are able to present a wide variety of antigens including
alloantigens, tumour antigens, soluble antigens such as nickel, some viral antigens and
particulate antigens such as tuberculin purified protein derivative to T cells in vitro
(Bjercke et al., 1984; Sontheimer, 1985; Rasanen et al., 1986; Res etal., 1987; Everness
etal., 1988; Grabbe etal., 1991). They can present antigen to both Thl and Th2
lymphocytes (see section on lymphocytes, pi 1; Tiegs et al., 1990). They also appear to
be the primary stimulators of both allogeneic and syngeneic mixed lymphocyte
reactions (Braathen and Thorsby, 1980; Stingl etal., 1981). In addition, LCs can prime
effector cells such as cytotoxic T cells (McKinney and Streilein, 1989), and play a
pivotal role in many DH reactions such as induction ofCH and the rejection of skin
grafts (Streilein and Bergstresser, 1983). Murine skin that is depleted of LCs by UV
irradiation, or that is naturally deficient in LCs, does not support the induction of CH to
dinitrofluorobenzene (DNFB; Toews etal., 1980b). The depletion of LCs in human
skin by topical steroid or by PUVA therapy also reduces antigen presentation in vitro
(Ashworth, Kahan, and Breathnach, 1989a,b). Furthermore, LC depletion in murine
epidermis by UVR in vivo leads to prolonged skin graft survival in allogeneic recipients
(Odling, Halliday and Muller, 1987). Finally LCs may even be responsible for
presentation of viral and tumour-associated antigens (Wolf and Stingl, 1983). The
enrichment of LCs in EC suspensions in vitro has been shown to enhance the
presentation of Candida and herpes simplex virus (HSV) antigens (Bjercke et al., 1984).
LCs express certain integrins on their surfaces. Integrin molecules consist of an a
subunit bound non-covalently to a (3 subunit. There are 3 distinct subfamilies of
integrins expressing different although homologous P subunits, (31, P2 and [33. The pi
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subfamily consists of the very late antigen (VLA) proteins and are involved in cell-
matrix as well as cell-cell interactions. The (32 subfamily of leukocyte integrins consist
of Lymphocyte function-associated (LFA)-l, Mac-1, and pl50-95 molecules. The [33
subfamily of cytadhesion molecules consists of gpIIa/IIIa and the vitronectin receptor.
LCs and basal keratinocytes express the integrin pi subunit (Staquet et al., 1989; Le
Varlet et al., 1991) and LCs express the P2 subunit of leukocyte integrins
CD1 lb/CD18 and CD1 lc/CD18 in addition to ICAM-1 which might facilitate their
adhesion to T cells (De Panfilis et al., 1989). The expression of LFA-3 has been
demonstrated on LCs and may be important for LFA-3/CD2 antigen-specific
recognition by T cells (De Panfilis et al., 1991). The interaction of LC integrin
molecules with ligands on T cells is required for optimal stimulation of the mixed
epidermal cell leukocyte reaction (MECLR) and the pre-incubation of LCs with anti-
CD 1 la/CD 18 and anti-ICAM-1 antibodies inhibits the reaction to a similar extent to
anti-HLA-DR antibody (Simon etal., 1991a).
When APCs present antigen to T lymphocytes, the APCs produce IL-1 which, in
subnanogram quantities, activates T cells in the presence of antigen and causes them to
secrete IL-2. Isolated human LCs produce the cytokines IL-ip and IL-6 (Schreiber et
al., 1992).
"INDETERMINATE CELLS" are resident within the normal epidermis and are
HLA-DR +ve, CD la +ve APCs with a dendritic morphology that is similar to that of
LCs. Their lack of cell-specific intracellular organelles such as pre-melanosomes (seen
in melanocytes), the granules that characterize Merkel cells or BGs has lead to the
definition of "indeterminate cells" (Breathnach, 1975). For many years indeterminate
cells were considered to differ from LCs by their absence of BGs on ultrathin
sectioning. However a recent detailed ultrastructural study demonstrated that
"indeterminate cells" may simply represent a sampling phenomenon in which ultrathin
sections of LCs which contained no BGs were mistaken as a separate cell type
(Silberberg-Sinakin etal., 1980; Bartosik etal., 1991). Cells that are morphologically
similar to "indeterminate cells" and that are CD la and CDlc +ve have been detected in
the papillary dermis (Murphy et al., 1983; Van de Rijn et al., 1984). Moreover, dermal
cells have been described which are transitional between dermal "indeterminate cells"
and epidermal LCs (Breathnach, 1980). The relationship between these cells is unclear,
but there is speculation that they represent LC precursors or LCs migrating from the
skin to the draining lymph nodes (Bos and Kapsenberg, 1986).
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KERATINOCYTES make up approximately 96% of the total EC pool and form a
multi-layered sheet of cells. Their most important function is to produce an
impermeable horny layer at the surface of the epidermis, which prevents the absorption
and penetration of various pathogens and harmful agents (such as bacteria, viruses,
chemicals and UVR). Murine keratinocytes produce macrophage colony stimulating
factor, GM-CSF, IL-1 [3, contra IL-1, IL-3, IL-7 and IL-10, whereas human
keratinocytes produce IL-1a and (3, IL-3-like factor, IL-6, IL-8, IFN-a, epidermal-
cell derived lymphocyte differentiation factor, transforming growth factor a and (3
(TGF a,(3), GM-CSF and TNF a,(3. This suggests that keratinocytes probably play
an active role in the SIS (Matsue et al., 1992; Schreiber et al., 1992).
Usually, keratinocytes do not express MHC II, except for a small subpopulation of
cells in the acrosyringium of sweat glands (Carr et al., 1986; McGregor et al., 1991).
Under the influence of T cell-derived "/-interferon (IFN) in inflammatory dermatoses,
however, or after in vitro stimulation with y-IFN, the majority of keratinocytes can be
induced to synthesize MHC II (Volc-Platzer etal., 1985; Nickoloff et al., 1985;
Aubock et al., 1986; Barker et al., 1988). They then express more HLA-DR than -DP
or -DQ (Gawkrodger et al., 1987; Volc-Platzer et al., 1988). Keratinocytes that are
HLA-DR+ve can cause lymphoproliferation in vitro but will not do so unless
exogenous IL-2 is present (Nickoloff et al., 1986; Morhenn and Nickoloff, 1987).
HLA-DR+ve keratinocytes may augment the presentation of purified protein derivative
of tuberculin antigen in vitro by ECs (Tjernlund and Scheynius, 1987). However, if
LCs are removed from the EC suspensions, antigen presentation is abolished
(Scheynius etal., 1988). Incubation of murine trinitrophenol (TNP)-modified MHC
Il+ve keratinocytes with TNP-specific T cell clones results in unresponsiveness of the
T cells to subsequent stimulation with TNP-modified LCs. In this case MHC Il+ve
keratinocytes seem to have been providing downregulatory signals to T cells
(Gaspari,Jenkins and Katz, 1988).
LYMPHOCYTES consist of two major functionally distinct subsets: B-lymphocytes
which produce antibodies in humoral immune responses, and T-lymphocytes which
interact with cell-associated antigens in cell-mediated immune responses (Miller, 1966).
Human T cells express the CD3 T cell antigen receptor (TCR) and the receptor for
sheep red blood cells (CD 11). A subdivision of T cells separates helper and delayed
hypersensitivity T cells (that express the CD4 antigen and generally upregulate immune
responses), from suppressor and cytotoxic T cells (that express the CD8 antigen and
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generally suppress immune responses). CD4 positive T cells are further subdivided
into two groups: helper and suppressor-inducer lymphocytes (Morimoto et al., 1985a,
b). Both mouse and human T helper cells can be divided into Thl and Th2 subsets that
are distinguished by functional criteria and by their cytokine profile. Thl cells produce
IL-2 and y-IFN and are primarily involved in providing help for DH reactions, whereas
Th2 cells are more efficient at mediating help for antibody production and secrete IL-4,
IL-5, and IL-10 (Noelle and Snow, 1992).
The lymphocytes located in skin are mainly T cells, and most are found in the dermis
around vascular channels and appendages. Dermal perivascular/appendageal
lymphocytes are a mixture of both CD4 and CD8+ve T cells. Epidermal lymphocytes
are sparsely distributed and predominantly of the CD2+ve/CD3+ve/CD8+ve
phenotype. However, more sensitive staining techniques have revealed greater numbers
of epidermal CD4+ve suppressor-inducer T cells than originally suspected (Rowden et
al., 1988).
T cells often return to and accumulate in sites at which they first became activated to an
antigen (Scheper et al., 1985; Drijvestijn and Hamann, 1989). The mechanism by which
they migrate to a specific site may involve expression of cell surface integrin molecules,
'addressins', on cells within those tissues. Such 'addressins' may interact with
lymphocyte-specific integrin molecules on the surface of T cells. For example,
migrating T cells interact with endothelium via the T cell integrin LFA-1 and the
'addressin' ICAM-1 which is present primarily on endothelia of draining lymph nodes
and to a lesser degree on vascular channels (Hogg, 1989). Epidermotropic migration of
a T cell clone can be inhibited in vivo and in vitro by monoclonal antibodies against
LFA-1 (Shiohara etal., 1988). Increased expression of 'addressins' occurs after
exposure to cytokines including y-IFN, IL-1 and TNF secreted by activated helper T
cells and macrophages.
THY-1 +VE CELLS are MHC class II -ve, bone marrow-derived dendritic T cells
which are only present in murine epidermis and that express abundant surface-bound
Thy-1 antigens (Tschachler etal., 1983; Bergstresser etal., 1983; Breathnach and Katz,
1984). The CD3 antigen is expressed by these cells in association with the TCR y/8
heterodimer, in contrast to the majority of peripheral T lymphocytes which express the
TCR ot/p heterodimer (Krueger and Stingl, 1989). Evidence suggests that Thy-1 +ve
cells have cytotoxic capabilities similar to natural killer (NK) cells and that they may
activate suppressor T cell circuits (Sullivan et al., 1986; Okamoto and Kripke, 1987).
The ratio of LCs to Thy-1 -i-ve cells correlates well with the intensity of a DH response
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oxazolone and trinitrochlorobenzene (TNCB; Bigby et al., 1987). However, there is no
evidence that Thy-l+ve cells can transport antigen to draining lymph nodes
(Cumberbatch and Kimber, 1990).
There is no Thy-1 positivity or reactivity in human epidermis. However, a possible
human equivalent of the Thy-l+ve cell has been described (Bos et al, 1988) which is
sparsely distributed through the epidermis and is distinguishable by its expression of
the y/5 TCR.
PERIVASCULAR DERMAL MHC 11+VE CELLS express high density of
MHC II, Factor XHIa, HLA-DR, HLA-DQ, OKM5 and monol (Cooper et al., 1986;
Cerio et al., 1989) but not CD1, Factor VIII or Thy-1.2 (Sontheimer et al., 1989).
Murine dermal MHC Il+ve cells can present antigen in DH responses, and may
present antigen to T cells migrating through the dermis (Tse and Cooper, 1990).
VEILED CELLS are DCs found in afferent lymphatics (Drexhage et al., 1979).
They express HLA-DR, CD la, receptors for Fc and C3, but not surface
immunoglobulins (Balfour et al., 1981). Occasional veiled cells contain BGs and
might represent LCs migrating from epidermis to lymphatics (Silberberg-Sinakin et
al., 1980; Macatonia et al., 1987). On arrival in the paracortex of lymph nodes, veiled
cells may become RFD1 +ve interdigitating cells which present antigen to T cells (Bos
and Kapsenberg, 1986). Veiled cells, DCs from draining lymph nodes and LCs all
react with the antibody NLDC-145 indicating that these cells may be related in origin
(Kraal etal., 1986).
MACROPHAGES are MHC Il+ve antigen presenting cells which in skin are present
mainly in papillary dermis and also scattered through the reticular dermis (Bos and
Kapsenberg, 1986). The presentation of antigen by macrophages in most in vitro
models, however, is much less efficient than by dendritic APCs (Van Voorhis et al.,
1983).
ENDOTHELIAL CELLS are normally MHC Il-ve, but like fibroblasts and
keratinocytes described above, can be induced to become MHC Il+ve under the
influence of y-IFN (Pober et al., 1983). Whether these cells are able to initiate primary
T cell responses is unknown.
Specialized endothelial cells which constitute high endothelial venules (HEV) are found
in lymph nodes and may facilitate the migration of lymphocytes across the vessel wall.
However, HEV are not present in normal skin and have only been described in some
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inflammatory skin conditions (Drijvestijn and Hamann, 1989). Therefore, HEV are
unlikely to play a major role in skin T cell infiltration.
1.4 The major histocompatibility complex.
The human MHC is located on the short arm of chromosome six, and comprises three
classes of proteins (fig. 1.6). Almost all nucleated cells express MHC class I (MHC I)
antigens. Human cell surface MHC I antigens consist of two polypeptide chains,
composed of a highly polymorphic heavy chain (-45 kDa) that spans the cell
membrane, and a non-polymorphic non-covalently attached light chain (-12 kDa) that is
extracellular. The light chain, (^-microglobulin, is encoded by chromosome 15,
whereas the heavy chain is encoded by the HLA-A,-B, and -C loci of chromosome six.
The heavy chain consists of five domains, one cytoplasmic, one transmembrane, and
three extracellular. The antigen-binding groove has been detected by X-ray
crystallography on the upper surface of the MHC I molecule (Bjorkman et al., 1987).
The CD1 family comprise at least three different cell surface glycoproteins, CD la,
CD lb and CDlc, which are encoded within chromosome six and have molecular
masses of 49,45, and 43 kDa respectively. They are considered to be non-classical
MHC I molecules and are expressed on cortical thymocytes, leukemic T cells, dendritic
cells and LCs. Although they are similar in gene structure to MHC I molecules,
possessing a highly conserved domain which is homologous with the domain that binds
[^-microglobulin, they differ from MHC I in that they lack significant polymorphism.
The function of these molecules has not yet been established. Recently, CD1 molecules
have been reported to act as ligands recognized by certain T cell lines (Porcelli et al.,
1989; Faure et al., 1990; Balk et al., 1991). This raises the speculation that they may be
involved in the activation of T cells by accessory cells. Indeed, a recent report has
shown that CD la molecules may play a role in the activation of allogeneic T cells
(Moulon etal., 1991).
The expression of MHC II antigens is limited to a group of cells collectively known as
accessory cells, which include APCs which constitutively express MHC II, and certain
other cell types which can be induced to express MHC II. Many types of accessory cell
have been identified, such as B cells, macrophages, spleen DCs, lymph node follicular
DCs, blood DCs, veiled cells, LCs, activated T cells, vascular endothelial cells, and
keratinocytes.
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Cell surface MHC II glycoproteins are heterodimers, consisting of non-covalently
linked a chains (-34 kDa) and (3 chains (~29kDa; fig. 1.7). The human HLA-D region
encodes the MHC II glycoproteins, and is divided into three main subregions: HLA-
DP, HLA-DQ and HLA-DR, but also includes genes called DNa and DO(3, the
products of which have not yet been detected (see fig. 1.6). These molecules are
highly polymorphic, the greatest polymorphisms occurring in the HLA-DQ a chain and
the (3 chains of all three loci (reviewed by Trowsdale et al., 1985). A further increase
in the repertoire of MHC II antigen expression exists if hybrid molecules form, such as
the a chain from one HLA-DQ allele associating with the (3 chain of a different HLA-
DQ allele (Giles et al., 1985). In mice, the MHC region is found on chromosome 17.
The I region of the murine MHC corresponds to the human HLA-D region and includes
genes for MHC II molecules. Products of the I region are termed la antigens, which is
also the generic name for human HLA-D products. The exact molecular structure of
MHC II molecules by X-ray crystallography has not yet been achieved. By analogy
with MHC I structure, it is assumed that the peptide binding site consists of a platform
of eight strands of (3-pleated sheet with two a-helices on the boundaries (Brown et al.,
1988; Gerlier and Rabourdin-Combe, 1989).
Expression of MHC II molecules on APCs can be modulated by soluble mediators. IL-
4, y-IFN, and GM-CSF induce, whereas prostaglandins El and E2, a-fetoprotein, and
colony stimulating factor-1 inhibit MHC II synthesis and expression (Snyder et al.,
1982; Willman et al., 1989). Qualitative or quantitative variation ofMHC II expression
may influence cellular function (Janeway et al., 1984). For example, pre-incubation of
monocytes in vitro with y-IFN augmented the expression of HLA-DP and HLA-DQ as
well as the antigen presenting function of these cells (Gonwa, Frost and Karr, 1986).
The functions of the HLA-D region products may be similar or overlapping. All three
types ofMHC II antigen can induce suppressor T cells (Sasportes et al., 1978; Pawelec
et al., 1984; Odum et al., 1986; Hirayama et al., 1987) and act as restriction elements
for T cell proliferation (Qvigstad et al., 1984). Furthermore, HLA-DR, HLA-DP and
possibly HLA-DQ (although this is difficult to establish due to tight linkage
disequilibrium between HLA-DQ and HLA-DR) can act as transplantation antigens
(Olerup et al., 1990). All three MHC II loci appear to be involved in the presentation of
HSV by ECs, and the presentation of nickel and chlamydial antigens by peripheral
blood adherent cells to T cells (Qvigstad et al., 1984; Emtestam et al., 1988; Evemess
et al., 1988; Vestey, 1990a).
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Conversely, it has been suggested that HLA-DP, HLA-DQ and HLA-DR have different
functions. Evidence from in vitro studies suggest that HLA-DQ molecules may be
involved in the activation of HLA-DR +ve cytotoxic and suppressor subpopulations of
T cells whereas HLA-DR molecules may be directly involved in T helper cell
proliferation (Navarette et al., 1985; Nieda et al.,1988). Most plastic-adherent cells
(monocytes) of peripheral blood express HLA-DP and HLA-DR in varying amounts
(Nunez et al., 1984). However, less than half of them express detectable levels of HLA-
DQ (Chen et al., 1984). The HLA-DQ -i-ve adherent cell subset is responsible for
presentation of C. albicans to T cells and is more effective than the HLA-DQ -ve
subset in stimulation of autologous mixed lymphocyte reactions (Gonwa et al., 1983).
Both the HLA-DQ+ve dendritic cells and monocytes are more efficient stimulators of
allogeneic T cells than the HLA-DQ-ve component of adherent cells (Nunez et al.,
1985). Nunez et al. have shown that concomitant expression of HLA-DQ and high
levels of HLA-DR are phenotypic markers of the main stimulatory adherent cell subset.
It is not clear whether these molecules are directly involved in antigen presentation or
whether they are simply markers for the ability to present antigen (Brooks and Moore,
1988). There is also evidence that particular HLA-DQ molecules (HLA-DQwl
expressed on T cells) are involved in the induction of suppressor T cells (Festenstein
and Oilier, 1987), and the activation of suppressor T cells by APCs during the
presentation of Schistosoma japonicum antigen and Streptococcal cell wall antigen to
CD4+ve T cells (Hirayama et al., 1987). Activated T cells which are HLA-DP+ve are
capable of suppressor T cell induction and may provide a negative feedback mechanism
for the cellular immune response (Pawalec etal., 1984).
The class II region of the MHC also contains genes whose products may be proteases
for degradation of peptides, and others which may mediate transport of these peptides
from the cytosol to the endoplasmic reticulum for the association with MHC I
molecules. These particular genes have been named Ham-1, Ham-2, Lmp-2 and Lmp-7
in the mouse or Ringl2, Ring 4, Ring 10 and Ringl 1 in the human (Monaco, 1992).
The products of MHC class III loci include proteins of diverse function such as TNFoc
and p, in addition to components of the complement system (C2, C4A, C4B, Factor B).
Presentation of antigen by macrophages to T cells can only occur if the cells are
histocompatible (Rosenthal and Shevach, 1973). The expression of MHC antigens is a
pre-requisite for the presentation of antigen by any cell, because T cells can only
recognize a complex consisting of the antigen and either an MHC class I or a class II
molecule. The requirement for an association between MHC I or II molecules and
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antigen, to enable that antigen to be presented to a lymphocyte, is called MHC
restriction. In general, CD4+ve T cells are restricted by MHC II molecules (Thomas et
al., 1977) and CD8+ve T cells are restricted by MHC I molecules (Zinkernagel and
Doherty, 1975) but there may be some overlap between the two groups (Braciale, 1987).
1.5 Antigen processing and presentation.
The processing of antigen for MHC I and II restricted presentation is fundamentally
different (Germain, 1986; Bevan, 1987). In general, antigens that are synthesized within
the cell or targeted to the cytosol, such as intracellular pathogenic bacteria and peptides
derived from viruses, endogenous antigens, are presented in the context of MHC I
molecules. Conversely, antigens internalized from the extracellular space, exogenous
antigens, are presented in the context of MHC II molecules, but there are exceptions to
this rule (Unanue, 1992). The site of antigen processing appears to be cytoplasmic and
the interaction of antigen with MHC I molecules appears to occur within the
endoplasmic reticulum (Braciale, 1992). Binding of MHC I to peptide stabilizes MHC
I in its association with p2-microglobulin and is followed by assembly and transport to
the cell surface. Virally infected cells which synthesize viral proteins, present these
proteins to CD8+ve T cells in the context of MHC I molecules (Townsend and Bodmer,
1989; Long and Jackobson, 1989). Viral peptides of 8-9 amino acid residues in length
have recently been shown to bind directly to MHC I molecules (Chen and Parham,
1989; Bouillot et al., 1989; Rotzschke et al., 1990). However, some viral proteins
produced in the cytosol are presented by MHC II at a lower efficiency than those
presented by MHC I (Hackett et al., 1991).
APCs internalize most exogenous proteins into endosomes and break them down into
peptide fragments either in acidic endosomes or in lysosomes. Then the antigen
fragments are linked to MHC II molecules most probably in endosomes, and presented
to CD4+ve T cells (Jenssen, 1990; Unanue, 1992). MHC II molecules become more
stable upon binding with peptide (Germain and Hendrix, 1991). Before MHC II
molecules are expressed on a cell surface, they are associated with an invariant chain
(reviewed by Cresswell, 1992). The invariant chain may protect the antigen-binding site
of MHC II molecules from being saturated with self-derived peptides, before reaching
the cell surface (Teyton et al., 1990). In addition, the invariant chain may facilitate
transport of the MHC/antigen complex out of the endoplasmic reticulum via endosomes
to the cell surface (Lotteau et al., 1991). Antigen processing by LCs correlated with
MHC II biosynthesis and expression of the invariant chain (Pure etal., 1990).
Furthermore, MHC Il+ve fibroblasts which were unable to process or present antigen to
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some T cell hybridomas, gained the ability to do so after experimentally increasing
levels of invariant chains (Stockinger etal., 1989). The precise function(s) of the
invariant chain, however, awaits clarification.
1.6 The T cell response to antigen.
The TCR is a molecular complex on the surface of T lymphocytes that is responsible
for recognition of processed antigen associated with MHC on APCs (Marrack and
Kappler, 1986; Davis and Bjorkman, 1988). The Ti portion of the TCR is the antigen-
specific binding component and is a disulphide linked a/b heterodimer on the majority
of T cells. Non-covalently associated with the Ti heterodimer are the CD3 subunits
(CD3y, CD38, CD3e, CD3£ , CD3r|). Since CD3 subunits have extensive
cytoplasmic tails compared with the Ti heterodimer subunits, they are almost certainly
involved in transducing signals from the cell surface across the cell membrane into the
intracellular compartment (Frank et al., 1990). In addition to the TCR complex, CD4 or
CD8 molecules on the T cell surface may be involved in the interaction with MHC and
antigen on APCs (Emmrich, 1988).
The binding of the TCR complex with MHC and antigenic peptide is, in most model
systems, insufficient to activate T cells. A further group ofT cell surface molecules
appear to co-stimulate T cells that are bound via TCR/MHC-antigenic peptide, enabling
the T cells to become fully activated (fig. 1.8). Some T cell accessory receptor
molecules and their ligands have recently been defined. For example, three receptor-
ligand couplets have been characterized for T cell APC interaction: CD2 and LFA-3;
LFA-1 and ICAM-1; CD28 and B7. It is now clear that T cell activation is a complex
process involving both adhesion and signal transduction. Co-stimulation of T cells can
also be achieved by ligands that are extracellular matrix proteins. Examples of T cell
adhesion receptors for such ligands are members of the VLA or (31 (CD29) subfamily
of integrins.
The binding ofT cells to APCs is followed by production of IL-1 by the APC. IL-1 in
association with antigenic stimulation causes signal transduction through the TCR
complex. This is initiated by calcium ion mobilization and activation of protein kinase
C. IL-2 is then secreted by T cells, which induces the further expression of IL-2
receptors on activated T cells (Koyasu et al., 1991). Binding of IL-2 to receptors on the










1.7 The penetration of skin by UVR
The penetration of UV radiation into skin depends upon its scattering and absorption
(Anderson and Parrish, 1981; Wan, Anderson and Parrish, 1981). The depth of this
penetration is wavelength dependant. Radiation of short wavelength tends to penetrate
tissues less well than that of longer wavelength. This is partly due to the greater
scattering of short wavelength radiation, mainly by non-absorptive particles or molecules
with a size of less than 1/100 of the wavelength. In addition, nucleic acids
and proteins absorb mainly in the UVC and shorter UVB wavelengths so there are
many chromophores available in skin for these wavebands. Very little radiation with
wavelength shorter than 290nm penetrates the epidermis (Bickers, 1989).
Absorption of radiation is more important than scattering in determining the depth of
penetration of UV and visible radiation through the epidermis. Absorption depends on
epidermal thickness and the effectiveness of epidermal chromophores. Radiation which
is absorbed by chromophores, causes excitation of electrons leading to a biological
response. In the epidermis, the major chromophores are proteins containing aromatic
amino acids, nucleic acids, melanin and urocanic acid (UCA; Tabachnick, 1957; Parrish
et al., 1982). Each chromophore has a unique absorption spectrum and tissue
distribution. Since proteins and nucleic acids are present in all cells, their distribution
and concentration is relatively constant throughout the epidermis. However, UCA is
concentrated mainly in stratum corneum. Early studies indicated that human skin has an
absorption maximum at 270-280nm and minimum at 250-260nm, an absorption
spectrum similar to that of proteins (Bachem and Reed, 1930).
Melanocytes are dendritic cells that rest on the basal lamina. They account for
approximately 2% of the total EC population. Melanin is produced in melanocytes by
the conversion of tyrosine by the enzyme tyrosinase to L-DOPA which is further
polymerized and then packaged into melanosomes (organelles of -ljam diameter).
Melanosomes are transferred into neighbouring keratinocytes where their distribution
largely accounts for skin colour. The total amount of melanin, its stability within
keratinocytes and the relative increase in melanin production after UVR are mainly
under genetic control.
Melanin absorbs wavelengths between 250 and 700nm, having the greatest effect on
shorter wavelengths. The total amount of epidermal melanin, therefore, dictates the
degree to which UV radiation can penetrate skin (Everett et al., 1966; Kligman, 1969;
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UROCANIC ACID is derived from the breakdown products of keratohyalin granules,
components of keratinocytes within the stratum granulosum and stratum corneum Scott,
1981; Scott et al., 1982). Keratohyalin granules contain large amounts of the amino
acid histidine. The deamination of histidine by the enzyme histidase (histidine-
ammonia-lyase) occurs particularly in the stratum corneum and the liver, producing
UCA (Baden and Pathak, 1967). In the liver, UCA is further metabolized by the
enzyme urocanase to form glutamic acid which is then excreted in the urine. The
absence of urocanase in stratum corneum results in accumulation of UCA. After
absorption ofUV either in vitro or in mammalian skin, UCA undergoes isomerization
from the naturally occurring trans-isomer to the cfs-isomer (Morrison et al., 1980;
Norval et al., 1989a; Pasanen et al., 1990).
UCA in normal guinea-pig skin, extracted by acid treatment of the skin, is reported to be
responsible for 80% ofUV absorption. The absorption maximum for UCA in vitro is
264nm, whilst isomerization efficiency is greatest at 313nm (Morrison et al., 1984).
Furthermore, an increase in the total concentration ofUCA in skin after irradiation of up
to 2 minimal erythemal doses (MEDs) ofUVR has been reported and is associated with
increased keratinization. Analysis of UCA in successive Sellotape strips of the
epidermis show that the majority is located in the 7 uppermost layers and that 40% of
UCA in the first Sellotape strip of sun-protected skin is in the cfs-isomer. After UVB
irradiation of human skin at a dose of 4 mJ/cm^, the isomerization ofUCA from the
trans - to the cis - form is detected only in the outermost stratum corneum. After a
higher dose ofUVR (32 mJ/cm^) the isomerization of UCA to the cis- form has
reached a 60% level which is detectable throughout the stratum corneum (Norval et al.,
1989a).
Postulated roles for UCA in skin include those of a natural "sun-screening" agent i.e. a
photoprotective substance against actinic DNA damage and, in contrast, a photoreceptor
mediating UV-induced immunosuppression (Zenisek et al., 1955; De Fabo and
Noonan, 1983a,b; Morrison, 1985). The latter role is now supported by a great deal of
experimental evidence (Morrison et al., 1985; Norval et al., 1989b,c). In animal models
cA-UCA mimics many of the effects ofUVB irradiation. For example, painting cis
-UCA onto mouse skin in vivo induces antigen-specific suppressor T cells and prevents
the induction of DH responses (Ross et al., 1986, 1987). Injection of cis - but not trans
- UCA in vivo into mice, suppresses antigen presentation by splenic DCs (Noonan et
al., 1988). The molecular target for cis -UCA may be histamine receptors (Norval etal.,
1990; Palazynski et al., 1992) or DNA, since UCA in vitro can form photoadducts with
DNA (Farrow et al., 1990).
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1.8 Acute effects of UVR on skin
Many mediators are released by ECs following exposure to erythemal doses ofUVR,
including histamine (Hawk et al., 1983), prostaglandin E2 (Mathur and Gandhi, 1972;
Black et al., 1980), prostaglandin F2, D2, prostacyclin and 12-hydroxyeicosatetraenoic
acid (Black, Hensby and Greaves, 1982). Indomethacin, an inhibitor of prostaglandin
synthesis, inhibits the initial stage of UVB-induced erythema (Snyder and Eaglstein,
1974). After 24 hours, prostaglandin levels return to normal and indomethacin has no
inhibitory effects on erythema. Eicosanoids have been implicated as mediators in UVB-
induced inflammation (Punnonen et al., 1987). The secretion of eicosanoid precursors
by cultured keratinocytes, and their incorporation into neutral lipids on epidermal cell
membranes, has been demonstrated after UVB irradiation. UV irradiation has also been
shown to effect the production of a variety of cytokines from both human and murine
epidermal cells (fig. 1.9). The secretion of IL-1, causing the expression of high affinity
IL-1 receptors by keratinocytes (see section 1.9,p33), IL-3, IL-6, TNF a and (3, TGF-a
and p, and GM-CSF are induced by UVR (Schwarz and Luger, 1989). UVR also
induces the production of an inhibitor of IL-1 and a serum suppressor factor with a
molecular mass of 15-50 kDa (Schwarz et al., 1986; Schwarz et al., 1988).
The skin undergoes a number of important changes in response to UVR, that minimize
the damage done by exposure to radiation, protect the organism from future exposures
and repair the damage that has already occurred. The initial response to UVR is damage
resulting in sunburn with the classical signs of erythema, swelling and pain. This is
followed by protective changes including thickening of the epidermis and stratum
corneum, and increased epidermal pigmentation.
The erythemal response to UVR is an indication of increased blood flow caused by
dermal blood vessel dilatation, which becomes visible after a mean increase in cutaneous
blood volume of 38% over normal values in Caucasian skin (Wan, Parrish and Jaenicke,
1983). In human skin erythema begins several hours after UVB exposure, and is
maximal 12-24 hours later.
The erythemal action spectrum can be obtained by plotting the reciprocal of the lowest
dose ofUVR required to induce a defined grade of erythema against the wavelength of
incident radiation. For minimal erythema the most active wavelengths are 250-290nm,
with rapidly decreasing activity above 290nm. Therefore, a thousand times more energy
is required to produce minimal erythema at 320nm as at 290nm. The proportion of
UVA in natural sunlight is much greater than UVB, therefore its contribution to
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erythema is significant. Approximately 15% of the noon-time radiation responsible for
erythema is within the UVA range, and the percentage increases during the later hours
of the day (Frain-Bell, 1985). Resistance to UV-induced erythema is conferred by
pigmentation due to both racial skin colour and, to a lesser degree, tanning (Cripps,
1981).
The first step in the inflammatory process may involve epidermal modification or
damage followed by the release of mediators which diffuse into the dermis, causing
dilatation of blood vessels. Lysosomal damage with the associated release of hydrolytic
enzymes in UV-exposed ECs may play a role in the development of erythema.
However, severely UV damaged cells may sometimes contain intact lysosomes
(Honigsmann, Wolff and Konrad, 1974).
Histological changes are apparent in human skin within 30 mins of UV irradiation
(Gilchrest et al., 1981). Damage to keratinocytes results in their transformation to
"sunburn cells", with brightly eosinophilic cytoplasm and pyknotic nuclei. Intercellular
oedema develops in epidermis, and epidermal cell nucleoli become prominent in cells
which otherwise appear normal. The epidermis thickens in response to UVR due to an
increased mitotic rate. The cytokine TGF-oc has been implicated in UV-induced
epidermal hyperplasia (Murphy etal., 1991).
LCs are also susceptible to UVR. The alterations to LCs as a result ofUVB exposure
are given in section 1.9.
Melanocytes become vacuolated and swollen in response to UVR, but return to normal
within 24 hours. Immediate pigmentation is induced by UVA during UV exposure and
reaches a maximum immediately after irradiation. This response is caused by
transferral of pre-existing melanosomes from melanocytes into keratinocytes and
oxidation ofmelanin (Pathak and Stratton, 1968). Delayed pigmentation (tanning), due
mainly to UVB, occurs within 72 hours of UVR exposure and is caused by increased
numbers of melanocytes and increased melanogenesis.
Dermal endothelial cells enlarge within 30 minutes ofUV exposure, causing the
occlusion of blood vessels. Perivenular oedema is also noted in early erythemal
responses. Perivascular infiltrates accumulate, consisting mainly of mononuclear cells.
The number of mast cells decreases shortly (1-4 hours) after irradiation and within 24
hours returns to normal.
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1.9 Chronic effects of UVR on skin
Solar radiation is an important contributing factor to ageing of the skin (photo-ageing),
giving chronically sun-exposed skin a wrinkled appearance that is similar to that of skin
with naturally occurring age-induced changes. Most of the histological alterations
associated with photo-ageing take place within the dermis. Regular use of sunscreens
containing molecules that absorb UVB may inhibit photo-ageing (Plastow, Harrison and
Young, 1988). Further protection against photo-ageing may be conferred by adding a
UVA filter in sunscreen preparations (Young, 1990). Therefore both UVA and UVB
appear to contribute to the photo-ageing process.
Epidemiological studies have revealed a relationship between long-term cumulative sun
exposure and increased risk of developing squamous cell and basal cell carcinomata.
Malignant changes leading to these two types of skin cancer occur most frequently on
sun-exposed skin and a correlation exists between geographic latitude and the incidence
of skin malignancy (Scotto and Fears, 1987). The correlation between sun exposure
and risk of developing malignant melanoma is less clear. Most types of malignant
melanoma, with the exception of lentigo maligna melanoma, may occur on covered body
sites. However, UV irradiation is also a significant risk factor for the development of
malignant melanoma (Lee, 1982). The prevalence of skin cancer is inversely related to
the degree of melanogenic pigmentation in skin (Doll et al., 1970) and the incidence of
malignant transformation increases with age, which might be due to both the cumulative
dose of UVR and by implication cumulative damage to the skin and decreased
immunological surveillance.
The risk of an individual developing sunlight-associated cancer is probably dependent in
part upon their genetic make-up. Some people are more likely to develop skin
malignancy than others, particularly those with celtic ancestry, light hair and eyes, and
those who freckle rather than tan in response to UVR. The greatest risk factor for
malignant melanoma is a history ofmelanoma in a first degree relative together with a
family history of the dysplastic naevus syndrome (Greene et al., 1987). The dysplastic
naevus is a naevus which contains atypical and hyperplastic melanocytes, and when
many of these naevi occur on an individual, that person is said to have the dysplastic
naevus syndrome. However, the occurrence of such factors is rare, and other factors
may also predispose to melanoma. The most common risk factors associated with
sporadic melanoma appear to be the total number of naevi, presence of freckles and
atypical naevi, and episodes of severe sunburn (Mackie, Freudenberger and Aitchison,
1989).
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The UVB component of sunlight is thought to be mainly responsible for
photocarcinogenesis (Green et al., 1978; Vitiliano and Urbach, 1980). Multiple
smaller doses of UVR may be less carcinogenic than single, large doses. This implies
that some steps of the carcinogenic process can be reversible or repairable (Blum, 1959;
Forbes et al., 1978).
Induction of UV-induced skin neoplasms is probably the result of direct DNA damage
or alteration ofDNA in ECs followed by inaccurate or faulty repair and the release of
free radicals, causing the cells to divide and become unresponsive to normal growth-
regulating factors (Harber and Bickers, 1981; Cerutti, 1985). It appears that DNA
becomes extensively demethylated after UV exposure possibly allowing the expression
of genes which were repressed prior to irradiation (Lieberman et al., 1983). Two-
dimensional electrophoresis of UV-exposed keratinocytes reveal expression of proteins
which are not expressed in normal unirradiated skin. However, these proteins have not
yet been characterized (Kartasova et al., 1988).
One of the effects of UVR may be the induction of lesions in DNA, one example of
which is the cyclobutyl pyrimidine dimer formed by covalent bonding between adjacent
pyrimidine residues on the same strand ofDNA (Patrick et al., 1976) These lesions
may be repaired by a process known as photoreactivation (Setlow and Setlow, 1963).
In this process, pyrimidine dimers are split and the integrity of the DNA is restored by
the action of the photoreactivating enzyme which is activated by visible light (Cook,
1970). The skin condition xeroderma pigmentosum is a rare autosomal recessive
disorder which is characterized by sun sensitivity, cutaneous and ocular abnormalities,
and an associated risk of multiple skin neoplasms which may result at least in part from
faulty DNA repair mechanisms. Cells from patients with xeroderma pigmentosum are
defective in the repair pathways which excise pyrimidine dimers from UV-exposed
DNA. This observation may implicate DNA damage with pyrimidine dimer formation
and faulty or inadequate repair for the induction ofUV-induced human neoplasia
(Kraemer, Lee and Scotto, 1984).
Work with animal models suggests that, under normal circumstances, developing
neoplasms may be detected and eliminated by the immune system. This may perhaps
explain the observation that individuals with suppressed immune responses, such as
organ transplant recipients, who receive immunosuppressive drugs, suffer from
increased incidence of skin tumours (Boyle et al., 1984). However, only chronically
immunosuppressed patients lacking a specific HLA allele appear to exhibit an increased
risk of developing skin cancer (Bouwes Bavinck et al., 1989).
Neoplasia in human skin appears to be associated with alterations in LCs (Sontheimer et
al., 1984; Odling, Halliday and Muller, 1987;Yoshikawa et al., 1990a; Brash et al.,
1991).
Hence UVR may be considered a "complete" carcinogen, since it can be a tumour
initiator, by damaging EC DNA and causing free radical release, and may also be a
tumour promoter, by altering the immune response to tumour antigens. This may lead
to failure of the immune system to recognize tumour antigens and/or to destroy
malignant cells (Kripke, 1983).
1.10 UVB-Induced immunosuppression.
Immunomodulation resulting from cutaneous UVB exposure in both man and
laboratory animals has been intensively studied in recent years. Irradiation of mice with
either high or low doses of UVB results in systemic or local immunosuppression
respectively. These types ofUVB-induced immunosuppression are discussed in the
following sections.
The high dose model of UVB-induced immunosuppression.
Studies relating to the immunological effects ofUVR on the skin, and the immunology
of UV-induced tumourogenesis started with the observation in mice that UV-induced
tumours are strongly antigenic. If such tumours are transplanted into mice of the same
strain (syngeneic), the recipients reject them efficiently (Kripke, 1974). However, in
syngeneic mice immunosuppressed by UVR, such tumours are not rejected but continue
to grow (Kripke, 1977).
UV-induced susceptibility to tumour growth in mice has been intensively investigated.
The wavelengths responsible for tumour susceptibility in albino mice are between 250
and 320nm (DeFabo and Kripke, 1980; Noonan etal., 1981). The susceptibility of
mice to the growth of UV-induced tumours is independant of whether it is administered
in multiple small doses or as a single large dose (DeFabo and Kripke, 1980).
Treating mice with high dose UVR not only interferes with tumour rejection but also
suppresses CH responses, a phenomenon that is independant of the site of irradiation
(Kripke and Fisher, 1976; Jessup et al., 1978). Thus the exposure of mice to high
doses ofUVR appears to suppress systemic as well as local cutaneous immune
responses (De Gruijl and Van der Leun, 1982). It has been demonstrated that transfer
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of splenic lymphoid cells from UV-irradiated mice to normal recipients confers
susceptibility to tumour growth. When T cells are removed from the lymphoid cells,
susceptibility to tumour growth is eliminated (Spellman and Daynes, 1977). The
immunosuppressive effects of lymphoid cells from UV-irradiated mice may therefore be
due to the presence of T cells with suppressor function.
In mice, tumour transplant rejection is associated with the production of tumour-specific
cytotoxic T cells in vitro. Addition ofUVR-induced T cells with suppressor function to
the in vitro cytotoxic reaction, had no suppressive effect (Thorn et al., 1981). Therefore,
the T cells with suppressor function induced by UVR do not appear to act on the
cytotoxic T cells directly. On the other hand, lymphocytes from immunized UV-
irradiated mice reduced the cytotoxic response when restimulated in vitro. It is possible
that these UV-induced T cells with suppressor function might prevent the generation of
secondary cytotoxic memory cells after repeated antigenic stimulation (Thorn, 1978).
The mechanism responsible for UV-induced systemic immunosuppression is poorly
understood, although it has been associated with morphologic and functional changes in
splenic macrophages and the presence of hapten-specific T cells with suppressor
function (Jessup et al., 1978; Noonan et al., 1981). UV-induced alterations in DNA
appear to be an initiating or essential step in producing this type of immunosuppression
(Morison, 1990). In addition, mediators produced by UV-irradiated ECs may also be
involved (see section 1.8).
The evidence just described has been derived from high dose UVB regimens, with
repeated doses of 540 mJ/cm^, which is much higher than doses normally tolerated by
humans. Information concerning the human situation and utilizing lower doses ofUVB
is still relatively scarce.
The low-dose model of UVB-induced immunosuppression
Using a guinea-pig model, it was observed that a 14 day course of relatively low dose
UVB suppresses the induction of CH to the antigen dinitrochlorobenzene (DNCB)
when it was painted onto UV-irradiated skin (Haniszko and Suskind, 1963). These
doses ofUVB did not suppress CH at sites which were not irradiated and were thus
believed to cause local immunosuppression. Since then, both UVB and PUVA have
been shown to partially inhibit the induction of CH to DNCB in the albino guinea-pig
(Morison et al., 1981). UVB-irradiated mice were unable to initiate DH responses to
HSV and certain microorganisms (Howie et al., 1986; Giannini, 1986), whilst induction
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ofDH responses to other microorganisms, BCG and Candida albicans , remained
unchanged, although the number of BCG mycobacteria recovered from the lymphatics
of UVB exposed mice was significantly increased (Jeevan et al., 1992).
In animals UVB suppresses the induction of CH, but enhances the elicitation of CH
responses (Polla et al., 1986). Since the induction of CH would appear to involve
antigen presentation to naive T cells, whereas the elicitation of CH would appear to
involve antigen presentation to antigen-specific memory T cells, UVB may prevent LC
interaction with naive T cells (Streilein et al., 1990; Simon et al., 1992).
The influence of low dose UVB on LCs
Since evidence suggests that LC are crucial APC for the induction of CH, the effect of
low dose UVB on CH may be attributable to loss of LC function. Low dose UV-
induced immunosuppression has been attributed to alterations in LC numbers,
morphology, surface molecule expression and function (Aberer et al., 1981; Lynch et
al., 1981; Iacobelli et al., 1985; Hanau etal, 1985; Simon etal, 1992), and the
appearance of hapten-specific suppressor-inducer CD4+ve CD45RA+ve T cells
(Baadsgaard etal., 1988, 1990). Inflammatory mediators (see section 1.8, p23) and cis-
UCA may play an active role in low dose UVB-induced immunosuppression. However,
both high and low dose models ofUVB-immunomodulation were found to have the
same wavelength dependencies (Noonan and DeFabo, 1990).
The mechanisms by which UV alters the appearance and function of LCs are largely
unknown. LC surface antigen expression may be altered, and LC DNA and/or
membrane damage may be involved (Iacobelli et al., 1985; Koulu et al., 1985; Aberer et
al., 1986).
The effect of low dose UVB on LC function
The administration of very low doses ofUVB (lOOJ/m^ = lOmJ/cm^ once a day for 4
days) prevented the induction of DNCB sensitization and reduced the number of
ATPase +ve LCs in murine skin from 800 cells/mm^ to <50 cells/mm^ (Toews et al.,
1980b). The LCs displayed altered morphology after UVB irradiation: they were
contracted, darkly stained and lacked dendrites. On recovery from UVB, the number of
ATPase +ve LCs returned to normal levels. The number of ATPase +ve LCs in skin
during recovery from UVB was proportional to the capacity of the skin to become
sensitized to DNFB and UVB irradiated skin became specifically unresponsive or
tolerant to a normally immunizing dose ofDNFB.
An in vitro murine model of CH has been developed by culturing andgen-specific T
cells with antigen-pulsed ECs, and measuring the T cell proliferative response (Stingl et
al., 1981). The T cell response was abolished by adding anti-MHC II antibody and
complement to the ECs, which depletes a small fraction, which are probably LCs. When
the ECs were pretreated with UVB at doses of 25-600J/m2 before culture with T cells,
the T cell response to various antigens was diminished in a UV dose-dependent manner.
They concluded that UVB may directly prevent antigen presentation by LCs. Similar
experiments have shown that low dose UVB irradiation of antigen (TNCB)-pulsed
murine ECs in vitro which are then introduced subcutaneously back into mice could
prevent their immunization and cause suppression of the expected CH response (Sauder
etal., 1981).
Intravenous infusion of trinitrophenol (TNP)-pulsed LCs into mice resulted in normal
CH responses, similar to those induced by skin painting with hapten. However, TNP-
LCs that were irradiated with 200J/m2 UVB in vitro prior to infusion, caused
diminished CH responses. When these mice were challenged with the hapten at a later
date, their CH responses were still diminished (Cruz et al., 1989). This low dose UVB
was not cytotoxic to LCs but induced long-term downregulation of CH responses
mediated by LCs the function of which had changed from one that induces an immune
response to one that induces tolerance.
Subsequent work revealed that murine LCs incubated with antigen normally induced the
proliferation of antigen-specific murine CD4+ve T cells, consisting of Thl and to a
lesser extent Th2 (Tiegs et al, 1990; Simon et al., 1990). LCs which had been
incubated with antigen and then UVB irradiated (200J/m2), lost the ability to stimulate
the Thl subset of murine CD4+ve T cells which appear to be responsible for mediating
DH responses, but retained the ability to stimulate Th2 cells (Simon et al., 1990). This
process appears to be due to functional inactivation of Thl cells rather than their
physical deletion, since the Thl cells retained the ability to proliferate in response to
exogenous IL-2 (Simon et al., 1991b).
Thus, low dose UVB appears to deplete the epidermis of LCs in vivo and inhibit the
antigen-presenting function of murine LCs in vitro.
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The mechanism by which low dose UVB alters LCs
Although low dose UVB exposure depletes epidermal LCs in all strains of mice and in
all humans tested so far, UVB-induced impairment of the induction of CH to DNCB in
untanned Caucasian skin has been shown in one study to occur only in approximately
40% of normal humans who are termed "UVB susceptible", whilst 60% display
normal induction of CH to DNCB after UVB exposure and have been termed "UVB
resistant" (Yoshikawa etal., 1990). The incidence of UVB susceptibility in healthy
volunteers in that study was around 30-40%, in contrast to 92% in patients with a past
history of basal or squamous cell carcinoma. Susceptibility to UVB, therefore, might
be a risk factor for skin cancer. However, recent results indicate that UVB resistance
may not exist in humans (Cooper et al., 1992).
Inbred strains of mice show distinctions between "UVB resistant" and "UVB
susceptible" strains which are genetically determined under polymorphic gene control,
despite the fact that T cells with suppressor function are generated universally in mice
after UVB irradiation (Streilein and Bergstresser, 1988; Glass et al., 1990). In mice, at
least two genetic loci govern this trait: Tnf-a and lipopolysaccharide (Lps; Yoshikawa
and Streilein, 1990). Since normal induction of CH could be restored in "UVB
susceptible" strains of mice by treatment with anti-TNF—a antibodies prior to
application of hapten, it is possible that susceptibility to UVB may be mediated by
excessive production or release of TNF-a (Yoshikawa, Kurimoto and Streilein, 1992).
UVB exposure may give rise to local TNF-a secretion by keratinocytes (Kock et al.,
1990). Intradermal injection ofTNF-a or cis-UCA at the site of application of a
contact allergen in mice, prevents the induction of CH, enhances the elicitation of CH
and alters LC number and morphology in a manner similar to that achieved by low
dose UVB (Yoshikawa and Streilein, 1990; Streilein et al., 1990). These effects of
TNF-a and cw-UCA may be specific since they can be abolished with neutralizing
anti-TNF-a antibodies which implies that the effects of cis-UCA may be mediated via
TNF-a. Furthermore, intradermal injection of TNF-a in mice can induce the
accumulation of DCs into draining lymph nodes, and may provide a signal for LC
migration from the epidermis (Cumberbatch and Kimber, 1992a).
However, anti-TNF-a antibodies did not prevent the loss of LC function in vitro
induced by UVB irradiation (Simon et al., 1991c). Thus both TNF-a and UVB can
act as suppressors of LC function but appear to do so via separate mechanisms.
Interpretation of these results requires caution, since the doses of TNF-a and anti-
37
TNF-oc injected into mice in such experimental protocols may bear little resemblance to
those produced in vivo as a result of UVB exposure. Indeed, the amount of TNF-a
produced in human suction blister fluid after a six week phototherapy course was
measured in picogram quantities per ml as compared with the microgram quantities per
ml injected experimentally into mice in the experiments described above (Gilmour et al.,
1993). Furthermore, it is probable that UVB-induced production ofTNF-a in vivo
occurs within the epidermis. Thus intradermal injection of TNF-a may not be an
appropriate model for UVB-induced immunomodulation.
There is also evidence to suggest that altered production of IL-1 might contribute to the
effects of UVB on LC function. Both increased and decreased IL-1 production have
been reported after exposure of ECs to UVB (Ansel et al., 1983; Sauder et al., 1983;
Gahring et al., 1984; Luger, 1986; Kupper et al., 1987). However, the addition of
exogenous IL-1 only partially reconstituted the lymphoproliferative response when
added to cultures of UVB-irradiated APCs in vitro (Sauder et al., 1983). A specific
inhibitor of IL-1 has also been detected in sera of mice exposed to UVB (Schwarz et al.,
1988).
Some studies have suggested that UV-induced alterations in LC morphology, number
and/or phenotype may occur independantly of measurable immunological effects or at
different wavelengths (Morison etal., 1984; Noonan etal., 1984). Nevertheless, LC are
probably central to the development of cutaneous immune responses to antigens
encountered in the epidermis and UV-induced alterations to LC appear to be important
in the low-dose model of immunosuppression. Thus the examination of LC alterations
may be relevant to the understanding of the low dose model of UVB-induced
immunosuppression, and the possible consequences of therapeutic or environmental UV
exposure of human skin.
The effect of low dose UVB on LC surface markers
Many membrane bound or soluble ligands are produced by LCs which appear to be
involved in their optimal binding to and interaction with T cells (see section on
lymphocytes, p 11). UVB-induced alterations in the expression of LC surface molecules
such as MHC II and adhesion molecules, including LFA-1, LFA-3 and ICAM-1, might
play an important role in their functional capacity to activate helper T cells. Therefore
much work has focussed on the modulation of LC surface expression of various
molecules after UVB exposure.
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Studies of UV irradiated animals and humans have generated conflicting results
regarding LC surface MHC II, CD la and ATPase expression. One study demonstrated
an increase in murine MHC II +ve LCs (Nordlund et al., 1981) while most others have
reported decreases in guinea pig, murine and human ATPase +ve, MHC II +ve or CD la
+ve LCs after UV exposure (Zelickson and Mottaz, 1970; Toews et al., 1980b; Lynch et
al., 1981; Hanau etal., 1985; Humm and Cole, 1986; Koulu and Jansen, 1988). The
UV-induced decrease in LC numbers in humans appear to be dose-dependent and vary
according to time after UV exposure (Liu et al., 1987; Koulu and Jansen, 1988). Racial
variation is another factor to be considered, since greater UV-induced LC depletion
occurs in the skin of Celtic subjects than in darkly pigmented skin of aboriginal subjects
(Scheibner et al., 1987).
Human LC surface antigens appear to vary in their sensitivity to the effects ofUVB,
such that surface ATPase activity is more susceptible to UVB radiation than either
MHC II or CD la (Koulu et al., 1985). It has been suggested that surface ATPase
activity on LCs might be reduced after exposure to low dose UVB (Aberer et al., 1981),
and may be altered from a linear to an uneven pattern of staining (Iacobelli et al., 1985).
The significance of this finding is difficult to interpret since the function of LC surface
ATPase activity remains obscure. However, exogenous ATP has been shown to
increase plasma membrane permeability for certain cell types which leads to cell death
(Gordon, 1986). Extracellular ATP may also be a mediator ofT cell mediated
cytotoxicity (Zanovello etal., 1990). LC surface ATPase activity, therefore, may protect
LCs against the potentially damaging effects of extracellular ATP. Indeed, the
susceptibility of keratinocytes and macrophages to exogenous ATP appears to be far
greater than that of LCs (Girolomoni et al., 1992). The UVB-induced loss of LC
surface ATPase might increase their susceptibility to ATP released from other cells
which have been damaged as a result of UVB exposure.
It is possible that the decrease in LC numbers observed following UV irradiation using
light microscopy may not reflect a genuine decrease in LC numbers but simply
diminished expression of the particular surface antigen being utilized to demonstrate
them. Thus the exposure ofmurine or human skin to moderately high doses of UVB
administered over 4 consecutive days caused almost complete disappearance of MHCII
+ve LCs and Thy-1 +ve dendritic ECs. However, ultrastructural examination revealed
that many LCs were still present and were morphologically unaltered, whereas Thy-1
+ve cells were genuinely depleted (Aberer et al., 1981, 1986). Similar results were also
obtained after low dose UVB irradiation of guinea pig or murine skin using ATPase and
MHC II markers (Hanau etal., 1985; Humm and Cole, 1986). This implies that UVR
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may modulate ATPase activity or CD la or MHC II expression on the surface of LCs
which remain in the epidermis, giving the spurious impression of a depletion in LC
number.
A more direct and sensitive method for measuring cell surface molecule expression than
light microscopy is fluorescent flow cytometry, which can be used to measure the
intensity of fluorescent label on the surface of individual cells. Once again, disparate
results have been obtained by different research groups. Fluorescent flow cytometric
studies have demonstrated that exposure of human LCs or peripheral blood monocytes
to UVB or PUVA therapy in vitro may be associated with retention ofMHC II on LCs,
but either depletion or retention ofHLA-DR,-DP, and DQ on peripheral blood
monocytes (Czernielewski etal., 1984; Ashworth etal., 1989b; Pamphilon etal., 1989;
Deeg and Sigarondinia, 1990). In contrast, canine DCs expressed between 30% and
40% less intense MHC II labelling 48 hours post UV irradiation (Aprile et al., 1987),
and the expression of LFA-1 on canine lymph node cells dropped from 95% to 5% as a
result ofUVB and UVC irradiation (Deeg et al., 1987). Other work has revealed that
the increased expression of ICAM-1 by murine LCs in vitro is abrogated by low dose
UV exposure (Tang and Udey, 1991). The depletion of surface ICAM-1 from human
LCs and peripheral blood monocytes by low dose UVB exposure has also been
documented using flow cytometry (Krutmann et al., 1990; Tang and Udey, 1992).
However, the doses ofUVB used in the former study, appear to have been cytotoxic to
LCs when administered in vitro (Tang and Udey, 1992).
Although controversy exists with respect to the exact nature of LC alterations as a result
of UVB irradiation, LC appear to be a target for cutaneous immunomodulation. In the
murine model, it has been suggested that reduced ICAM-1 expression by irradiated LCs
might prevent their co-stimulatory activity for Thl cells (Simon et al., 1992). Naive T
cells, responding to antigen for the first time, include cells with TCRs of much lower
affinity for antigen than the TCR ofmemory T cells. Thus, accessory signals by cell
adhesion molecules and cytokines may be far more important for the activation of naive
T cells than for the activation ofmemory T cells (Byrne et al., 1989). Therefore, the
decreased expression of ICAM-1 on UVB-irradiated LCs may specifically damage the
immune response by naive T cells to cutaneous neoantigens.
Clearly further work is required to establish whether UVB modulates the expression of
LC surface molecules in humans after in vivo irradiation. Little is known about the
differential effects of UVB on the cell surface expression of human MHC II subregion
products, HLA-DP-,DQ and -DR. Discrepancies in results from different research
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groups may be a consequence of doses ofUVR, the timing of examination after
irradiation, or differential modulation of HLA-DP,-DQ or -DR by UVR. It is also
possible that UV alters LC surface molecules qualitatively rather than quantitiatively.
Alternative APCs which mav be involved in low-dose UVB induced
immunosuppression
The evidence given above suggests that LC may be the epidermal targets principally
responsible for the immunological consequences of low dose UVB. However, other
ECs may also contribute to immunomodulation evoked by low dose UVB irradiation,
such as keratinocytes, human HLA-DR+ve/CDla-ve macrophages, murine Thy-l+ve
dendritic ECs, and murine Ia+ve/Thy-l-ve ECs.
In humans, exposure to moderately high (erythemogenic) doses of UVB induces the
appearance of a population of ECs which are HLA-DR+ve, OKM5+ve and CDla-ve
and which may preferentially activate T cells with suppressor-inducer and
suppressor/cytotoxic function (Cooper etal., 1985; Baadsgaard et al., 1987a,b;
Baadsgaard, Fox and Cooper, 1988; Baadsgaard etal., 1990). This raises the
possibility that heterogeneity among MHC Il+ve ECs may exist, both in terms of their
expression of CD la and in their ability to induce or suppress immune responses.
In mice, antigen-bearing Thy-l+ve dendritic ECs suppress CH when introduced into
syngeneic mice intravenously (Sullivan et al., 1986). The immunosuppressive effect of
Thy-l+ve dendritic ECs appears to be unaltered by in vitro low-dose UVB irradiation
(Cruz et al., 1989). After in vivo low dose UVB exposure, antigen-bearing Thy-l+ve
dendritic ECs have been identified in draining lymph nodes, which may inhibit CH
when injected into normal mice (Okamoto and Kripke, 1987). A further population of
murine ECs which are UV-resistant and can activate suppressor T cells are identified by
their expression of MHC II and their lack of Thy-1 expression (Granstein etal., 1987).
In summary, low doses ofUVB irradiation may cause an alteration in LC number,
morphology and/or surface characteristics, so that the presentation of antigen is altered,
resulting in immunosuppression. This immunosuppression prevents the induction of
DH responses to antigens (to contact, tumour or microbial antigens) encountered in the
epidermis. Whether such immunosuppression is the result of an active process
(through the presentation of antigen in a different way, either by LCs or other APCs) or
due to a passive process (through simply bypassing epidermal LC because of their
decrease in number and/or impaired ability to present antigen) is unknown. There are
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several possible explanations of low dose UVB-induced immunosuppression which are
not necessarily mutually exclusive (fig. 1.9):
(1) the initiation of a chain of reactions starting with absorption ofUV irradiation by
UCA.
(2) the loss of epidermal LCs because of their damage or emigration from the epidermis,
or defective LC function in irradiated skin, possibly due to disruption of their DNA or
the structure or function of surface MHC II or adhesion molecules.
(3) the induction of APCs other than LCs, such as human CDla-ve/DR+ve
macrophages, human dermal dendrocytes, murine Thy-l+ve dendritic ECs, or murine
Ia+ve/Thy-l-ve ECs, which may induce suppressor T cells.
(4) the production of immunosuppressive mediators by irradiated ECs.
(5) the UV-induced functional modification or damage to circulating immune cells in the
dermal capillaries directly.
It is possible that UVB-induced immunosuppression may play a physiological role in
preventing immunological reactivity to new (but not necessarily harmful) antigens
produced in the skin as a result of cellular damage by UVB irradiation. This may
prevent the induction of autoimmunity against UVB-induced neoantigens. However,
such immunosuppression might have negative repercussions due to the loss of immune
reactivity to UVB-induced tumour antigens or infectious agents.
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1.11 Aims of the study
The aims of this study were to irradiate human subjects with moderate doses of UVB
radiation, in similar fluences to those used therapeutically in our department and to those
normally experienced in the environment, in order to document UVB-induced changes
to epidermal LCs. As outlined in section 1.10, p35, the effects of UVB on the
expression of LC surface antigens are unclear. Previous studies have not quantified the
expression of surface MHC II or CD la on normal and UVB-exposed LCs, nor have
they documented the variation in expression of these molecules, or examined the
influence ofUVB irradiation on LC surface expression ofMHC II subregion products
(HLA-DP,HLA-DQ and HLA-DR). In addition, the observed changes in LC
morphology after UVB exposure have not been well characterized. Therefore, various
methods were used in this study to clarify the UVB-evoked alterations in:
1) LC number
2) LC morphology
3) LC expression of surface MHC II (pan-MHC II, HLA-DR, HLA-DQ and HLA-
DP) and CD la antigens.
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2.1 Subjects and irradiation schedules.
Nine volunteers were recruited from the Department of Dermatology, University of
Edinburgh. The volunteer group consisted of four women and five men, with skin types
I, II and HI (mean age of 42 years, age range 29-59 years). All volunteers were healthy,
but one volunteer had a history of atopic eczema. Subjects received the standard UVB
regimen for treatment of psoriasis in our phototherapy unit. They were irradiated with
incremental UV doses thrice weekly over a period of six weeks (between August and
December) in aWaldmann 1000 UVB cabinet, lined with 26 Sylvania UV6 tubes (fig.
2.1). The main UV peak of these tubes occurs at a wavelength of 312nm (fig. 2.2). The
UVB output measured in the centre of each of six banks of tubes (a-f, see below) is
recorded in table 2.1.
Table 2.1 The UVB output of the Waldmarin 1000 cabinet
Position within
the UVB cabinet










The initial UVB dose was 37mJ/cm2 which was then increased by 50% and
subsequently by smaller increments to a minimum of 15%. This regime was intended
to be sub-erythemal. If a subject experienced erythema during treatment, the UVB
dose was not increased until the inflammation subsided. The subjects received a total
mean dose of 4.2J/cm2 (range 2.58-5.58 J/cm^), equivalent to a mean of 26 MEDs.
This is a dose normally sufficient to clear stable plaque psoriasis.
During UVB irradiation, subjects wore clothing that exposed only the arms and
positioned their inner arm (a site that is not normally exposed to UV) toward the UV6
tubes (figs. 2.3, 2.4). Between UVB treatments subjects refrained from exposing
themselves to sunlight. The MED was calculated for each subject using a template
consisting of 4 squares, each measuring 2cm2, and irradiating the template positioned
on the inner ami with incremental doses of UVB. The lowest dose of UVB to
produce visible erythema at 48 hours was taken as the MED.
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2.2 Preparation of epidermal samples.
Epidermal sheets were obtained with a suction blister device prior to UVB therapy and
48 hours after completion of UVB therapy (Kiistala and Mustakallio, 1967; Vestey et
al., 1990b). Four sterile cups, each producing five blisters of 5mm diameter, were
attached to a vacuum pump and applied to the flexor aspects of the upper and lower
arms at a suction pressure of 150mm Hg below atmospheric (fig. 2.5). After
approximately two hours dermoepidermal separation had occurred (fig. 2.6).
Confirmation that separation occurred within the lamina lucida of the epidermal
basement membrane was gained by electron microscopy (figs. 2.7 - 2.10). The blister
roofs were removed and divided for immunohistochemical labelling, confocal laser
scanning microscopy and pre-embedding immunogold labelling. One blister roof
from the forearm of each subject was snap frozen in liquid nitrogen, using a
cryoprotectant (OCT), for immunohistochemical staining. In four subjects, a blister
roof was prepared for confocal laser scanning microscopy. The remaining epidermal
samples were incubated in 0.25% trypsin in Hanks buffered salt solution (Ca2+,
Mg2+, and phenol red free; Flow laboratories, Irvine, Scotland) at 37°C for 1 hour for
the purpose of immunogold transmission electron microscopy (TEM). The roofs were
agitated and pipetted gently to form an EC suspension (fig. 2.11). ECs were washed
twice in RPMI 1640 (Flow laboratories), containing 15% heat-inactivated foetal calf
serum (FCS), and twice in RPMI 1640 alone, counted and then, using a
haemocytometer, their viability determined by trypan blue exclusion (always > 80%).
2.3 Measurement of UCA and TNF-a .
In four subjects, suction blister fluid was collected before and after UVB irradiation and
stored at -70°C for UCA and TNF-a analysis. UCA analysis was also performed on
epidermal samples obtained using filter paper discs soaked in 0.1M KOH and applied
to inner forearm, 30 mins, under Finn Chambers (Jansen etal., 1991). Quantification
of total epidermal UCA and the relative concentrations of the isomers was carried out
by reverse phase high pressure liquid chromotography (HPLC; Norval et al., 1988).
HPLC was performed using a Waters 6000A solvent delivery system, a Rheodyne
7125 sample injection valve with a 20|il loop, a Waters M440 UV detector fixed at
254nm, a plotting integrator (Spectra-Physics autolab Minigrator), and a 15x4.6mm
cartridge column (Capital HPLC, Scotland) packed with 5p.m APS hypersil. The
mobile phase was lOmM acetic acid, pH 5, and the flow rate 1.0 ml/min. TNF-a was
measured using an ELISA kit with a quantitative 'sandwich' enzyme immunoassay
technique (Research and Diagnostic Systems, Minneapolis, USA).
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Figure 2.3: The positioning of the inner arm and the clothing worn
during irradiation are demonstrated by Professor Hunter outside the
Waldmann 1000 UVB cabinet.
Figure 2.4: The arm of a subject who had finished the six week course of
UVB phototherapy, showing tanning of the inner arm.
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Figure 2.5: The suction blister device with two
sterile cups attached.
Figure 2.6: Blisters produced by the suction blister
device.
Figure 2.7: Diagram to show the suction blister technique for
obtaining epidermal samples. The suction blister roof is excised by
cutting through the epidermis, as indicated by the zig-zag lines.
SUCTION BLISTER
Figure 2.8: Electron micrograph to show the lower portion of a
suction blister roof. Note that some keratinocytes have become
highly vacuolated (arrows), whereas the Langerhans cell
(arrowhead) and melanocyte (asterisk) appear normal.
Magnification 1,400 x
5 2
Figure 2.9: Keratinocytes at the base of the suction
blister roof show clean dermo-epidermal separation
above the basement membrane.
Magnification 4,000 x
Figure 2.10: Blister floor with melanocyte (asterisk).
The basal lamina (arrowheads) of the basement
membrane is attached to the blister floor.
Magnification 7,600 x
5 3




Briefly, 100(il of the samples and standards (serial dilutions of recombinant TNF-a)
were incubated with buffer in a 96 well microtitre plate coated with murine monoclonal
anti-TNF-a antibody, 2 hours at room temperature. The solutions were aspirated and
the wells washed in buffer three times. Then a polyclonal antibody against TNF-a
conjugated to horseradish peroxidase was added for 2 hours at room temperature, and
the wells were washed three times in buffer. The amount of TNF-a was measured by
a colorimetric reaction. After stopping colour development, TNF-a was detected by
spectrophotometry at 450nm wavelength and the amount calculated from a standard
curve. These measurements were made by Ms. Jill Gilmour, Department of Medical
Microbiology, University of Edinburgh.
2.4 Monoclonal antibodies.
The monoclonal antibodies used in the following experiments are listed in table 2.2.
The monoclonal antibody DA6.231 was used to label HLA-DP, -DQ, and -DR (Guy
et al., 1982), L243 was used to label HLA-DR, B7/21 to label HLA-DP (Watson et al.,
1983), and TU22 to label HLA-DQ (Pawelec et al., 1982). OKT6 monoclonal
antibody was used to label CDla (Murphy et al., 1983). The monoclonal antibodies
against alpha fetoprotein were included in the study as irrelevant control antibodies for
LCs, and have the same isotypes as the LC-specific antibodies.




DA6.231 IfiGl 1/10 K.Guy HLA-DP,DQ,DR
L243 IgG2a 1/10 B.Dickinson HLA-DR
TU22 IgG2a 1/10,000 K.Guy HLA-DQ
B7/21 IfiGl neat K.Guy HLA-DP
OKT6 IgG2a 1/100 B.Dickinson CDla
Anti-AFP IfiGl 1/10 Serotec a-fetoprotein
Anti-AFP IgG2a 1/10 Serotec a-fetoprotein
*=optimal dilutions for both immunocytochemistry and for immunogold labelling.
2.5 Determination of optimal dilutions of monoclonal antibodies.
Optimal dilutions of the antibodies were determined by analysing antibody labelled
ECs in suspension (10^ cells per ml in RPMI 1640 medium) with a fluorescence
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activated flow cytometer and FACScan software (Becton Dickinson, California,
U.S.A.). Tubes containing 0.1 ml of the EC suspension were incubated for 20 mins
with an equal volume of phosphate buffered saline/ 0.01% bovine serum albumin/
0.02% sodium azide/ 20% normal rabbit serum (PBS/BSA/Azide/NRS) at 20°C.
Varying dilutions of primary antibody (0.1ml) in PBS/BSA/Azide/NRS were added
for 30 mins at 20°C, followed by 1ml of PBS/BSA/Azide/NRS. The cells were spun,
the supernatant decanted, and 0.01 ml rabbit anti-mouse IgG, F(ab')2 fraction,
conjugated to fluorescein isothiocyanate (FITC; DAKO,UK) 1:80 added for 30 mins at
20°C. Then 1ml of PBS/BSA/Azide/NRS was added, the cells spun, the supernatant
decanted and the cells were fixed in 1% formaldehyde. The flow cytometer calculated
the mean intensity of fluorescent marker per cell. This value was plotted against
antibody dilution to give the optimal dilutions for the antibodies listed in table 2.2. The
analysis was repeated on four occasions using skin obtained from four patients who
were undergoing breast reduction surgery. These dilutions were used to label ECs in
suspension for immunogold labelling.
2.6 Labelling and enumeration of LC visualized by an immunohistochemical
technique.
Cryostat sections (6|im) were cut perpendicular to the surface of the blister roofs from
the forearm, air-dried, and fixed in acetone for 10 mins. The epidermal sections were
stained by an indirect immunoperoxidase technique with the primary antibodies listed
in table 2.2, at optimal dilutions determined by testing antibody titres on sections
(which were identical to those used for EC suspensions), followed by peroxidase-
conjugated rabbit anti-mouse IgG, diluted 1:20 in 20% normal rabbit serum (NRS) as
the secondary antibody. Sections were incubated in NRS alone as a negative control.
The range of antibodies against CD la and MHC II molecules served as positive
controls for each other. The reaction product was visualized with diaminobenzidine.
Sections were counterstained with Mayer's haemalum. The number of positively-
stained ECs were manually counted within two randomly-selected fields (objective lens
magnification lOx) in each of five sections from all subjects both before and after UVB
irradiation and expressed permillimetre of basal cell plasma membrane, measured by
image analysis (Seescan, Cambridge, England). This metric measurement system was
used because epidermal thickness was increased after UVB irradiation, and would give
a spurious impression of LC depletion per unit area even if no absolute change in LC
number had occurred. All positively-labelled ECs with a cell body in the section were
counted.
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2.7 Confocal laser scanning microscopy.
One blister roof was taken from the forearm of each of four subjects before and after
UV irradiation. One subject donated tissue which was removed by scalpel without
local anaesthetic. The blister roof was incubated in anti-CDla antibody directly
conjugated with FITC, diluted 1:100 in PBS/3% BSA, overnight at 4°C. No fixative
was used in order to prevent any chemically-induced tissue shrinkage. The epidermal
sheet was then washed 3 times, 10 mins each wash, in PBS/BSA and then mounted in
Citifluor antifadent mountant (Citifluor Ltd., London, U.K.). The 488nm line from an
argon ion laser was used to excite FITC. In each sample the total fluorescent area and
the number of LCs were measured in five low power fields by image analysis (using a
Kontron Ibas 20 analyser) before and after exposure to UVB using a Zeiss LSM 10
confocal microscope at an objective lens magnification of 40x and a zoom of 20x
(800x magnification) with sections in the z plane separated by 1 pm. The morphology
of ten CD la+ LCs was examined in each sample. Every cell was optically sectioned
throughout the entire z plane which involved taking a maximum of forty sections at a
magnification of 3200x (40x objective lens with an 80x zoom), sections being
separated by 0.5pm. The sections were superimposed to reconstruct two-dimensional
images which represented the three-dimensional shape of the cells. The first section in
a series of z sections through a cell was always positioned immediately above the cell,
and the sections continued until no more fluorescent marker could be detected. Cell
reconstructions in two dimensions were produced with the confocal laser scanning
microscope and these images were saved onto 20 megabyte cartridge and analysed on
an image analyser (Kontron IBAS 20) for dendrite numbers, lengths, perimeter of the
entire cell, perimeter of the putative cell body, area of the entire cell and area of the
putative cell body. Ten cells from one subject before and after UVB exposure were
reconstructed to make three-dimensional cell images using an image analysis software
package (Software provided by Vital Images Inc., Fairfield, U.S.A., and hardware by
Silicon Graphics, U.S.A.).
2.8 Labelling of EC surface markers for immunogold TEM.
The ECs were prepared from blister roofs, as described above, and resuspended at a
concentration of 10^ ECs/ml prior to a light prefixation with periodate-lysine-
paraformaldehyde. The ECs were then washed in cacodylate buffer (pH 7.4), blocked
with PBS containing 1% BSA, 0.2% azide and 10% decomplemented human AB
serum for 30 mins, and washed in PBS containing 0.1% BSA (PBS-0.1% BSA). The
ECs were then labelled with the primary antibody, diluted in PBS-0.01% BSA, at
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37°C for 30 mins, washed, and incubated with 15 or 30nm gold particles conjugated to
goat anti-mouse IgG (GAM-G15 or GAM-G30, Janssen Pharmaceutica, Beerse,
Belgium), diluted 1:2 in PBS-0.01% BSA, as described previously (De Panfilis et al.,
1990a). After washing in cacodylate buffer, the ECs were fixed and processed for
TEM. Controls consisted of omission of the primary antibody or its substitution with
another antibody of the same isotype (alpha-fetoprotein, IgGl and IgG2a isotypes).
2.9 Processing of ECs for immunogold TEM.
The ECs were fixed in 2% formaldehyde and 2.5% glutaraldehyde in 0.04M cacodylate
buffer, containing 0.05% calcium chloride and 5% sucrose (pH 7.4) and post-fixed in
2% aqueous osmium tetroxide (Karnovsky, 1965). The ECs were then dehydrated in a
graded series of ethanol and embedded in Araldite CY212 (Agar Scientific Ltd., Essex,
England). Ultrathin sections with a pale gold interference colour were cut on a LKB
Ultratome III, post-stained with methanolic uranyl acetate and lead nitrate, mounted on
400 mesh copper grids, then viewed with a Philips EM301 electron microscope at an
accelerating voltage of 60kV (fig. 2.12). A calibration grid with 2160 lines per mm
(Agar Scientific, England) was photographed during each session on the electron
microscope.
2.10 Measurement of section thickness.
The precise thickness of 22 ultrathin sections of pale gold interference colour was
determined. The sections were collected on 400 mesh copper grids and re-embedded at
90° to the original plane of section. They were resectioned and measured directly from
electron micrographs.
The next two sections describe methods for the examination of the distribution of
CD 1 a and MHC II antigens over the surface of individual LCs.
2.11 Quantification of gold label on single ultrathin sections.
Electron micrographs of ten single LC sections for each antibody used in this study
were divided into halves and into quarters. The gold particles on these portions of LC
sections were manually counted and LC plasma membrane length was measured
directly from electron micrograghs using planimetry. The results were expressed as
gold particles per pm LC plasma membrane.
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Figure 2.12: The Philips 301 transmission electron
microscope.
2.12 Quantification of gold label on a series of sections (step-sections) through
single cells.
ECs were prepared before and after UVB irradiation and labelled with anti-CD la and
MHC II antibodies (DA6.231, L243, B7/21, Tu22), followed by GAM-G30. The
distribution of the surface MHC II molecules on individual labelled cells was then
calculated. The number of gold particles per (am plasma membrane was counted in
two to five step-sections through each of fifteen DA6.231+ve, five B/721+ve, five
TU22+ve and five L243+ve LCs and indeterminate cells before UVB and LCs after
UVB irradiation (a total of 60 cells), derived equally from five subjects before and after
UVB irradiation. Step-sections were separated by approximately 1 (am (every 20th
section was examined) and all labelled ECs in that section were photographed at 2,800x
and 5,900x magnifications. Recognition of individual LCs or indeterminate cells in
adjacent step-sections was achieved by comparing neighbouring ECs. The number of
gold particles was counted either manually or with the aid of image analysis and
expressed per |_tm of plasma membrane. The plasma membrane length was measured
either by planimetry of the cell perimeter on electron micrographs or by image analysis.
2.13 Determination of intra-subject variation of surface MHC II expression.
EC suspensions were prepared prior to UVB irradiation and labelled with anti-CD la
and MHC II antibodies (DA6.231, L243, B7/21, Tu22) followed by either GAM-G15
or GAM-G30. During an early stage of the study, GAM-G15 was used as a
secondary antibody after labelling with anti-pan MHC II, DA6.231, solely for analysis
of intra-subject variation of pan-MHC II expression by LCs. It was discovered that the
image analysis system used here could neither accurately count nor separate closely
adjacent 15nm gold particles, but it could do so for 30nm gold particles. Therefore all
measurements of such 15nm gold particle densities were done manually and all
subsequent labelling of EC suspensions was carried out using 30nm gold particles (the
cell surface densities of which could be measured using image analysis). Steric
hinderance may be caused by the use of large (30nm) gold particles conjugated to
secondary antibody and prevent its penetration to the site of primary antibody
attachment on the cell surface. Steric hinderance would thus lead to reduced densities
of large gold particles on cell surfaces compared with densities of smaller gold
particles. Steric hinderance in this study caused by use of 3()nm gold particles may
prevent the detection of absolute numbers of cell surface antigens, but would
presumably be a constant factor for a given size of gold particle, and therefore allow a
comparative quantitative measure of gold particle densities on cell surfaces.
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Single sections through approximately 100 LCs and indeterminate cells from individual
subjects were examined for each antibody (separate subjects for each antibody), to
examine intra-individual variation in expression of these molecules. The same
methods as above were used to determine the surface density of these antigens.
2.14 The effect of UVB on LC or indeterminate cell surface molecule expression.
The influence of a six week course of suberythemal UVB phototherapy on surface
CD la and MHC II expression by ECs from nine subjects was studied. EC
suspensions were prepared from each volunteer before and after UVB irradiation and
labelled with the primary antibodies listed in table 2.2, followed by GAM-G30
secondary antibody. The cell suspensions were processed and sectioned for TEM, and
the number of gold particles per micron plasma membrane determined on five different
LCs or indeterminate cells for each subject before UVB irradiation and five different
LCs per subject after UVB irradiation. All positively labelled cells on a particular grid
were photographed irrespective of whether the cells were partially obscured by grid
bars, with the exception of very small cell portions with less than a quarter of the cell
perimeter visible. Five cells per sample were then picked randomly for analysis.
2.15 A semi-automatic technique for measuring the density of gold label on ECs.
The gold label density on the surface of ECs was measured from the negatives of
electron micrographs mounted on a light box, using an image analyser with an
interactive (semi-automatic) software programme specifically developed by Seescan
pic, Cambridge, Great Britain. This technique involved the automatic counting of gold
particles by the computer, the results of which could be examined and edited manually.
This allowed the operator of the image analyser to override the decision of the analyser,
if, for example, the computer had counted two overlapping gold particles as one, or if
gold particles had been either incorrectly omitted or incorrectly counted. Then the
image analyser automatically measured the cell perimeter in pm, and calculated the
density of gold particles per pm cell membrane.
2.16 Assessment of image analysis: correlation, repeatability and agreement with
a manual technique.
Correlation: The density of gold label on a series of LCs was measured in two ways,
1) manually and 2) using the semi-automatic image analysis technique described
61
above. The two types of measurements were directly plotted to make an initial
assessment of the correlation between them.
Repeatability: A series of fifteen cells were measured on two occasions both
manually and by image analysis. The differences between the two measurements, the
mean difference and the standard deviation of the differences were calculated. We
expect 95% of the differences to vary by less than two standard deviations from the
mean difference. This is the definition of a repeatability coefficient adopted by the
British Standards Institution (British Standards Institution, 1979). The coefficient of
repeatability was calculated for both methods.
Agreement: A statistical comparison was made between the manual and image
analysis methods in order to establish whether the image analysis results were
sufficiently similar to the manual results to be confident of their accuracy (Bland and
Altman, 1986). A correlation coefficient was calculated. A high correlation coefficient
(one that approaches a value of 1) indicates that the results obtained by the two methods
are linearly related. However, this does not necessarily indicate that the methods agree.
Agreement was assessed by examining the differences between the results and
calculating the mean difference (d) and the standard deviation of the differences (s).
The differences were plotted against the mean of the two results in order to highlight
any discrepancies. The values falling between d + 2s and d - 2s were taken as the
limits of agreement (95% of the differences will lie between these two limits). If the
differences vary in a systematic way over the range of measurement i.e. the scatter of
the differences increases as the measurement increases, then the limits of agreement
would be wider than necessary for small measurements and narrower than necessary
for large measurements. A log transformation of the data was performed where the
differences between the measurements were proportional to the mean of the two
measurements.
2.17 Statistics
The two sample t test was used to analyse data derived from the measurements of gold
label density on single LC sections. The analysis of variance (ANOVAR) was used
for statistical analysis of the data regarding UVB-induced alterations in cell
morphology derived from confocal laser scanning microscopy, and LC surface MHC
II expression derived from immunoperoxidase and immunogold labelling. A p value
of < 0.05 was considered significant.
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3.1 Subjects, MED values and UVB doses received
The subject details are recorded in table 3.1. The subjects decided which skin type
category they belonged to according to the system devised by Dr. Fitzpatrick and his
colleagues in Boston, on the basis of their skin reactivity to the sun. In this system,
people with:
skin type I - always burn and never tan;
skin type II - sometimes burn and never tan;
skin type III - never burn and sometimes tan;
skin type IV - never burn, always tan;
skin type V - Asian subjects;
skin type VI - Black African subjects.
Although this system is useful in predicting a person's sun sensitivity, it may not be as
accurate as testing small areas of skin with increasing doses of UVR in order to
determine the MED. This is demonstrated in table 3.1, in which subjects 2, 3, 4, 7 and
9 reported skin types which did not correspond well to the determined MED values.
Table 3.1
subject initials skin MED total UVB total UVB
type (mj/cm^) (J/cm^) (MEDs)
1 MJT II 148 4.1 27.6
2 JPV III 148 3.6 24.5
3 EM II 290 5.6 19.2
4 MJS II 205 5.6 27.2
5 JAAH II 148 5.6 37.7
6 SK I 106 2.6 24.3
7 GCP III 148 2.9 19.6
8 MG III 290 5.6 19.2
9 NH III 106 3.7 35.3
3.2 Optimal dilutions ofmonoclonal antibodies
The optimal antibody concentrations were determined using fluorescent flow
cytometric analysis of labelling on ECs in suspension (described in section 2.5). The
flow cytometer produces a stream of single cells and passes the cells through a laser
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Figure 3.1: Histogram produced by fluorescent flow
cytometric analysis of approximately 10^ epidermal
cells in suspension. The electronic "gates" are
depicted as a box, which excluded the cluster of small
particles of low granularity shown in the bottom left
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beam. The laser is deflected at a forward angle as a result of the cells passing through
the beam, which is proportional to the cell size, and is deflected at a 90° angle, which is
proportional to cell granularity. This information can be used to construct a histogram
and a typical example derived from this work is shown in figure 3.1. The cluster of
material depicted in the bottom left hand corner of this histogram probably represents
small particles, possibly ruptured cells, and was electronically "gated" out. The mean
intensity of fluorescent labelling on positively labelled cells was plotted against the
antibody dilution to give the optimal dilutions. Figure 3.2 shows the results from one
experiment and table 3.2 shows the optimal dilutions. Note from figure 3.2d that
although the optimal dilution of HLA-DP was apparently 1:100, the avidity of this
antibody is very low, and therefore was used neat.
Table 3.2 The optimal dilutions ofmonoclonal antibodies against LC surface
molecules.






3.3 Development of the immunogold labelling technique
Variations in section thickness could influence the gold density measurements, with
labelled cells on thick sections appearing to be more densely labelled than those on thin
sections. Therefore uniformity of section thickness is desirable. Thus the thickness of
sections selected for TEM was initially examined, as described in section 2.10. The
mean thickness of 22 ultrathin sections of pale gold interference colour was found to be
68.15nm +/- 0.73 (standard error), data given in table 3.3. These results indicate that
section thickness has a normal distribution with low standard error. Initially
corrections were made for section thickness for gold label density measurements, but
since the corrections made no significant difference to the result, these were considered
unnecessary in further measurements (see appendix 6, abstract 1).
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Figure 3.2a: Experiment to determine the limiting dilution
















Figure 3.2b: Experiment to determine the limiting dilution











Figure 3.2c: Experiment to determine the limiting dilution
of L243 (anti-HLA-DR) monoclonal antibody









Figure 3.2d: Experiment to determine the limiting dilution
of B7/21 (anti HLA-DP) monoclonal antibody.
mean intensity of fluorescence
per epidermal cell
92-
85 -1 1 1 ' 1 ' 1 1 1 ►
neat 1:1 1:10 1:100 1:1000
antibody dilution
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Figue 3.2e: Experiment to determine the limiting dilution
of TU22 (anti HLA-DQ) monoclonal antibody.
mean intensity of fluorescence
per epidermal cell
90- I . | i | i | ' i
1:5,000 1:10,000 1:50,000 1:100,000 1:500,000
antibody dilution
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Table 3.3 Measurement of the thickness of ultrathin
sections.
ultrathin section section thickness
(nm)
ultrathin section section thickness
(nm)
1 64.93 12 66.66
2 60.12 13 75.30
3 69.14 14 70.06
4 68.53 15 67.90
5 69.44 16 72.84
6 68.84 17 68.84
7 62.53 18 69.14
8 70.95 19 71.60
9 69.14 20 67.90
10 62.96 21 68.49
11 65.43 22 68.49
The distribution of gold label on ultrathin sections through LCs or
indeterminate cells.
Quantification of gold label on the plasma membrane of one section through each of
ten separate LCs, electron micrographs of which had been divided into halves and
quarters, was performed for each monoclonal antibody. The results are given in
appendix 1. The data were analysed by means of two sample t tests. No significant
differences were detected between the measurements on quarter and half cell portions
for any of the antibodies. This result indicates that the gold particle density is uniform
over the surface of a single LC section.
The distribution of gold label on a series of sections (step-sections) through single
cells (LCs and indeterminate cells).
Multiple sections were taken at equal intervals through single LCs and indeterminate
cells (approximately 1 micron separated these step-sections) in order to examine the
surface distribution of CD la and MHC II molecules (fig. 3.3-3.10, table 3.5, appendix
2). The assessment of step-sections through 15 DA6.231+ve, 5 L243+ve, 5 TU22+ve
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Figure 3.3:
a-c) Three step-sections through a single DA6.231+ve (pan MHC
Il+ve) Langerhans cell from unirradiated skin showing the uniformity of
surface MHC II expression. The MHC II is labelled with DA6.231
primary antibody and secondary antibody conjugated to 30nm gold
particles (arrows). Note the absence of labelling on neighbouring
keratinocytes. d) Birbeck granules (arrowheads) within the Langerhans
cell cytoplasm (inset from figure 3.3c).
Magnification a-c) 8,850 x
Magnification d) 37,800 x
7 4
Figure 3.4:
a-c) Three step-sections through a single DA6.231+ve (pan MHC
Il+ve) Langerhans cell from UVB-irradiated skin showing the
expression of a similar density of surface MHC II as that demonstrated
on the surface of the control unirradiated Langerhans cell (see figure
3.3). The MHC II is labelled with DA6.231 primary antibody and
secondary antibody conjugated to 30nm gold particles (arrows). Note
that the Langerhans cell has a normal ultrastructural morphology, d)
Birbeck granule (arrowhead) within the Langerhans cell cytoplasm (inset
from figure 3.4b).
Magnification a-c) 9,100 x
Magnification d) 38,700 x
7 5
Figure 3.5:
a-c) Three step-sections through a single L243+ve (HLA-DR+ve)
Langerhans cell from unirradiated skin. The cells are labelled with
L243 primary antibody followed by a secondary antibody conjugated to
30nm gold particles. Note the uniform distribution of gold label over
the cell surface, d) A Birbeck granule (arrowhead) is present within
the Langerhans cell cytoplasm (inset from figure 3.5b).




a-c) Three step-sections through a single L243+ve (HLA-DR+ve)
Langerhans cell from UVB-irradiated skin , labelled with L243 primary
antibody and secondary antibody conjugated to 30nm gold particles, d)
A Birbeck granule (arrowhead) is present within the Langerhans cell
cytoplasm (inset from figure 3.6c).
Magnification a-c) 10,700 x
Magnification d) 36,500 x
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Figure 3.7:
a-c) Three step-sections through a single TU22+ve (HLA-DQ+ve)
Langerhans cell from unirradiated skin. Surface HLA-DQ is labelled
with TU22 primary antibody and a secondary antibody conjugated to
30nm gold particles. Note the sparse but uniform distribution of gold
particles over the cell surface, d) Birbeck granules (arrowheads) are
present within the cytoplasm of the section shown in figure 3.7c.
Magnification a-c) 8,400 x
Magnification d) 28,000 x
7 8
Figure 3.8:
a-c) Three step-sections through a single TU22+ve (HLA-DQ+ve)
Langerhans cell from UVB-irradiated skin. The HLA-DQ is labelled on
the cell surface by TU22 primary antibody and a secondary antibody
conjugated to 30nm gold particles, d) Birbeck granules (arrowheads)
within the Langerhans cell cytoplasm (inset from figure 3.8c).
Magnification a-c) 8,200 x
Magnification d) 26,650 x
7 9
Figure 3.9:
a-c) Three step-sections through a single B721+ve (HLA-DP+ve)
Langerhans cell from unirradiated skin showing the surface distribution
of HLA-DP labelled with B721 primary antibody and secondary
antibody conjugated to 30nm gold particles, d) Birbeck granules
(arrowheads) near the surface of the Langerhans cell (inset from figure
3.9c).
Magnification a-c) 9,200 x
Magnification d) 36,800 x
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Figure 3.10:
a-c) Three step-sections through a single B721+ve (HLA-DP+ve)
Langerhans cell from UVB-irradiated skin showing the surface
distribution of HLA-DP labelled with B721 primary antibody and
secondary antibody conjugated to 30nm gold particles, d) Birbeck
granule (arrowhead) within the cell cytoplasm (inset from figure 3.10c).
Magnification a-c) 8,700 x
Magnification d) 34,800 x
8 1
and 5 B721+ve LCs before and after UVB irradiation, showed that the density of gold
label varied little between sections through a single cell. Gold particles appeared to be
evenly distributed over the LC surface, with small standard errors. There was no
evidence for clustering or capping of these surface molecules on either unirradiated LCs
or indeterminate cells or UVB-exposed LCs.
Table 3.5 The mean density of surface MHC II on step-sections through 15
separate DA6.231 +ve LCs or indeterminate cells before and after a standard 6
week course of UVB radiation.
pre UVB post UVB
LC ep/um SEM n* ep/um SEM n*
1 3.52 0.48 3 5.14 0.32 3
2 4.35 0.36 3 5.74 0.29 3
3 4.69 0.21 3 6.22 0.42 4
4 4.82 0.27 4 6.48 0.40 3
5 5.47 0.24 3 7.03 0.37 3
6 6.21 0.44 3 7.44 0.61 3
7 6.83 0.31 3 7.63 0.18 3
8 6.95 0.61 3 8.17 0.15 3
9 8.16 0.17 3 8.47 0.20 3
10 8.16 0.44 5 11.45 0.83 3
11 8.69 0.26 3 12.49 0.36 3
12 9.36 0.53 3 13.14 0.45 3
13 11.26 0.36 3 13.97 0.63 3
14 13.94 0.75 3 14.16 0.45 3
15 15.56 0.69 4 23.40 1.80 3
*n = number of sections per LC/ indeterminate cell
3.4 Assessment of the semi-automatic method for counting gold particles on the
plasma membrane using image analysis.
The measurements of gold particle densities on ECs using a semi-automatic image
analysis method were compared with manual measurements. The correlation between
the semi-automatic and the manual measurements was initially assessed visually by
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plotting them against each other and including the line of equality in the graph (fig.
3.11). The correlation coefficient (r) was calculated to be 0.91 and demonstrates that
there is a high correlation between the two methods. However, it would be unusual if
two methods designed to measure the same quantity were not related. The two sets of
data were compared using a two sample t test, and the p value was 0.05>p>0.02,
indicating no significant difference. This result does not necessarily imply that the
measurements derived from the two methods agree. Perfect correlation occurs if the
points in our graph lie along any straight line, but perfect agreement only occurs if the
points lie on the line of equality.
The agreement between the two methods was determined by analysing the differences
between the measurements. The differences between the methods were then plotted
against the mean measurement (fig. 3.12). The mean difference between
measurements (manual - image analysis) was 0.3 gold particles/|im and the standard
deviation was 1.4 gold particles/fim. Since the mean values obtained manually and by
image analysis were found to be 4.4 and 4.1 respectively, the mean difference of 0.3
gold particles/(im represents a value of less than 10% of the mean measurement.
Confidence intervals (95%) were derived from these data by calculating the mean
difference plus or minus two times the standard deviation. The 95% confidence
interval was between the values of 3.1 and -2.5, indicating that approximately 95% of
the image analysis-derived measurements will have a value of between 3.1 gold
particles/pm above and 2.5 gold particles/jam below that derived manually. The values
plotted in figure 3.12 demonstrate that the scatter of differences increases with
increased density of gold particles. The differences in measurements therefore appear
to be greater than the actual ones for small values and less than the actual ones for large
values. Analysis of log-transformed data may remove these systematic variations in
the data. The log-transformed data reveal that 95% of the image analysis
measurements will have values between 24% below and 41% above the manual ones.
Repeatability was examined by taking paired measurements by both methods on a
series of fifteen cell sections (method outlined in section 2.15). The mean and standard
deviations of the differences were calculated for each method and used to determine the
repeatability coefficient. If we assume that the mean difference is zero, then the
differences squared and summed, divided by n gives the square of the standard
deviation. Table 3.6 gives the repeated measurements and table 3.7 gives the means
and standard deviations of the differences and thus the repeatability coefficients for data
obtained by the two methods. The repeatability coefficients are similar, with a lower
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repeatability coefficient for the image analysis measurement system than for the
manual one.
In conclusion, although the agreement between the two methods was not excellent, the
repeatabilities were similar which is important if the systems are to be comparable. In
addition, the image analysis method was much quicker than the manual one and was
therefore adopted for most gold particle density measurements.
84
Fig. 3.11: Graph to compare the manual and semi-automatic









Figure 3.12: The mean of the two gold particle density
measurements plotted against the difference between them.
difference between manual
and semi-automatic measurements
ofgold particles per micron cell
membrane
mean of the manual and the
semi-automatic measurements
ofgold particles per micron cell
membrane
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Table 3.6 Repeated gold label density measurements on 15 LC or indeterminate









1 17.57* 17.76 14.40 14.11
2 6.31 6.43 5.73 6.51
3 8.28 7.22 6.13 6.16
4 11.76 10.62 9.67 9.14
5 0.56 0.58 0.69 0.58
6 9.87 11.17 7.28 7.91
7 11.41 12.77 9.55 10.51
8 5.66 5.43 6.02 6.60
9 5.31 5.06 3.67 3.74
10 0.82 0.82 0.81 0.86
11 0.51 0.53 0.35 0.42
12 0.61 0.66 0.43 0.50
13 0.49 0.48 0.41 0.46
14 4.04 4.16 3.13 2.98
15 2.61 2.60 2.12 2.12
* measurements are expressed as gold particles/micron plasma membrane.
Table 3.7 The means and standard differences of repeated measurements given
in table 3.6.
manual image analysis
mean difference -0.03 -0.1
sd of differences 0.64 0.49
repeatability coefficient 1.28 0.98
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4.1 The number of CDla+ve, pan MHC Il+ve, HLA-DP+ve,-DQ+ve, and -DR
+ve cells in human epidermis.
The number of CDla+ve ECs and the percentage area of CD la label in epidermal
sheets from four subjects were determined using confocal laser scanning microscopy
(see section 2.7, table 4.1, fig. 4.1).
Table 4.1 The mean number ofCDla+ve ECs and the mean percentage labelled
area in 5 low power fields of epidermis.





SK 1030 54.6 5.6 0.6
GP 858 44.8 6.8 0.5
MG 302 18.0 2.0 0.3
NH 324 29.1 3.0 1.2
* standard error of the mean.
The numbers ofCDla+ve, DA6.231+ve, L243+ve, B7/21+ve and TU22+ve ECs
were counted in vertical sections through epidermis (see sections 2.6, table 4.2,
appendix 3 and figs 4.2-4.9). There was a small number of MHC Il+ve non-dendritic
ECs which were readily identified as cells of the acrosyringium and were not counted.
In general the CDla+ve cell counts were greater than the DA6.231+ve cell counts,
although statistical analysis revealed no significant differences between these values.
However, HLA-DR labelling usually revealed fewer positive cells than those detected
by either CD la or pan MHC II labelling, but greater than those detected by HLA-DQ
or HLA-DP labelling (although HLA-DQ positivity was not detected in two of nine
subjects which were labelled using the immunoperoxidase technique). Statistical
analysis showed significant differences between the numbers of antibody labelled ECs,
such that the number of pan MHC Il+ve and CDla+ve ECs > HLA-DR+ve ECs >
HLA-DQ+ve ECs > HLA-DP+ve ECs.
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Figure4.1ILangerhans cells within an epidermal sheet labelled
with OKT6 (anti-CDla) antibody directly conjugated to fluorescein
isothiocyanate.
Magnification 2,700x
Figure 4.2: Vertical section through a suction blister-derived
epidermal sheet labelled without a primary antibody (control) using
the immunoperoxidase method. The sections shown in figures 4.2-
4.7 are all from subject 3.
Magnification 80x
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Figure 4.3 IVertical section through a suction blister-derived
epidermal sheet labelled with OKT6 (anti-CDla) antibody using the
immunoperoxidase method.
Magnification 80x
Figure 4.4: Vertical section through a suction blister-derived
epidermal sheet labelled with DA6.231 (anti-pan MHC II) antibody





Figure 4.5: Vertical section through a suction blister-derived
epidermal sheet labelled with L243 (anti-HLA-DR) antibody using
the immunoperoxidase method. Note that figures 4.2 and 4.5 are
serial sections.
Magnification 80x
Figure 4.6: Vertical section through a suction blister-derived
epidermal sheet labelled with TU22 (anti- HLA-DQ) antibody using
the immunoperoxidase method. Note an absence of HLA-DQ+ve
Langerhans cells in this section.
Magnification 80x
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Figure 4.7: Vertical section through a suction blister-derived




Figure 4.8: Vertical section through a suction blister-derived
epidermal sheet labelled with L243 (anti-HLA-DR) antibody using
the immunoperoxidase method. Note that figures 4.8 and 4.9 are
serial sections from subject 8.
Magnification 80x
Figure 4.9: Vertical section through a suction blister-derived







Table 4.2 The mean number of CDla+ve. pan MHC Il+ve. HLA-DP+ve. HLA-
DQ+ve. and HLA-DR+ve ECs per mm basal cell membrane meaured from five
vertical sections through blister roofs of nine subjects.
subj Monoclonal antibody
CDla pan MHC II HLA-DR HLA-DQ HLA-DP
1 37.38 29.26 21.09 13.18 8.73
(1.95)* (1.75) (1.24) (1.77) (1.01)
2 23.20 19.91 15.50 13.02 10.05
(2.77) (2.67) (1.18) (0.34) (1.68)
3 21.07 23.25 16.31 0 6.83
(1.12) (3.20) (0.68) (0.72)
4 24.75 22.89 16.65 5.72 6.14
(2.77) (1.46) (0.99) (0.60) (0.70)
5 35.76 33.09 19.10 14.03 6.99
(1.68) (1.24) (2.10) (0.90) (0.69)
6 20.62 18.51 17.13 11.39 6.14
(0.96) (1.57) (0.84) (1.68) (0.70)
7 20.28 19.11 20.21 0 11.87
(2.34) (2.04) (0.85) (1.19)
8 21.13 21.82 20.26 16.44 12.93
(2.39) (0.98) (1.50) (1.68) (0.95)
9 14.10 15.91 12.57 4.43 5.90
(1.25) (2.08) (1.03) (0.13) (0.50)
*numbers in parentheses represent the standard errors of the means.
4.2 The morphology of LCs.
Certain aspects of LC morphology in situ were examined with the aid of an image
analyser using images obtained by confocal laser scanning microscopy of CDla+ve
ECs (see section 2.7). The data which relate to LC or indeterminate cell morphology
and which were obtained from two-dimensional reconstructions are given in appendix
5. The graph in fig 4.10 demonstrates a con-elation between the total cell area and the
dendrite area, implying that only a certain proportion of a cell can be extended as
dendrites.
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Figure 4.10: Graph to show the LC dendrite area





The mean cell area, dendrite area, dendrite number, dendrite length, and cell dendricity
(defined as the cell perimeter divided by the putative cell body perimeter) are given in
table 4.3. Examples of cell reconstructions in three-dimensions are given in figs. 4.11
to 4.16. These images show that LCs or indeterminate cells possess dendrites which
appear to extend mainly in the horizontal plane within the epidermal sheet.
Table 4.3 Quantitative analysis of the morphology ofCDla+ve ECs
reconstructed in two dimensions.
cell parameter n=40 mean sem* range
cell area (ftm^) 285 15.5 167-501
dendrite area ((im^) 144 14.5 38-407
dendrite length (|im) 12.7 1.7 1.2-49.1
number of dendrites/cell 5.0 1.9 2-9
dendricity (arbitrary units) 3.4 0.2 1.7-7.4
* standard error of the mean
The ultrastructural morphology of control LCs in suspension was examined. The
morphology of LCs in EC suspension was highly variable with respect to dendricity,
electron density of cytoplasm, presence or absence of long cell surface projections or
'veils' and the shape of the cell section profile. The morphologies of these cells fell
within five main categories:
I Cell round in profile, with microvillous surface.
II Cell round in profile with fewer surface microvilli than type I.
III Cell round in profile with fewer surface microvilli which are long (veils).
IV Cell round in profile with no surface microvilli and some damage to
cytoplasm and/or membranes.
V Cell round in profile with no surface microvilli, an unusually high number of
intracellular vacuoles and BGs, but intact plasma membrane.
Examples of cells with these morphological features are given in figures 5.11-21 (see
pages 124-134).
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Figure 4.11: Three-dimensional reconstruction of a Langerhans
cell in situ viewed from above.
Figure 4.12: The central image is the same as that in figure 4.11, whilst the
surrounding images represent different views of the same cell which would be
seen if the cell was rotated by steps of 30° around its central axis. The images on
the bottom left hand corner and that immediately below the top left hand corner
represent side views of the cell. Note that dendrites do not appear to extend
vertically in the epidermal sheet.
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Figure 4.13: Three-dimensional reconstruction of a Langerhans
cell insitu viewed from above.
%
Figure 4.14: The central image is the same as that in figure 4.13, whilst the
surrounding images represent different views of the same cell which would be
seen if the cell was rotated by steps of 30° around its central axis. The images on
the bottom left hand corner and that immediately below the top left hand corner
represent side views of the cell. Note that dendrites appear to extend laterally




Figure 4.15: Three-dimensional reconstruction of a Langerhans
cell insitu viewed from above.
Figure 4.16: Three-dimensional reconstruction of two neighbouring
Langerhans cells insitu connected by a long, straight dendritic process.
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4.3 The expression of LC and indeterminate cell surface antigens.
Examination of sections through many normal LCs and indeterminate cells from one
subject labelled with anti-pan MHC II monoclonal antibody (DA6.231) and another
subject labelled with anti-CD la monoclonal antibody (OKT6), revealed considerable
variation in surface MHC II and CD la densities between different cells which was
normally distributed. There was no evidence for separate subpopulations of pan MHC
Il+ve or CD la +ve cells expressing a higher or lower level of antigen. No pan MHC
Il-ve or CDla-ve LCs or indeterminate cells were detected (fig. 4.17).
The label density on many sections through HLA-DR+ve LCs and indeterminate cells
from an individual was variable, with differences approaching 45 fold. The frequency
distribution approximated a normal curve but was skewed to the right (fig. 4.18).
There were no HLA-DR-ve cells, but there was one particularly densely labelled cell
(HLA-DR++ve) out of 71 cells examined.
The frequency distribution of label density on HLA-DQ+ve LCs and indeterminate
cells was similar to that of HLA-DR+ve cells (fig. 4.19). The main difference,
however, was the existence of one HLA-DQ-ve cell and three particularly densely
labelled cells (HLA-DQ++ve). The label density on sections through a large number
of different HLA-DQ+ve cells varied up to approximately 80 fold.
In contrast, the variation in label density on sections through HLA-DP+ve LCs and
indeterminate cells was not normally distributed (fig. 4.20). Approximately 5% of
these cells were particularly densely labelled (5 out of 97 cells) with anti-HLA-DP
antibody and approximately 3% were HLA-DP-ve (3 out of 97). There was a variation
in HLA-DP label density on sections through different cells which approached 400
fold.
LCs and indeterminate cells expressed similar densities of all three MHC II surface
antigens, HLA-DP, -DQ and -DR. There was no evidence to support the claim that
indeterminate cells express greater cell surface MHC II antigen densities than LCs









Fig. 4.17 Histogram showing the frequency distribution









Fig. 4.18 Histogram showing the frequency distribution
























Fig. 4.19 Histogram showing the frequency distribution
of surface HLA- DQ density on 95 ECs from subject 3.
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Fig. 4.20 Histogram showing the frequency distribution
of surface HLA- DP density on 90 ECs from subject 2.
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The density of surface CD la, Pan-MHC II, HLA-DP, HLA-DQ and HLA-DR was
quantified semi-automatically on five different positively labelled LC or indeterminate
cell sections from each subject per antibody (for results see table 4.4 and appendix 4).
Table 4.4 The mean number of gold particles per micron plasma membrane on
five CDla+ve. pan MHC Il+ve. HLA-DP+ve. HLA-DQ+ve. and HLA-DR+ve
LCs or indeterminate cells per subject.
subj Monoclonal antibody
CDla pan MHC II HLA-DR HLA-DQ HLA-DP
1 0.90 3.49 2.13 0.40 0.29
(0.45)* (0.33) (1.24) (0.08) (0.08)
2 0.25 4.06 0.09 0.54 0.45
(0.05) (1.13) (0.05) (0.20) (0.13)
3 0.78 6.60 0.23 0.16 0.71
(0.11) (1.29) (0.03) (0.04) (0.14)
4 0.82 5.03 0.12 0.32 0.33
(0.22) (1.24) (0.03) (0.10) (0.13)
5 1.03 5.09 0.39 0.58 1.05
(0.23) (0.94) (0.13) (0.13) (0.16)
6 0.55 6.13 1.13 ND ND
(0.09) (0.47) (0.74)
7 0.99 5.85 0.10 0 ND
(0.06) (0.74) (0.06)
8 0.24 5.33 0.35 ND ND
(0.05) (0.77) (0.11)
9 1.51 4.77 ND ND ND
(0.24) (0.91)
*numbers in parentheses represent the standard errors of the means.
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5.1 The number of CDla+ve, pan MHC Il+ve, HLA-DP+ve,-DQ+ve,-DR+ve
ECs in UVB-irradiated epidermis.
The number of CDla+ve ECs and the percentage area of CDla label were determined
in UVB exposed epidermal sheets using confocal laser scanning microscopy. The
results are given in table 5.1 in which the results of table 4.1 are repeated for ease of
reference.
Table 5.1 The number of CDla+ve ECs and the percentage area of CDla label
a) before and hi after a standard 6 week course of UVB phototherapy.
a)





6- SK 1030 54.6 5.6 0.6
7 - GP 858 44.8 6.88 0.5
8 - MG 302 18.0 2.0 0.3
9 - NH 324 29.1 3.0 1.2
b)





6 - SK 454 37.4 2.4 0.2
7 - GP 226 23.4 4.5 0.6
8 - MG 208 25.6 1.2 0.2
9 - NH 188 21.5 2.3 0.4
* standard error of the mean
Table 5.1 and fig. 5.1 shows that decreased numbers ofCDla+ve ECs and decreased
areas of CDla label were detected within epidermal sheets of four subjects. These
differences proved to be statistically significant (p<0.05).
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Figure 5.1: Langerhans cells within a UVB-
irradiated epidermal sheet labelled with OKT6 (anti-
CDla) antibody directly conjugated to fluorescein
isothiocyanate. Note the depletion of Langerhans




The numbers ofCDla+ve, DA6.231+ve, L243+ve, B7/21+ve and TU22+ve ECs in
vertical sections through UVB-irradiated epidermis were counted (see appendix 3 for
raw data and figs 5.2-5.6). There was a marked reduction of labelled cells in epidermal
sections after the six week UVB phototherapy course, irrespective of the antibody used
to visualize them. The only exception to this observation was found to be a rise in
number ofHLA-DQ labelled ECs in one subject (see appendix 3 and table 5.2). The
data in table 5.2 a) has been copied from chapter 4 for ease of reference.
The intra-individual percentage decrease of labelled EC number measured with all of
the LC specific antibodies were approximately equal, although inter-subject differences
in LC number per mm basement membrane were great. Graphical representations of
the decreases in cell number (labelled with all five LC-specific antibodies) for each
subject demonstrates that the slopes of the lines are similar within each subject (fig. 5.7
a)-i)). The percentage decrease in LC (pan-MHC Il+ve EC) number was weakly
correlated (r=0.46) to the total number ofMEDs of UVB that a subject had received,
but was unrelated to the total number of Joules of UVB that a subject had received (fig.
5.7 j).
Analysis of variance was used to test the statistical significance of the decrease in LC or
indeterminate cell number. The decrease in number of CDla+ve, DA6.231+ve,
L243+ve, TU22+ve and B7/21+ve ECs was shown to be highly significant (p< 0.005
for all antibodies).
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Figure 5.2: Vertical section through a suction blister-derived
UVB-irradiated epidermal sheet labelled with OKT6 (anti-CDla)
antibody using the immunoperoxidase method. The sections shown
in figures 5.2 - 5.6 are all from subject 3.
Magnification 80 x
Figure 5.3: Vertical section through a suction blister-derived
UVB-irradiated epidermal sheet labelled with DA6.231 (anti-pan
MHC II) antibody using the immunoperoxidase method. Note that
figures 5.2 and 5.3 show serial sections.
Magnification 80 x
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Figure 5.4: Vertical section through a suction blister-derived
UVB-irradiated epidermal sheet labelled with L243 (anti-HLA-DR)
antibody using the immunoperoxidase method.
Magnification 80 x
X"* ^
Figure 5.5: Vertical section through a suction blister-derived
UVB-irradiated epidermal sheet labelled with TU22 (anti-HLA-DQ)
antibody using the immunoperoxidase method.
Magnification 80 x
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Figure 5.6: Vertical section through a suction blister-
derived UVB-irradiated epidermal sheet labelled with




Figure 5.7: Graphs showing the drop in numbers ofCDla+ve,
panMHC Il+ve, HLA-DP+ve, HLA-DQ+ve, HLA-DR+ve
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Figure 5.7: Graphs showing the drop in numbers ofCDla+ve,
panMHC Il+ve, HLA-DP+ve, HLA-DQ+ve, HLA-DR+ve






















Figure 5.7: Graphs showing the drop in numbers ofCDla+ve,
panMHC Il+ve, HLA-DP+ve, HLA-DQ+ve, HLA-DR+ve












Figure 5.7: Graphs showing the drop in numbers of CDla+ve,
panMHC Il+ve, HLA-DP+ve, HLA-DQ+ve, HLA-DR+ve
















Figure 5.7: Graphs showing the drop in numbers ofCDla+ve,
panMHC Il+ve, HLA-DP+ve, HLA-DQ+ve, HLA-DR+ve
















Fig 5.7 j) Graph to demonstrate the
correlation between the drop in epidermal
LC numbers and total dose of UVB in MEDs
%drop in number of
pan MHC Il+ve
ECs per mm basal
cell membrane after
irradiation
UVB dose in MEDs
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Table 5.2 The mean number of CDla+ve. pan MHC Il+ve. HLA-DP+ve. HLA-
DQ+ve. and HLA-DR+ve ECs per mm basal cell membrane measured from five




CDla pan MHC II HLA-DR HLA-DQ HLA-DP
1 37.38 29.26 21.09 13.18 8.73
(1.95) (1.75) (1.24) (1.77) (1.01)
2 23.20 19.91 15.50 13.02 10.05
(2.77) (2.67) (1.18) (0.34) (1.68)
3 21.07 23.25 16.31 0 6.83
(1.12) (3.20) (0.68) (0.72)
4 24.75 22.89 16.65 5.72 6.14
(2.77) (1.46) (0.99) (0.60) (0.70)
5 35.76 33.09 19.10 14.03 6.99
(1.68) (1.24) (2.10) (0.90) (0.69)
6 20.62 18.51 17.13 11.39 6.14
(0.96) (1.57) (0.84) (1.68) (0.70)
7 20.28 19.11 20.21 0 11.87
(2.34) (2.04) (0.85) (1.19)
8 21.13 21.82 20.26 16.44 12.93
(2.39) (0.98) (1.50) (1.68) (0.95)
9 14.10 15.91 12.57 4.43 5.90
(1.25) (2.08) (1.03) (0.13) (0.50)




CDla pan MHC II HLA-DR HLA-DQ HLA-DP
1 12.17 10.67 6.56 3.81 2.12
(2.30) (1.87) (0.84) (0.78) (0.42)
2 11.49 11.09 12..29 7.74 3.76
(0.99) (2.53) (2.90) (0.93) (0.41)
3 13.27 16.04 8.31 8.98 6.15
(0.82) (2.52) (0.68) (1.67) (0.58)
4 14.72 9.95 9.79 3.56 4.71
(2.22) (1.63) (3.64) (0.55) (0.94)
5 20.56 12.32 10.82 0.66 2.98
(4.06) (2.07) (0.80) (0.27) (0.84)
6 12.24 8.20 6.51 5.22 2.70
(1.22) (0.81) (1.01) (1.43) (0.54)
7 9.90 7.48 9.74 0 6.41
(1.05) (0.32) (1.23) (1.38)
8 9.29 10.63 8.93 4.49 3.78
(0.74) (1.02) (1.09) (0.84) (0.78)
9 5.98 5.02 5.64 2.31 2.55
(1.21) (0.37) (0.79) (0.41) (0.25)
*standard error of the mean is given in parentheses.
5.2 The morphology of LCs and indeterminate cells in UVB-exposed epidermis.
LC and indeterminate cell morphology in situ was examined and analysed
quantitatively with the aid of an image analyer using images obtained by confocal laser
scanning microscopy. The data obtained from two-dimensional reconstructions is
given in appendix 5, and examples of three-dimensional recontructions of LCs after
UVB exposure are given in figs. 5.8-5.10. Note the reduction in the number of LC
dendrites detected after UVB irradiation.
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Figure 5.8: The central image is a three-dimensional reconstruction of a
UVB-irradiated Langerhans cell and the surrounding images represent different
views of the same cell which would be seen if the cell was rotated by steps of 30°
around its central axis.
Figure 5.9: The central image is a three-dimensional reconstruction of a
UVB-irradiated Langerhans cell and the surrounding images represent different
views of the same cell which would be seen if the cell was rotated by steps of 30°
around its central axis.
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Figure 5.10: The central image is a three-dimensional reconstruction of a
UVB-irradiated Langerhans cell and the surrounding images represent different
views of the same cell which would be seen if the cell was rotated by steps of 30°
around its central axis.
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Various parameters of LC or indeterminate cell morphology in situ within control
epidermis, and in epidermis which has been UVB-irradiated are given in table 5.3. The
data in table 4.3 has been repeated here for ease of reference, for comparison with data
from UVB-irradiated samples.
Table 5.3 Quantitative analysis of the morphology of a) control LCs and
indeterminate cells and b) UVB-irradiated LCs and indeterminate cells
reconstructed in two dimensions.
a)
cell parameter n=38 mean sem* range
cell area (pm^) 285 15.5 167-501
dendrite area (pm^) 144 14.5 38-407
dendrite length (pm) 12.7 1.7 1.2-49.1
number of dendrites/cell 5.0 1.9 2-9
dendricity (arbitrary units) 3.4 0.2 1.7-7.4
b)
cell parameter n=38 mean sem* range
cell area (pm^) 220.3 19.5 71-454
dendrite area (pm^) 93.6 17.7 0-611
dendrite length (pm) 11.5 2.2 1.0-99.9
number of dendrites/cell 3.4 0.3 0-9
dendricity (arbitrary units) 2.9 0.3 1.0-9.8
* standard error of the mean
n = number of cells
The mean cell area, mean dendrite area and mean number of dendrites per cell were all
significantly decreased after UVB exposure. No statistically significant changes were
noted in the mean cell body area, mean length of dendrites or mean dendricity of the
cells after UVB irradiation. However, the range of dendrite lengths was greater after
UVB exposure and the median value for dendrite lengths was decreased in all of the
four cases after UVB irradiation. This indicates that the majority of dendrites were
shorter after UVB exposure, but a minority of dendrites were greatly attenuated.
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The ultrastructural morphology of UVB-irradiated LCs in suspension was examined,
and was found to be similar to that of control unirradiated LCs i.e. highly variable with
respect to dendricity, electron density of cytoplasm, presence or absence of long cell
surface projections ('veils'), and the shape of the cell section profile (figs 5.11-5.21).
However, the morphologies of these cells fell within six main categories; the five
described previously in chapter 4, section 4.2, page 97, and type VI, where the cell is
extremely elongated in profile.
Moreover, the proportions of UVB-exposed LCs in suspension which possessed
ultrastructural morphologies I - V was unaltered when compared with the proportions
of unirradiated LCs and indeterminate cells in suspension (table 5.4). However, 3/200
UVB-irradiated LCs examined had a different morphology compared with LCs prior to
UVB irradiation, and appeared greatly elongated with little evidence of membrane
damage (fig. 5.21).
Table 5.4 Comparison of LC and indeterminate cell ultrastructural morphology
before and after a standard six week course of phototherapy.
Type of morphology Proportion of LCs/ICs within category




























Figure 5.16: UVB-irradiated Langerhans cell in
suspension with type I morphology.
Magnification 12,200 x
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Figure 5.17: UVB-irradiated Langerhans cell in
suspension with type II morphology.
Magnification 14,800 x
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Figure 5.18: UVB-irradiated Langerhans cell in
suspension with type III morphology.
Magnification 20,600 x
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Figure 5.19: UVB-irradiated Langerhans cell in
suspension with type IV morphology.
Magnification 17,900 x
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Figure 5.20: UVB-irradiated Langerhans cell in
suspension with type V morphology.
Magnification 15,900 x
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Figure 5.21: UVB-irradiated Langerhans cell in
suspension with type VI morphology.
Magnification 12,600 x
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Whereas no CDla-ve LCs or indeterminate cells were observed in normal unirradiated
epidermis, a small number ofCDla-ve dendritic cells were detected in epidermis
which had been exposed to UVB irradiation. These cells were present in small
numbers, possessed no BGs or other distinguishing cytoplasmic granules, little
cytoplasm and the distribution of nuclear heterochromatin was similar to that seen in
lymphoid cells. However, the cells also appeared similar in ultrastructure to cells of the
macrophage/dendritic cell lineage (fig 5.22).
After UVB irradiation, some keratinocytes (which did not resemble acrosyringeal
keratinocytes in ultrastructure) were detected which expressed cell surface pan MHC II
(as detected by DA6.231 antibody labelling) in quantities similar to those expressed by
LCs (fig. 5.23). Although no pan MHC Il+ve keratinocytes were observed in normal
unirradiated epidermis, a small group of HLA-DQ+ve keratinocytes, with an
ultrastructure compatible with acrosyringial keratinocytes, were seen in unirradiated
epidermis (fig. 5.24).
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Figure 5.22: A CDla-ve dendritic cell in UVB
irradiated epidermal cell suspension.
Magnification 19,700 x
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Figure 5.23: A pan-MHC II +ve keratinocyte in
UVB-irradiated epidermal cell suspension. The
MHC II molecules are labelled with DA6.231 primary
antibody and secondary antibody conjugated to
30nm gold particles (arrowheads).
Magnification 15,200 x
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Figure 5.24: HLA-DQ +ve keratinocytes with
ultrastructure compatible with that of acrosyringeal
keratinocytes, present in unirradiated epidermal cell
suspension. The HLA-DQ molecules are labelled
with TU22 and secondary antibody conjugated to
30nm gold particles (arrowheads).
Magnification 13,300 x
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5.3 The influence of UVB irradiation on LC surface expression of CDla and
MHC II antigens.
The density of surface CDla, Pan-MHC II, HLA-DP, HLA-DQ and HLA-DR was
quantified semi-automatically on five different LC sections from each subject (for
results see appendix 4 and table 5.5). The data from table 4.4 is repeated in table 5.5 a)
for ease of reference.
Increases in the surface expression of all five molecules were detected. The statistical
significance of these increases were tested and the p values found to be p<0.005 for all
except for the increase in L243 antigen expression which was p<0.05.
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Table 5.5 The mean number of gold particles per micron plasma membrane on
five CDla+ve. pan MHC Il+ve. HLA-DP+ve. HLA-DO+ve. and HLA-DR+ve
LCs or indeterminate cells per subject a) before and b) after a standard six week
course of phototherapy
a) (measurements made on sections of both LCs and indeterminate cells).
subj Monoclonal antibody
CDla pan MHC II HLA-DR HLA-DQ HLA-DP
1 0.90 3.49 2.13 0.40 0.29
(0.45)* (0.33) (1.24) (0.08) (0.08)
2 0.25 4.06 0.09 0.54 0.45
(0.05) (1.13) (0.05) (0.20) (0.13)
3 0.78 6.60 0.23 0.16 0.71
(0.11) (1.29) (0.03) (0.04) (0.14)
4 0.82 5.03 0.12 0.32 0.33
(0.22) (1.24) (0.03) (0.10) (0.13)
5 1.03 5.09 0.39 0.58 1.05
(0.23) (0.94) (0.13) (0.13) (0.16)
6 0.55 6.13 1.13 ND ND
(0.09) (0.47) (0.74)
7 0.99 5.85 0.10 0 ND
(0.06) (0.74) (0.06)
8 0.24 5.33 0.35 ND ND
(0.05) (0.77) (0.11)
9 1.51 4.77 ND ND ND
(0.24) (0.91)
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b) (measurements made on LC sections, not indeterminate cell sections).
subj Monoclonal antibody
CDla pan MHC II HLA-DR HLA-DQ HLA-DP
1 3.20 7.00 0.84 1.06 2.20
(0.36)* (1.94) (0.26) (0.29) (1.18)
2 1.33 4.60 0.95 1.17 1.31
(0.28) (1.79) (0.84) (0.38) (0.71)
3 1.55 9.27 1.58 1.23 1.77
(0.24) (1.49) (0.46) (0.64) (0.69)
4 1.62 6.62 0.59 1.11 1.27
(0.53) (1.13) (0.31) (0.49) (0.53)
5 2.06 11.61 3.94 1.66 3.08
(0.65) (1.46) (1.04) (0.55) (0.79)
6 1.34 5.52 ND ND ND
(0.12) (1.33)
7 1.00 8.50 ND ND ND
(0.29) (1.15)
8 0.38 5.71 ND ND ND
(0.14) (1.24)
9 1.38 6.92 ND ND ND
(0.13) (2.64)
* numbers in parentheses are standard errors of the means.
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5.4 The effect of UVB irradiation on epidermal UCA and on TNF-a levels in
suction blister fluid.
Only four of the nine subjects could be examined with respect to UCA and TNF-a
quantification. The significance of these factors was not appreciated until the study had
progressed to the stage where five subjects had already finished the course of
irradiation and time constraints did not allow recruitment of further volunteers.
Samples of cellotape-stripped epidermis and samples of suction blister fluid were taken
from four subjects before the start of UVB irradiation, and during the course of UVB
irradiation (after four weeks of UVB exposure). The percentage of cis-UCA rose in
both the epidermis and in the blister fluid during the course ofUVB irradiation (see
table 5.6).
Table 5.6 The total UCA and percentage cts-UCA in epidermis and suction
blister fluid before and during a standard six week course of UVB phototherapy.


































ND = not done
n = number of subjects
The standard errors of the means are given in parentheses.
The increase in percentage c/s-UCA during treatment in epidermal samples was
statistically significant (p< 0.05) as was that in suction blister fluid (p< 0.001). The
increases in total UCA in epidermal and suction blister fluid were not statistically
significant.
Three of the four subjects in which TNF-a was measured showed increased levels of
this cytokine during treatment (fig. 5.25).
142
Figure 5.25: TNF-a concentration in suction blister fluid
before and during a six week course ofUVB phototherapy.
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This study has characterized the influence of suberythemal doses of UVB radiation,
similar to those used therapeutically, on human LC morphology, number and surface
antigen expression.
LC morphology was studied in situ in both control and UVB-irradiated epidermis
using confocal laser scanning microscopy. UVB-exposed LCs were found to be less
dendritic than LCs in control, unirradiated skin. The majority of LC dendrites in UVB-
exposed skin were shorter than those in control skin, but a few were greatly attenuated,
giving the appearance of cells in the process of emigrating from the epidermis. After
UVB irradiation, 48 hours after the last irradiation, a reduced number of LCs were
detected using both immunohistochemical and immunofluorescence methods. Great
variation in the density of surface MHC II and CD la antigen expression on LCs was
demonstrated using an ultrastructural immunogold technique. At 48 hours after the last
UVB irradiation, increased surface MHC II and CD la antigen expression was
demonstrated on residual LCs. These results will be discussed in detail in the
following sections.
6.2 Justification of the methodologies used in this thesis.
Immunoelectron microscopy was the method chosen to examine the cell surface
expression of CD la and MHC II antigens and its modulation by UV irradiation. The
technique is very sensitive and allows the examination of the surface expression of
antigens on single cells. However, the size of gold particles conjugated to the
secondary antibodies is critical in determining the density of cell surface gold label,
with small gold particles generally giving higher gold label densities than larger gold
particles due to steric hinderance. Therefore immunogold labelling would not be
expected to give data which reflects the absolute number of antigens on a cell surface,
as if one gold particle were bound to one antigen; but immunoelectron microscopy can
be effectively used to examine the distribution of cell surface antigen and in some cases
to compare gold label densities on cells which have been experimentally manipulated.
If large gold particles which might cause steric hinderance are utilized then alterations in
surface antigen density may not be detectable using immunoelectron microscopy (fig.
6.1).
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Figure 6.1: Diagram to illustrate the principle of
Steric Hinderance.
a) Continous surface antigen labelled with antibody conjugated to small
gold particles (left hand side) and large gold particles (right hand side).
Due to steric hinderance the large gold particles do not allow one antigen
to one antibody labelling.
b) Discrete surface antigen labelled with antibody conjugated to small
gold particles (left hand side) and large gold particles (right hand side).
Here one antigen is labelled by one antibody despite the gold particle
size differences.
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The mean density of immunogold-labelled surface antigen on entire cells can be
estimated mathematically by approximating the cell to a sphere, assuming that one gold
particle is bound to one antigen and that no steric hinderance is occurring. This was
performed previously on B cell lines and panning-enriched LCs (Trucco et al., 1980;
Dezutter-Dambuyant et al., 1984). Others have simply counted the number of gold
particles on LC sections which were sectioned close to their mid-plane in order to get
semi-quantitative data reflecting antigen density on cells labelled by immunogold
electron microscopic techniques (Schmitt et al., 1984; De Panfilis et al., 1991).
A much quicker, but less sensitive method for examination of LC surface antigen
expression would be to analyse the cells using a fluorescence-activated cell analyser.
The fluorescence-activated cell analyser is less sensitive because it would be unlikely to
detect the presence of LCs expressing no surface antigen and may not detect LCs
expressing very low levels of surface antigen. Although it would have been interesting
to compare the two techniques of immunoelectron microscopy and fluorescence-
activated cell analysis, the limiting factor in this study was the amount of suction
blister-derived epidermis volunteers were willing to donate.
Although the overall variation in expression of surface MHC II (HLA-DP,-DQ,-DR)
antigens between different LCs was considerable due to small numbers of outlying
values (see chapter 4, section 4.3), most cells expressed surface densities within a
reasonably narrow range. Because of this and due to the scarcity of LCs in the
irradiated EC suspensions, it was decided to examine five cells per subject in order to
address the question of UV-induced alterations in surface MHC II antigens. However,
the examination of such small numbers of cells may lead to sampling errors. It is
therefore possible that the observed increases in LC surface antigen densities shown in
chapter 5, section 5.3, were simply due to sampling error and that UVB-induced
alterations in cell surface antigen expression may not be detectable using this
methodology. However, the consistency with which this result was shown for all cell
surface antigens examined (for a total of 45 CDla+ve and 45 pan-MHC Il+ve LCs
both before and after irradiation, and for a total of 25 HLA-DP, 25 HLA-DQ, and 25
HLA-DR+ve LCs both before and after irradiation), may give us some confidence in
the result.
No time-sequence studies were performed during the six week phototherapy course,
but a sampling point at 48 hours after the last irradiation was chosen because it was
consistent with a time point in which the nadir in reduction of human LC number
occurred after a single dose of UVB (Koulu and Jansen, 1988). However, single doses
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of UVB may have different influences on human skin when compared to multiple
doses. In addition, it is possible that the timing of LC surface antigen modulation may
precede the 48 hour time point after irradiation sampled here or may include other
surface antigens than the MHC II and CD la antigens studied here. However, at the 48
hour post irradiation time point, immunocytochemical techniques demonstrated that LC
numbers were reduced to approximately 50% of pre-irradiation values. At this same
time point, immunoelectron microscopic techniques were used to demonstrate
increased levels of LC surface MHC and CD la molecule expression. Therefore, the
reduction in LC numbers shown at this time cannot be explained simply by a reduction
or by the absence of LC surface MHC or CD la expression.
6.3 Morphometric methods
Throughout this work there was an attempt to mimimize the sampling errors associated
with the ultrastructural morphometric methods used. For example, the number of
objects projected onto the observation plane is increased when the section thickness is
larger. This is known as the Holmes effect (see figure 6.2). Therefore the estimation
of surface density of objects, such as the gold label density determined on LCs in this
project, may be biased if wide variations in section thickness exist. The thickness of an
ultrathin section may be measured in several ways including the use of an interference
microscope, measurement of folds in the section and direct measurement of re-
sectioned sections.
Interference microscopy is reported to be the most accurate non-destructive method for
precise measurement of ultrathin section thickness (Calverley et al., 1988). The
measurement of the width of folds in a section gives a value which should represent
twice the section thickness (Small, 1968). The principle of the re-sectioned section
method is to transversally resection sections embedded in resin and to measure the
section profiles from electron micrographs (Phillips and Short, 1964). The
demonstration (see chapter 3, section 3.3) that re-sectioned sections of pale-gold
interference colour were relatively uniform in thickness confirms that errors relating to
section thickness were minimal.
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Figure 6.2: Holmes effect due to section thickness
(afterWeibel, 1979).
section section
projection plane projection plane
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The sampling method for LCs and indeterminate cells in suspension was designed to
obtain a random sample without cell size bias. Therefore, all LCs or indeterminate cells
present in a section were photographed irrespective of whether they were partially
obscured by bars of the grid on which the sections were collected. This prevents the
size bias which may occur ifmeasurements arc taken only on cells with their entire cell
perimeter visible, since cells not obscured by grid bars are likely to be smaller than
those partially obscured by grid bars. However, measurements of label density were
not made if the visible portion of the cell appeared to be less than a quarter of the cell
perimeter.
The precise distribution of gold particles on the surface of single LCs and indeterminate
cells was examined in order to determine whether the observed variations in label
density reflected differences within or between cells. Firstly, the cell sections were
divided into small portions (halves and quarters) and the gold label density on them
was quantified. No significant differences in gold label density were detected between
portions of a single section (see chapter 3, section 3.4). Secondly, a small number of
individual cells (LCs and indeterminate cells in control samples, and LCs in UVB-
irradiated samples) were repeatedly sectioned and the gold label density on these step-
sections was measured. The gold label appeared to be evenly distributed over the cell
surface (see chapter 3, section 3.5) and thus any one cell section or portion of a section
(of approximately 1/4 cell perimeter or more) was considered to be representative of
that cell concerning CD la orMHC II density. It was concluded that any variation in
surface label density on sections from separate LCs or indeterminate cells was due to
differences in antigen expression between cells.
6.4 Image analysis
A high correlation, acceptable agreement and similar reproducibility were demonstrated
between manual and image analysis methods for assessing gold particle densities on
LC plasma membrane in the immunogold labelling experiments (see chapter 3, section
3.6). Because of this and because the semi-automatic image analysis method was
faster than the manual one, which allowed the examination of a greater number of
specimens and is therefore statistically advantageous, the image analysis system was
adopted for all gold particle density measurements. The only exception was for the
measurement of 15nm gold particles on DA6.231+ve unirradiated ECs, which were




LCs visualised in situ using light and electron microscopy have been shown to be
dendritic cells which form a discontinuous network (Shelley and Juhlin, 1976; Yu et
al., 1992). The majority of work concerning LC morphology has been performed on
chemically fixed and/or sectioned epidermal samples. Chemical fixation may cause
tissue shrinkage and sectioning may cause mechanical damage.
Confocal laser scanning microscopy in conjunction with image analysis has been used
to examine and quantify features relating to the morphology of both unirradiated LCs
and UVB-irradiated LCs in epidermal samples which were not chemically fixed or
sectioned. Although the epidermal samples used to study LC morphology by confocal
laser scanning microscopy were suction blister-derived, similar results were obtained
with epidermal samples taken by scalpel without anaesthetic (data not shown). This
implies that the suction blister technique did not alter LC morphology.
The results described in this thesis are similar to those obtained in a previous confocal
laser scanning microscopic study of the morphology of acetone-fixed LCs (Yu et al.,
1992). These authors described LCs as large cells with 5-7 long dendritic processes
per cell which did not directly contact adjacent LCs. They measured the mean cell
volume as 213 (im^, and the mean cell density per unit volume as 1.6 x 10^
cells/mm^. The work presented in this thesis demonstrated that unirradiated LCs
possess 2-9 dendrites which extended predominantly in the horizontal plane of the
epidermis and only very occasionally contacted neighbouring LCs. A small proportion
of the adjacent cells which did contact each other might have been dividing, since at
least one interconnecting pair of LCs detected in this study were approximately
spherical and were connected to each other by processes which were unusually broad
and straight.
Another recent application of confocal microscopy was to quantify the total amount of
CD la label in control skin samples and in irritant contact dermatitis reactions
(Scheynius et al., 1992). Although a large decrease in the total epidermal CD la
reactivity was reported after exposure to 80% nonanoic acid, and small decreases after
exposure to 2% or 4% sodium lauryl sulphate, no morphological comparisons were
made between irritant-exposed and normal LCs.
UVB-induced morphological alterations to LCs have often been described (but not
quantified) using immunohistochemical visualization of LCs and conventional light
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microscopy. In one study, the majority of LCs were reported to disappear after
exposure of murine skin to single doses of UVB or PUVA, due to UV-induced cell
damage (Obata and Tagami, 1985). Although 20-30% of UVB-exposed LCs
remained morphologically normal, others were considered to be ultrastructurally
damaged and possessed swollen and ruptured mitochondria and lysosmes. More
severely damaged LCs were highly vacuolar and contained pyknotic nuclei or nuclear
fragments (Obata and Tagami, 1985). In direct contrast, little evidence of LC damage
was observed after mice or guinea pigs received single exposures of low dose UVB
(Humm and Cole, 1986; Hanau et al., 1985) or after humans were exposed to summer
sunlight (Zelickson and Mottaz, 1970). Furthermore, PUVA therapy or low doses of
UVA or UVB caused a small proportion of human LCs to become round, vacuolar
and damaged with cytoplasmic condensation but most remained morphologically
unaltered (Aberer et al., 1981, 1986; Friedmann et al., 1983) and no ultrastructural
evidence of LC death was observed in situ after PUVA therapy (Friedmann et al.,
1983). In one study, human LC dendrites were shorter after UVB or UVA irradiation
(Koulu et al., 1985). In another study, LCs were rounded with short dendrites at 48
hours after UVB irradiation, but thereafter LCs were enlarged with elongated dendrites
(Humm and Cole, 1986 ). Similarly, irradiation of human skin with simulated sunlight
or UVA caused a dimorphism of HLA-DR positive epidermal cells; some were
extremely dendritic and large while others were small and rounded (Scheibner et al.,
1986; Liu et al., 1987). In addition, giant LCs have been seen in the epidermis of
patients undergoing bath PUVA therapy (Tjernlund and Juhlin, 1982). After UV
exposure residual LCs appeared to have enlarged to a degree closely related to the
extent of LC depletion, suggesting a process compensating for the LC loss (Obata and
Tagami, 1985; Juhlin and Shelley, 1979 ; Koulu and Jansen, 1982 ). Quantification of
various morphological parameters of normal and UVB-exposed LCs reconstructed in
two dimensions was achieved in this study (see chapters 4 and 5, sections 4.2 and 5.2).
In addition, qualitative images of LCs reconstructed in three dimensions were
produced. Care must be exercised when interpreting data generated from LCs
reconstructed in two dimensions, however, since dendrites or portions of them which
extend exactly vertically through the epidermis or which lie immediately above or
below the cell body may be indistinguishable.
The main UVB-evoked morphological alterations in LCs noted in the two-dimensional
confocal laser scanning microscopy analysis performed in this study (see chapter 5,
section 5.2), were reductions in the mean cell size, which was due to a reduction in the
mean area occupied by dendrites per LC and a reduced mean number of dendrites per
cell. However, following UVB exposure, some residual LCs retained fewer dendrites,
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which were mainly shortened although some cells possessed one or two dendrites
which were greatly attenuated. This was consistent with a decrease in median dendrite
length and increase in range of dendrite length without significant alteration in mean
dendrite length after UVB irradiation (see chapter 5, section 5.2). The biological
significance of these findings is unclear, but it is possible that the cells with elongated
dendrites might reflect a compensation for the UV-induced reduction in epidermal LC
number. It is also possible that the LCs with attenuated dendrites are LCs which are in
the process of emigrating from the epidermis, and this explanation would agree with
the findings of others in which increased numbers of DCs were observed in the
draining lymph nodes of UVB -irradiated mice (Moodycliffe et al., 1992).
Six different types of ultrastructural morphology of LCs in suspension were evident, as
described in chapter 5, section 5.2. In this study three types of morphology were of
particular interest regarding UVB-induced LC alterations; Types IV, V and VI. The
type IV LC morphology was exemplified by damage to the plasma membrane and/or
damage within the cytoplasm. Since the question of low-dose UVB-induced damage
to LCs is unresolved, it was interesting to note that there were very few LCs with this
morphological type either before or after irradiation and no significant difference in the
number of LCs with this morphological type after irradiation. It is possible that the
experimental procedures necessary to produce EC suspensions were responsible for
the cellular damage seen in LCs with type IV morphology. The LCs with type V
morphology were exemplified by lack of surface microvilli, an unusual number of
vacuoles and BGs, and clumped nuclear heterochromatin. These morphological
features might imply that the cells are mitotic. Although mitosis has been noted
previously after UVB irradiation (Miyauchi and Hashimoto, 1987; Bos, Teunissen,
Kapsengerg, 1988), in this study the number of LCs with this morphological type was
unaltered after UVB irradiation. However, LCs with the type VI morphology in EC
suspensions, which were greatly elongated cells, were detected only after UVB
irradiation. They may represent cells which were compensating for the reduction in LC
numbers by extending enlarged dendrites and thus spanning greater areas of epidermis
or perhaps the more likely explanation is that these LCs were emigrating from the
epidermis. The ultrastructure of these cells suggests that they are identical to LCs with
few but extremely long dendrites which were described using confocal laser scanning
microscopy, but it is unclear whether the morphology of LCs in suspension bear any
resemblance to that in situ . The trypsinization and lengthy processing entailed in the
production of cell suspensions may cause morphological alterations.
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There was little evidence of UVB-induced LC ultrastructural damage in this study.
However, LC damage may be difficult to detect using the pre-embedding immunogold
labelling technique on ECs in suspension, due to the epidermal disruption
(trypsinization) required for production of cell suspensions. The lengthy processing of
ECs involved in immunogold TEM preparation may reduce the chances of retaining
damaged LCs in suspension, because they might be less dense than other ECs and
therefore be erroneously discarded with changes of solution during these processing
procedures. In a recent ultrastructural study of UVB-irradiated LCs in situ, in contrast
to the findings reported here, significant LC damage was documented, although the
expression of MHC II antigens on residual LCs was unaltered (Mommaas etal., 1993)
6.6 LC and indeterminate cell surface expression of pan MHC II, HLA-DP,-
DQ,-DR and CDla antigens.
Using histochemical methods in conjunction with light microscopy or FACS analysis
it has been observed by various authors that more ECs are labelled with anti-CD la than
anti-MHC II antibodies (Harrist et al., 1983), or anti-HLA-DR antibodies (Scheibner et
al., 1986) or that there are three different subsets of human LCs which differ with
respect to their surface expression of CDla and HLA-DR (Czernielewski et al., 1983).
Others have claimed that similar numbers of LCs are detected by anti-CD la, anti-
HLA-DR, anti-HLA-DQ and anti-HLA-DP monoclonal antibodies in human skin or
in oral mucosa (Sontheimer et al., 1986; Crutchley et al., 1989).
The numbers of LCs and indeterminate cells detected using an immunohistochemical
method with anti-CDla and anti-pan MHC II antibodies were similar (see chapter 4,
section 4.1). However, fewer cells were detected by this immunohistochemical
method with anti-HLA-DP, -DQ, and -DR antibodies than with anti- CDla or anti-pan
MHC II antibodies, and these differences were statistically significant. One possible
explanation for this is that only certain proportions of LCs and indeterminate cells
express the HLA-D subregion products, with a small proportion expressing HLA-DP
and progressively larger proportions expressing HLA-DQ and HLA-DR.
Another possible explanation is that some LCs or indeterminate cells may have
expressed levels of certain surface HLA-D molecules which were too low for detection
using an immunoperoxidase labelling technique. This possibility was examined using
the more sensitive quantitative ultrastructural immunogold labelling technique for
measuring cell surface MHC II. The results given in chapter 4, section 4.3 indicate that
most LCs and indeterminate cells express all three HLA-D subregion antigens,
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although surface densities of the antigens may be very low. Therefore, it appears that
most LCs and indeterminate cells constitutively express all three MHC II subregion
products, and that differences in results obtained by different investigators may be due
to variation in methodologies, antibodies or demonstration techniques.
Using the immunogold labelling technique it was shown that the majority of LCs and
indeterminate cells expressed densities of MHC II antigens within a narrow range of
values, but that small numbers of LCs and indeterminate cells were either especially
densely labelled for HLA-DP,-DQ, or -DR antigens or were HLA-DP,-DQ, or -DR
antigen negative. There were great differences between the least and the most densely-
labelled cells (approaching 400 fold differences in the case ofHLA-DP+ve LCs, see
chapter 4, section 4.3, plOl). This raises the possibility that subpopulations ofMHC II
positive cells exist on the basis of such phenotypic heterogeneity. Alternatively, the
frequency distributions of HLA-DP, -DQ or -DR surface densities on LCs and
indeterminate cells may be normal but gready skewed. However, of two subjects in
whom no epidermal labelling with anti-HLA-DQ antibody was demonstrated using an
immunohistochemical technique, one was subsequently shown to possess LCs and
indeterminate cells which expressed HLA-DQ antigens at extremely low surface
densities by ultrastructural immunogold labelling. The other was shown to possess
LCs and indeterminate cells which were completely HLA-DQ negative. The TU22
monoclonal antibody used to demonstrate HLA-DQ is haplotype specific, so one of
nine subjects included in this study appears not to express the haplotype recognized by
the antibody.
LCs and indeterminate cells exhibited a uniform distribution of MHC II over the whole
cell surface before and after UVB irradiation. There have been few previous reports of
the surface distribution of these antigens on ECs by TEM, perhaps because of the
difficulty of producing semi-serial sections (step-sections) through single cells. These
results agree with previous investigations using both TEM and scanning electron
microscopy (Tadini et al., 1988; De Panfilis et al., 1988,1989).
There was no evidence in this study of either capping or clustering of low densities of
MHC II antigens on ECs, as had been suggested previously using an
immunofluorescence technique (Sontheimer et al., 1986). There was also no evidence
for aggregation of HLA-DR gold label on the cell surface of LCs or indeterminate cells,
as has previously been demonstrated by TEM and an immunogold method on EDTA
split skin in situ (Imayama et al., 1992).
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It has been suggested that HLA-DR+ve ECs, including LCs, may be divided into
subsets expressing high or low levels of surface HLA-DR. Indeterminate cells were
described as expressing uniformly high levels of this antigen (Dezutter-Dambuyant et
al., 1984). In this study, no differences in the densities of either pan MHC II, or HLA-
DP, -DQ or -DR were noted between the LCs and indeterminate cells. This provides
further evidence that indeterminate cells may be a sampling phenomenon in which LC
sections which contain no BGs may be mistaken as a separate cell type (Bartosik,
1991).
The MHC II label density on unirradiated LCs and indeterminate cells reveals a greater
density of pan MHC II antigens than the sum of the densities of surface HLA-DP,-DQ
and -DR antigens. This may be because the anti-pan MHC II antibody (DA6.231)
recognizes more than one determinant on the common core of the MHC II molecules,
or that this antibody may have higher avidity than the other anti-MHC II antibodies
used here.
In a study using ultracryomicrotomy and an immunogold labelling technique for the
examination of pan-MHC II, HLA-DR and HLA-DQ expression by LCs in
suspension, immunogold labelling of these molecules was present in cytoplasm,
intracellular vesicles, and on LC surfaces (Vermeer et al., 1988). The presence of
intracellular HLA-DR and HLA-DQ molecules suggests that some degree of recycling
of cell surface MHC II may occur in LCs. The LCs in suspension used in this study
were lightly pre-fixed before antibody labelling, approximately one hour after removal
from the subject and it is possible that some MHC II molecules may have been
recycled from the cell membrane during the period of time before fixation. Recently,
the same investigators used cryo-immunogold techniques to demonstrate surface LC
MHC II labelling, albeit at low levels, which was mainly restricted to dendrites, but the
majority ofMHC II molecules were located within lysosomes and endosomes
(Mommaas et al., 1993; and personal communication, 1994). Therefore they
concluded that LCs in situ do not constitutively express high levels ofMHC II
molecules. They suggested that the isolation of LCs into a suspension, a technique
utilized in this study and one which is commonly used for LC immunogold labelling,
might activate them even within 1 hour of isolation, thereby causing increased MHC II
expression. This would explain the discrepancy between their results and those of
others who have suggested that LCs do constitutively express high surface levels of
MHC II. Whatever the explanation of this difference, it seems reasonable to assume
that, providing the conditions of the preparation are kept constant, as in the study
reported in this thesis, comparisons which have been made are valid.
156
6.7 LC subpopulations
The results reported in chapter 4, section 4.3 may be consistent with the suggestion that
there is a subpopulation of densely-labelled HLA-DR+ve ECs (Dezutter-Dambuyant et
al., 1984). However, the densely-labelled HLA-DR+ve ECs detected in our study only
constituted approximately 1% of HLA-DR+ve ECs, a much lower proportion than that
described previously (which was reported as approximately 25% of HLA-DR+ve ECs;
Dezutter-Dambuyant et al., 1984). The densely-labelled HLA-DR+ve cells reported by
Dezutter-Dambuyant and co-authors were detected by immunofluorescence and cells
were directly counted or assessed by flow cytometry (Dezutter-Dambuyant etal.,
1984). Such methods are probably less sensitive for detecting cells expressing low
levels of surface antigen than the ultrastructural immunogold method used here.
Indeed, a spurious overestimate of densely-labelled HLA-DR+ve ECs might be
expected when using immunofluorescence methods to detect HLA-DR+ve ECS,
because cells expressing very low surface densities of HLA-DR antigen may be below
the level of resolution of this method. There were also small numbers of densely-
labelled HLA-DP and HLA-DQ+ve LCs and indeterminate cells and a small
proportion of HLA-DP and HLA-DQ and HLA-DR-ve LCs and indeterminate cells.
The results reported in this thesis are similar to those of a previous study in which a
subpopulation of intensely MHC Il+ve LCs were detected in murine epidermal sheets
(Schuler et al., 1985a). The question of whether the densely labelled HLA-DR+ve LCs
also express high surface densities of HLA-DP and HLA-DQ has not been addressed
in this study. This could be determined using a double or triple immunogold or
immunofluorescence labelling technique, as has been described previously for various
LC surface antigens (Dezutter-Dambuyant et al., 1985; Sontheimer et al., 1986; De
Panfilis etal., 1988).
Quantitative variation in MHC II expression may play a role in determining the
functional ability of a cell during an immune response (Janeway et al., 1984). DCs
which constitutively express high levels ofMHC II are the main APCs in spleen
(Steinman and Nussenzweig, 1980), and quantitative variation in HLA-DR and HLA-
DQ on plastic-adherent cells of the blood influences T cell activation (Nunez et al.,
1985). Moreover, macrophages which facultatively express la antigens become
excellent APCs after they have been induced to express la antigens by co-culture with
Listeria (Unanue, 1981). It is possible that the epidermal LCs with high densities of
surface MHC II described in this thesis might comprise a functionally distinct subset
with an increased ability to present antigen to T cells.
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Certain functional and phenotypic alterations have been demonstrated after short-term
culture of LCs; these include loss of the Fc gamma receptor type II and BGs, and
increased expression of surface MHC I, MHC II, ICAM-1 and LFA-3 (Witmer-Pack
et al., 1988; Teunissen et al., 1990, 1991). These changes are considered to be similar
to those occurring when LCs "mature" into potent APCs after migration from the
epidermis into draining lymph nodes (Romani et al., 1989). In general, cultured
human and murine LCs are much more efficient than freshly prepared LCs in the
generation of primary allogeneic or autologous T cell proliferation, in the presentation
of haptens to antigen-specific T cells, and the presentation of peptides to T cell
hybridomas (Inaba et al., 1986; Picut et al., 1988; Demidem et al., 1991).
Furthermore, the enhanced presentation of the antigen TNP by cultured LCs was
accompanied by increased expression of MHC II which could be abrogated by
treatment with UVR or cyclohexamide (Shimada et al., 1987). Therefore, increased
MHC II expression by cultured LCs may be accompanied by an increased ability to
present antigen to primed T cells.
Evidence suggests that resident or freshly isolated LCs represent a phenotypically
heterogeneous cell population. Thus, approximately 70% of CDla+ve ECs contained
CD la mRNA and 70% expressed the low affinity receptor for the Fc portion of IgG.
Other subgroups of LCs have been distinguished by their ability to take up L-DOPA
(Warfvinge et al., 1991), by their lectin binding profiles (Schuler et al., 1983;
Nakamura et al., 1990) and by their cell surface expression of CD23, the low affinity
receptor for the Fc portion of IgE (Torresani et al., 1991), CD45RA, an antigen
associated with suppressor-inducer capabilities, (De Panfilis et al., 1990b), CD32, the
low affinity receptor for the Fc portion of IgG (Schmitt et al., 1992), and CD36, a
receptor for thrombospondin and collagen (Taylor et al., 1991). Additional
heterogeneity may exist with respect to LC morphology, as described in section 6.3.
Recently two types of LC have been distinguished within murine epidermis. These LC
types differed with respect to their ultrastructural morphology: type II was shown to
possess BGs within the perinuclear space, whilst type I was devoid of BGs in this
intracellular area. Type II LCs differed from type I LCs in that they included more
rough and smooth endoplasmic reticulum, endosomes, ribosomes and mitochondria,
and were more dendritic than type I LCs (Karas et al., 1992).
It is not known whether the phenotypic heterogeneity of LCs which was noted here is
due to the existence of genuine subpopulations of LCs, or whether such differences
might simply correlate with particular stages of the cell cycle or state of cell activation
(Aiba and Katz, 1990).
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6.8 UVB-induced LC depletion.
The therapeutic doses of UVB used in this study depleted immunoperoxidase-labelled
CD la, pan MHC II, HLA-DR, HLA-DP, and HLA-DQ+ve ECs. The percentage
decrease in CDla+ve and pan MHC Il+ve LC number at 48 hours after the last
irradiation ranged from between 31 and 68%, and was on average 49% for CDla+ve
cells and 55% for pan MHC Il+ve cells. For each subject the percentage LC depletion
was similar, irrespective of the antibody used to demonstrate them. An exception to
this was a rise in number of immunoperoxidase-labelled HLA-DQ+ve ECs in one
subject after UVB irradiation. This was due to an inability to detect any HLA-DQ+ve
ECs prior to UVB irradiation using the immunoperoxidase labelling technique, because
of their unusually low surface expression of HLA-DQ antigen which was below the
level of resolution by the immunoperoxidase labelling method. The presence of HLA-
DQ antigen (albeit at low levels) on these ECs was subsequently demonstrated using
the more sensitive immunogold labelling method. After UVB irradiation, however, the
levels of surface HLA-DQ expression appeared to have increased to the level at which
they could be demonstrated using the immunoperoxidase labelling technique. Thus,
the results gave the spurious impression of increased numbers of HLA-DQ+ve ECs.
There was considerable variation in the percentage drop in LC numbers after irradiation
between different subjects. This was found to be weakly correlated to the total dose of
UVB received when measured in MEDs, but was not correlated to the total number of
Joules/cm^ of UVB that a subject had received (see chapter5, section 5.3).
These results confirm the well-documented LC depletion after irradiation with high and
low dose UVB, UVA, PUVA and sunlight (Zelickson and Mottaz, 1970; Toews,
Bergstresser, and Streilein, 1980b; Lynch et al., 1981; Hanau etai, 1985; Koulu et al.,
1985; Hum and Cole, 1986; Liu etal, 1987; Scheibner et al., 1987; Koulu and Jansen,
1988). However, these results are in variance with the reported increase in MHC n+ve
LCs in mice after UV irradiation (Nordlund et al., 1981). The MHC Il+ve ECs in
Nordlund's study were presumed to be LCs, however this may have been an erroneous
assumption in UV-irradiated skin since the MHC Il+ve ECs may have included other
MHC Il+ve UVB-induced APCs.
It is plausible that the reductions of immunoperoxidase-labelled EC numbers noted in
this study were due to reduced surface expression of all five antigens on LCs and
indeterminate cells, and that the reductions were of a similar magnitude. However, a
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more plausible explanation for the data is that a reduction in LC number had occurred
and not a reduction of surface antigen on LCs which had remained in the epidermis.
Two methods were used to count LCs in this project. One method involved the
quantification of immunoperoxidase labelled LCs in epidermal sections. All labelled
cells with cell bodies in the section (the presence of dendrites was ignored) were
counted and expressed per mm basal cell plasma membrane. The other method
involved counting fluorescence labelled CDla+ve LCs in five low power fields of
epidermal sheets, visualized by confocal laser scanning microscopy. These two
methods gave similar results since the percentage reduction in LC number in vertical
epidermal sections paralleled the percentage reduction in CDla+ve LC number in
epidermal sheets and the percentage reduction of total CD la +ve fluorescence label
after UVB irradiation.
The cause of the decrease in epidermal LC number after the therapeutic UVB treatment
reported here is not clear. The possibilities include alteration in LC surface antigen
expression, LC damage or death, and LC migration from the epidermis. In this study,
little evidence of UVB-induced LC damage or death was obtained (see section 6.3). In
some experimental systems the doses of UVB required to cause immunosuppression
have been shown to be cytotoxic, whilst in others this has not been the case. For
example, doses of UVR which can suppress the mixed skin cell lymphocyte reaction
of human ECs in vitro appear not to be cytotoxic (Czernielewski etal., 1984), but
fluences of UVB which suppress immune responses initiated by murine LCs and
which decrease LC expression of ICAM-1 in vivo are cytotoxic to LCs in vitro (Tang
and Udey, 1992). Whether such doses of UVB administered to LCs in vitro are
similar to UVB doses reaching LCs in vivo has not been established.
An increase in murine DCs has been noted in draining lymph nodes at 42 and 66 hours
after exposure to single doses of UVB. This provides evidence of LC migration from
the epidermis to draining lymph nodes after UVB exposure. The migration appeared
to occur mainly between 12 and 48 hours after irradiation. The mean intensity of la
labelling per cell, however, was unaltered throughout the experiment (Moodycliffe et
al., 1992). Therefore, some evidence exists that UVB may cause LC emigration from
the epidermis in the murine model of UVB-induced immunosuppression. This may
be the cause of the reduction in epidermal LC number after irradiation with UVB.
However, the examination of DCs in draining lymph nodes after UVB irradiation has
revealed surface antigen profiles which may not be consistent with an epidermal origin
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and imply that these DCs might have been macrophages rather than LCs (Kripke et al.,
1992).
6.9 UVB-induced alterations in LC and KC surface antigen expression.
Residual epidermal LCs after UVB phototherapy have been shown in this study to
express increased surface densities ofMHC II and CD la antigens. The mean increase
in LC surface expression of either HLA-DP, -DQ or -DR after UVB treatment
approached ten times in some subjects. There was no consistent pattern with respect to
the magnitude of these increases in expression of CD la or HLA-D subregion products.
These results are in contrast with those of other investigators who have demonstrated
using fluorescence-activated cell analysis and immunoelectron microscopy that no
changes in surface marker expression or ability to present antigen per LC occurred after
PUVA or UVB therapy was administered to healthy human volunteers (Ashworth et
al., 1989b; Mommaas etal, 1993).
The reasons for the observed increases in LC surface MHC II and CD la molecule
expression are unclear, but include:
1) The influence of cytokines produced in the epidermis as a result of UVB irradiation,
such as T cell-derived y-IFN as a result ofminimal inflammation, or EC-derived GM-
CSF and TNF-ot. All of these cytokines may regulate the expression of MHC II (see
section 6.10) and might have caused increased MHC II and CD la expression on
residual LCs.
2) The doses ofUVB irradiation used in these studies may cause total LC depletion,
and then lead to subsequent replacement by LCs which have recently migrated into the
epidermis and which express higher surface densities of MHC II and CDla antigens.
3) UVB irradiation may cause partial LC depletion, perhaps mainly depleting those
cells which express low surface densities ofMHC II and CDla antigens. If this
occurred, there would be a group of residual LCs expressing higher surface antigen
densities.
4) Since the numbers of LCs examined per subject were low, the observed increases in
MHC II and CDla molecule expression may simply be due to sampling errors (see
section 6.9).
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Other investigators have noted increased intensity of fluorescence label on human
CDla+ve or murine MHC Il+ve LCs after irradiation with UV which may have been
due to increased expression of surface antigen (Nordlund et al., 1981; Scheibner et al.,
1987). However, the only other previous attempts to quantify LC MHC II expression
are reported in two recent studies by Mommaas' group, one of which reported no
alteration in MHC II antigen expression by long-term UVB-irradiated LCs in situ
examined using a post-embedding ultracryomicrotomy technique. They reported a
decrease in the mixed epidermal cell -lymphocyte reaction by irradiated ECs, but no
alteration in number of LCs or MHC II expression on LCs after irradiation. It is
interesting that these investigators did not examine the intercellular variation in
expression of MHC II or state the number of LCs examined by ultracryomicrotomy,
and therefore the validity of the conclusions they draw may be questionable
(Mommaas et al., 1993; Van Praag etal., 1994).
The functional implications of an increase in MHC II expression by UVB-irradiated
LCs are unclear. Increased expression of MHC II and CD la antigens by residual LCs,
however, may be accompanied by an increased ability to present antigen to T cells,
which might be compensating to some extent for their depletion. In a previous study,
presentation of HSV antigen in vitro by UVB-irradiated ECs was impaired when
compared to normal ECs (Gilmour et al., 1993). However, this probably simply
reflects a UV-induced depletion in number of LCs. It would be possible to assess the
antigen presentation of UVB-irradiated LCs on a per cell basis if the LCs were
separated out of EC suspension either by antibody panning, centrifugation techniques,
magnetic beads or by using FACS. Although this is a theoretical possibility, the total
number of ECs needed in order to separate out the required number of LCs for
functional analyses would be large. Although this may be feasible in animal
experiments, it may be difficult to persuade human volunteers to participate in such an
experiment.
It would also be interesting to assess the adhesiveness of UV-irradiated and control
LCs to T cells by looking at their ability to form clusters with T cells in vitro, although
this has not been addressed here. The expression of LC surface ICAM-1 appears to be
decreased after low-dose UVB irradiation, but it is unknown whether UVB irradiation
may also influence LFA-3 and B7 expression. The surface expression of these
antigens may influence the way in which LCs can adhere to T cells during antigen
presentation.
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The reason for examining the expression of CD la antigens in this study was to provide
a control antigen for any observed changes in MHC II expression. CD la was chosen
because it shows considerable homology with MHC I and is considered to be similar
to MHC I. Since there is no evidence for alteration in MHC I antigen expression by
UVR, anti-CD la was believed to be an appropriate control antibody. Any alterations in
expression of both CD la and MHC II antigens, might represent non-specific findings.
However, CD 1 molecules may be involved in the interaction between certain T cells
and accessory cells via the TCR-CD3 complex. For example, the mixed epidermal cell
lymphocyte reaction was inhibited by the use of anti-CD la antibodies (Moulon et al.,
1991). Furthermore, the CD1 molecule was induced on monocytes by GM-CSF
(Kasinrerk et al., 1993). In view of this, the observed increase in expression of both
CDla and MHC II after UVB phototherapy (chapter 5, section 5.3) might be expected
since GM-CSF is induced by UVB irradiation and might be of some functional
significance. With the benefit of hindsight, therefore, a more appropriate control
antibody would be one directed against MHC I molecules.
Others have described the retention of HLA-DR and CDla antigens by human ECs
after in vitro UVB exposure using FACs analysis of surface antigens (Czernielewski et
al., 1984). PUVA therapy resulted in depletion of epidermal LCs and reduction of the
alloantigen-presenting capacity of the ECs derived from PUVA treated skin. The
residual LCs from PUVA treated epidermis, however, retained normal fluorescence
labelling with anti-CD la and anti-HLA-DR antibodies and retained in vitro alloantigen-
presenting function on a per-cell basis (Ashworth et al., 1989b).
A decreased expression of some LC surface antigens has been reported after UV
irradiation, such as ATPase activity and the expression of the S-100 protein (Schneider
et al., 1985; Humm and Cole, 1987; Koulu and Jansen, 1988). In the murine model,
UVB irradiation may lead to decreased expression of surface adhesion molecules,
ICAM-1 on LCs and accessory cells of peripheral blood (Krutmann et al., 1990; Tang
andUdey, 1991).
Most unirradiated keratinocytes were CDla and MHC II negative, although occasional
keratinocytes of the sweat gland acrosyringium were MHC U positive. However, after
UVB irradiation some keratinocytes expressed MHC II but did not appear to be
acrosyringeal cells, although this possibility could not be excluded. Murine and human
MHC Il+ve keratinocytes are unable to induce primary allogeneic T cell responses or to
present antigens such as ovalbumin, hen egg lysozyme, pigeon cytochrome C or PPD
to CD4+ve T cells (Gaspari, Jenkins and Katz, 1988; Niederweisser et al., 1988; Bal et
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al., 1990). However MHC Il+ve keratinocytes may induce antigen-specific
unresponsiveness or clonal anergy. It has recently been demonstrated that MHC Il+ve
keratinocytes may presentMycobacterium leprae to antigen specific CD4+ve T cells
and cause antigen-driven T cell proliferation (Mutis et al., 1993). Therefore, it is
unclear whether the MHC n+ve keratinocytes noted here after UVB irradiation may
play a functional role in immunosuppression by inducing clonal anergy, or whether
they may compensate for the loss of LCs by assuming APC function to CD4+ve T
cells.
A small number ofCDla-ve dendritic cells were detected in the EC suspensions after
UVB irradiation (see chapter 5, section 5.3), although none were found in the
unirradiated EC samples. The CDla-ve dendritic cells in UVB-irradiated epidermal
samples were detected in small numbers and appeared similar in ultrastructure to either
lymphoid cells or to cells of the macrophage/dendritic cell lineage. They did not
contain BGs or melanosomes, but contained lysosomes (their ultrastructure was
relatively indeterminate). These CDla-ve dendritic cells may correspond to the CDla-
ve, OKM5+ve ECs previously described in human skin after UVB and UVA
irradiation (Cooper et al., 1986, 1992; Scheibner et al., 1986; Liu et al., 1987). Such
CDla-ve cells, which appeared after UVB irradiation, were reported to be HLA-
DR+ve and HLA-DQ+ve and to contain numerous melanosomes, lysosomes, lipid
bodies but no keratin, premelanosomes or BGs. Furthermore, CDla-ve cells made up
approximately 4% of UVB-exposed ECs whereas LCs made up 0.6% of UVB-
exposed ECs (Cooper et al., 1992). The differences in number and ultrastructure of the
CDla-ve cells described in this study (chapter 5, section 5.3) and those reported by
Cooper et al. may be due to widely differing experimental UVB regimens or due to
different sampling times after cessation of irradiation: they used single 4 MED doses
of UV and took epidermal samples 72 hours later, whereas subjects in this study
received suberythemal doses and samples were taken 48 hours after irradiation. Since
the peak in numbers ofCDla-ve, HLA-DR+ve cells was reported to occur on the 4th
day after irradiation of human epidermis with UVA, the sample point used in this
study may have been too early to have detected them in the same proportions (Liu et
al., 1987). A further study indicated that erythemogenic UVB doses may be more
likely to induce epidermal OKM5+ve, CDla-ve macrophages than suberythemogenic
UVB doses (Cooper et al., 1992).
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6.10 The regulation of MHC II expression.
It is probable that the factors which result in altered expression of LC MHC II after
UVB-irradiation include cytokines and prostaglandins released by ECs (TNF-oc, TGF-
a , GM-CSF, PGE), and T cells (y-IFN). TNF-a may enhance MHC II expression
on LCs and act synergistically with y-IFN for MHC II induction on monocytes (Chang
and Lee, 1986; Belsito et al., 1989). In this study (see chapter 5, section 5.4), three of
four subjects in which TNF-a was measured showed increased levels of this cytokine
during UVB treatment (Gilmour et al., 1993).
GM-CSF may increase MHC II expression on LCs and macrophages (Willman et al.,
1989; Belsito et al., 1989). It has been demonstrated that the production ofGM-CSF
by cultured keratinocytes may be induced by UVB exposure (Matsue et al., 1992).
TGF-p, on the other hand, may prevent the induction of MHC II on LCs by y-IFN or
other cytokines although it was shown to have no effect on the constitutive expression
of MHC II by LCs (Epstein et al., 1991). In addition, prostaglandin E may suppress
the expression of MHC II (Warren and Vogel, 1985).
Table 6.1 Factors regulating MHC II expression (Fabre. 1991).
factors examples






hormones thyroid stimulating hormone
corticosteroids
viruses neurotropic murine hepatitis virus
(JHM)
non-specific cell activators phorbol esters
prostaglandins of the E series PGE
Human keratinocytes were induced to synthesize and express MHC II after incubation
in vitro with y-IFN (Basham et al., 1984; Griffiths et al., 1989). The differential
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induction of MHC II subregion product expression on various cells by y-IFN has been
well-documented. For example, the expression of HLA-DR in greater amounts than
either HLA-DP or -DQ has been shown to occur on keratinocytes in lesional skin of
inflammatory dermatoses and was thought to be induced by y-IFN (Gawkrodger et al.,
1987). In addition, eight of eleven patients with cutaneous T cell lymphoma and three
of eleven patients with lichen planus demonstrated keratinocyte expression of HLA-DR
and HLA-DQ which was presumably induced by T cell-derived y-IFN (Volc-Platzer et
al., 1987). The expression of HLA-DR and HLA-DP but not HLA-DQ antigens was
induced on amniotic fluid cells and on dermal fibroblasts by culturing in the presence
of y-IFN (Geppert and Lipsky, 1985; Maurer et al., 1987). In contrast, the induction
of HLA-DQ by y-IFN was reported on melanocytes and on monocytes which were
previously HLA-DQ-ve (Basham et al., 1984; Tsujisaki et al.', 1987).
The expression of MHC II on LCs may also be increased after culture with cytokines
such as y-IFN (Belsito et al., 1989). Enriched human LCs in suspension were induced
to express higher levels of HLA-DR molecules but not HLA-DQ or CD la molecules
after incubation for 24 hours with y-IFN (Schmitt et al., 1987).
It has also been shown that aT-UCA may also modulate MHC II expression.
Decreased numbers of HLA-DR+ve ECs and decreased expression of HLA-DR on
the surface of peripheral blood monocytes were noted after incubation with c/s-UCA in
vitro (Rasanen et al., 1989). The percentages of cis-UCA in both epidermis and
suction blister fluid of four subjects in this study were shown to be increased during the
course ofUVB irradiation (see chapter 5, section 5.4; Gilmour et al., 1993).
Altered LC surface expression of MHC II may also occur after exposure to contact
allergens in vivo. DCs isolated from draining lymph nodes 18 hours after application
of FTTC to murine skin displayed signs of cellular activation and internalization of
MHC II (Bucana et al. 1992). Murine LCs have also been shown to internalize MHC
II after application of DNCB, DNFB, oxazolone and K2Cr207 and displayed
simultaneous reductions in surface MHC II (Becker et al., 1992). Therefore, antigen
processing or presentation may be associated with internalization of MHC II and thus
decreased cell surface MHC II.
The influence of UVB-induced factors within the epidermis on LC MHC II expression
may be difficult to establish, since the effects of these factors is usually dependent upon
their concentration and interaction with other factors. However, a combination of
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factors may be responsible for the observed increase in MHC II on LCs and the
induction of MHC II on keratinocytes following UV exposure.
6.11 Mechanisms involved in UVB-induced immunosuppression.
There are various ways in which UVB is thought to exert its immunosuppressive
effects (a model is given in fig. 6.3). In the outermost layers of the epidermis urocanic
acid absorbs UVB and transforms from the trans- to the cis-isomer. The subsequent
binding of c/.v-urocanic acid to histamine-like receptors may lead to a local release of
cytokines. In addition, UVB can induce the synthesis of various keratinocyte
mediators such as IL-1, IL-3, IL-6, IL-10 and TNF-a. UVB may also generate free
radicals (such as the superoxide anion) which have been implicated in the generation of
"sunburn cells" (damaged keratinocytes), and in the depletion and morphological
alteration of epidermal LCs. The peroxidation of EC membrane lipids by free radicals
can result in the release of prostaglandins and other inflammatory mediators, and lead
to leucocyte infiltration.
TNF-a appears to induce LC emigration leading to suppression of the induction of the
CHS response by a mechanism which is independant of ciT-UCA induced
immunosuppression (Moodycliffe et al„ 1994). This changes antigen presentation
either by LCs which have been functionally altered, or through presentation by
alternative APCs, or possibly by a combination of both events which results in the
suppression of cell-mediated immune responses.
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Figure 6.3: Model of The Mechanisms of
UVB-induced Immunosuppression.
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suppression of cell- mediated immune responses
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6.12 Conclusions and areas in which this work might be extended.
Conclusions:
In conclusion, the studies described in this thesis have:
1) clarified the normal expression of MHC II and CD la on both single LCs and
between many LCs from an individual: both CD la and MHC II antigens were evenly
distributed over the surface of single cells, but wide ranges of antigen densities were
noted between cells from an individual.
2) defined the influence of therapeutic UVB irradiation on LC morphology: LCs were
generally less dendritic after irradiation, but a small proportion of LCs possessed
elongated dendrites and may have been emigrating from the epidermis.
3) defined the influence of therapeutic UVB irradiation on LC numbers: The number
of LCs was decreased to approximately 50% of the number prior to irradiation,
irrespective of the antibody used to demonstrate them.
4) defined the influence of therapeutic UVB irradiation on LC surface antigen
expression: residual LCs at 48 hours after the final UVB irradiation diplayed increased
surface densities of CD la and MHC II antigens.
Therefore, a six week course of suberythemal, therapeutic UVB irradiation resulted in a
genuine reduction in the number of epidermal LCs, which were mainly rounded and no
longer dendritic. This LC depletion could not be explained merely by the loss of LC
surface MHC II or CD la antigen expression. This result implies that moderate,
suberythemal doses ofUVB irradiation experienced over a six week period, in similar
doses to those one might expect to receive during British spring or summertime and
which produce little visible evidence of epidermal alteration, cause significant
reductions in number of epidermal LCs. This could have profound effects on the
ability of the skin to respond to potentially harmful antigens which are encountered
there for the first time,whether the antigen be endogenous or exogenous. This
therapeutic UVB regimen is given to many patients suffering from skin diseases,
particularly to those suffering from psoriasis and eczema. These results imply that it
would be wise to limit the use of phototherapy as far as possible, and to monitor
patients who are receiving phototherapy regularly for signs of cutaneous
carcinogenesis.
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Areas in which this work might be extended:
A number of questions regarding UVB-induced immunomodulation remain
unresolved and deserve further attention, and these include:
1) The question of whether human LC damage or death occurs in response to
moderate doses of UVB irradiation is unresolved. It would be interesting to compare
both the general ultrastructural features and the DNA of LCs before and after exposure
to suberythemal doses of UVB. For example, membrane alterations could be assessed
ultrastructurally, DNA damage in the form of thymidine dimers (which are implicated
in UV-induced LC damge) could be assessed by calculating the number of
endonuclease-sensitive sites in LCs derived from irradiated skin (Wolf et al., 1993;
Schothorst et al., 1991)
2) It would be interesting to examine the effect of UVB, in similar fluences to those
used in this study, on the quantitative expression of other LC surface antigens, such as
the accessory / adhesion molecules ICAM-1, LFA-3 and B7. Since there is evidence
that reduced expression of ICAM-1 may play a role in the low-dose UVB-induced
suppression of immune reponses in murine and human epidermis (Simon et al.,
1992), this may also be important in the human response to UVB irradiation in
therapeutic doses.
3) Some evidence for UVB-induced alterations in antigen presentation by human ECs
has already been demonstrated (Gilmour et al., 1993). Comparisons of the ability of
human LCs to process and present antigens on a per cell basis or to form T cell clusters
in vitro (which is an indication of their adhesive properties and may reflect alterations in
surface expression of ICAM-1, LFA-3 or B7) before and after moderate doses of
UVB irradiation in vivo might yield further information regarding the underlying
mechanisms of UVB-evoked immunosuppression in humans.
4) A logical continuation of these studies would be to examine the human epidermal
and dermal expression of TNF-oc, GM-CSF, IFN-y, TGF-(3, PGE and c/s-UCA
before, during and after UVB exposure by immunohistochemical methods and also to
examine the transcription of those genes using in situ hybridisation techniques. In
addition, the effects of these factors could be determined both singly and in
combination on MHC II and CD 1 a expression on LCs in vitro using FACS analysis in
order to establish the time-course and dose-response curves for the UVB-evoked
increased expression of LC surface antigens.
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5) The influence of therapeutic doses ofUVB irradiation on LC numbers, surface
antigen expression and function in patients who receive phototherapy with various skin
diseases is not very clear. This information may determine whether immune
dysfunctions in patients occur as a result of therapeutic UVB exposure.
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Appendix 1
a) Gold label density on sections of CD la positive cells
divided into halves.
cell label density on 1st
cell half
label density on 2nd
cell half
1 1.07 0.99





7 ~| 0.81 0.65
8 1.80 1.55
9 n 1.62 1.08
10 0.41 0.37 '
t = 0.62 (18 degrees of freedom).
Appendix 1
b) Gold label density on sections of CDla positive cells
divided into quarters.
cell A B C D
1 0.76 1.38 1.18 0.80
2 0.76 0.78 1.03 1.18
3 2.03 1.31 1.18 1.69
4 1.36 0.94 1.04 1.24
5 0.49 0.41 0.59 0.35
6 0.50 0.82 0.71 0.84
7 0.89 0.74 0.61 0.70
8 1.75 1.86 1.59 1.52
9 1.39 1.85 1.24 0.93
10 0.33 0.50 0.32 0.43
Two sample t tests were used to compare these data.
t (comparison of A and B) = -0.12
t (comparison of A and C) = 0.36
t (comparison of A and D) = 0.26
t (comparison of B and C) = 0.52
t (comparison of B and D) = 0.43
t (comparison of C and D) = -0.10
Appendix 1
c) Gold label density on sections of L243 positive cells
divided into halves.
cell label density on 1st
cell half
label density on 2nd
cell half
1 1.12 0.98







9 1 1.02 0.62
10 1.58 1.53
t = 0.17 (18 degrees of freedom.)
Appendix 1
d) Gold label density on sections of L243 positive cells
divided into quarters.
cell A B C D
1 1.42 0.83 0.84 1.33
2 0.55 0.47 0.32 0.33
3 0.01 0.28 0.20 0.30
4 0.60 0.83 0.56 0.69
5 0.34 0.44 0.50 0.33
6 2.77 2.50 3.02 2.43
7 0.36 0.28 0.55 0.63
8 2.77 2.46 2.22 2.36
9 0.95 1.09 0.84 0.39
10 1.55 1.61 1.85 1.21
Two sample t tests were used to compare these data.
t (comparison of A and B) = 0.12
t (comparison of A and C) = 0.09
t (comparison of A and D) = 0.32
t (comparison of B and C) = 0.02
t (comparison of B and D) = 0.22
t (comparison of C and D) = 0.20
Appendix 1
e) Gold label density on sections of TU22 positive cells
divided into halves.
cell label density on 1st
cell half










9 0.73 "1 0.59
10 0.42 0.37
t = 0.24 (18 degrees of freedom).
Appendix 1
f) Gold label density on sections of TU22 positive cells
divided into quarters.
cell A B C D ~~~~|
1 0.44 0.52 0.40 0.54
2 1.90 1.80 1.27 2.21
3 0.59 0.79 0.62 0.99
4 1.33 1.92 1.25 1.25
5 2.49 2.95 2.34 2.24
6 0.44 0.39 0.69 0.69
7 0.90 1.03 1.15 0.79
8 0.15 0.23 0.12 0.21
9 0.79 0.67 0.74 0.44
10 0.35 0.50 0.40 0.34
Two sample t tests were used to compare these data.
t (comparison of A and B) = -1.0
t (comparison of A and C) = 0.29
t (comparison of A and D) = -0.20
t (comparison of B and C) = 1.27
t (comparison of B and D) = 0.80
t (comparison of C and D) = -0.50
Appendix 1
g) Gold label density on sections of B7/21 positive cells divided into
halves.
cell label density on 1st
cell half












t = 0.62 (18 degrees of freedom).
Appendix 1
h) Gold label density on sections of B7/21 positive cells divided into
quarters.
cell A B C D
1 0.82 0.84 0.98 0.59
2 1.24 1.36 1.55 1.36
3 5.33 7.87 8.07 6.29
4 0.03 0.07 0.09 0.07
5 0.31 1 0.21 0.22 0.24
6 0.39 0.39 0.84 0.42
7 0.32 0.67 0.50 0.43
8 0.45 0.75 0.59 0.57
9 0.51 0.80 0.73 0.33
10 7.18 10.13 11.33 8.85
Two sample t tests were used to compare these data.
t (comparison of A and B) = -0.52
t (comparison of A and C) = 1.19
t (comparison of A and D) = -0.20
t (comparison of B and C) = -0.11
t (comparison of B and D) = 0.29
t (comparison of C and D) = 0.37
Appendix 1
i) Gold label density on sections of DA6.231 positive cells divided into
halves.
cell label density on 1st
cell half












t = -0.28 (18 degrees of freedom.)
Appendix 1
j) Gold label density on sections of DA6.231 positive cells divided into
quarters.
cell A B C D
1 8.63 9.70 9.59 9.19
2 12.79 9.33 11.36 11.95
3 12.85 14.02 13.22 12.34
4 4.52 5.08 5.36 5.01
5 10.52 11.68 11.42 12.17
6 9.11 9.53 8.33 8.12
7 10.07 7.08 6.54 9.44
8 8.67 7.36 7.66 8.54
9 5.06 5.76 6.19 6.49
10 5.79 4.49 6.71 6.49
Two sample t tests were used to compare these data.
t (comparison of A and B) = 0.30
t (comparison of A and C) = 0.13
t (comparison of A and D) = -0.14
t (comparison of B and C) = -0.19
t (comparison of B and D) = -0.46
t (comparison of C and D) = -0.28
Appendix 2











pre UVB 1 2.56 3.88 4.11
2 3.63 J 4.60 4.82
3 4.66 5.08 4.34
4 4.09 4.83 4.96 5.39
5 5.10 5.41 5.91
6 6.96 6.22 5.45
7 7.29 6.25 6.95
8 6.70 6.04 8.10
9 7.82 8.30 8.35
10 9.66 8.32 7.31 8.25 7.25
11 9.20 8.39 8.48
12 8.70 8.98 10.4
13 11.80 11.41 10.58
14 12.90 13.54 15.39
15 15.47 17.48 15.12 14.19
post UYB 16 5.08 4.61 5.72
17 5.22 5.78 6.21
18 6.34 6.15 7.23 5.18
19 7.09 7.64 6.37
20 7.14 5.75 6.55
21 8.65 6.84 6.82
22 7.83 7.26 7.80
23 8.43 7.91 8.16
24 8.57 8.09 8.76
25 12.85 11.77 12.85
26 10.05 11.39 1.91
27 12.98 13.99 12.46
28 12.74 14.36 14.80
29 13.36 j 14.21 14.91
30 25.55 24.82 19.82
Appendix 2










pre UVB 1 1.21 1.17 1.79
2 0.56 0.66 0.41
3 0.15 0.21 0.34
4 0.88 °-90 J 0.89
5 0.34 0.44 0.41
post UVB 6 0.04 0.08 0.04
7 4.97 4.15 4.13
8 3.16 3.06 3.23
9 0.75 1.17 1.30
10 0.07 0.10 0.08












pre UVB 1 0.55 0.46 0.34 0.53
2 0.65 0.85 0.57
3 0.44 0.42 0.53
4 0.96 0.81 1.00
5 0.22 0.17 0.35
post UVB 6 1.11 0.95 1.48
7 0.57 0.74 0.43
8 3.49 3.18 3.24 3.20
9 1.18 1.32 1.43
10 1.57 1.81 1.80
Appendix 2










pre UVB 1 0.83 0.85 0.99
2 0.72 0.59 0.84
3 2.16 2.17 3.08
4 0.04 0.12 0.08
5 0.20 0.23 0.20
post UVB 6 0.65 0.70 0.80
7 4.06 3.69 4.55
8 0.66 0.33 0.57
9 6.13 6.28 7.02
10 9.95 10.51 10.10
Appendix 3a
The number of OKT6+ve ECs per millimetre basal keratinocyte plasma
membrane.
Number of OKT6+ve ECs/mm in five separate sections
subject 1 2 3 4 5
MJT 38.04 42.22 40.20 35.35 31.07
JPV 33.14 25.00 19.92 20.51 17.43
EM 20.89 20.21 23.36 23.46 17.44
MJS 29.27 37.78 15.71 20.80 19.05
JAAH 38.30 35.83 38.98 36.21 29.46
SK 18.13 13.84 27.27 18.49 23.68
GCP 23.28 18.04 21.97 18.88 20.93
MG 13.95 27.91 17.58 14.63 19.23
NH 13.23 13.18 18.52 14.60 10.95
The number of OKT6+ve ECs per millimetre basal keratinocyte plasma
membrane after a standard six week course of UVB phototherapy.
Number of OKT6+ve ECs/mm in five separate sections
after UVB irradiation
subject 1 2 3 4 5
MJT 12.12 15.38 10.53 18.18 4.65
JPV 9.86 12.28 14.81 9.17 11.35
EM 14.00 13.33 13.09 15.48 10.45
MJS 21.95 9.80 10.43 16.66 14.77
JAAH 30.20 29.76 18.56 13.95 10.31
SK 8.33 8.70 13.04 7.69 11.76
GCP 11.27 11.76 15.55 14.15 8.49
MG 8.57 9.88 7.78 11.90 8.33
NH 7.64 5.85 5.69 4.31 6.43
Appendix 3b
The number of DA6.231+ve ECs per millimetre basal keratinocyte
plasma membrane.
Number of DA6.231+ve ECs/mm in five separate sections
subject 1 2 3 4 5
MJT 29.54 29.17 34.92 23.88 28.78
JPV 26.76 20.45 16.61 24.03 11.70
EM 15.55 31.98 26.74 16.11 25.87
MJS 26.17 21.21 24.35 24.69 18.03
JAAH 33.00 35.23 29.73 36.42 31.08
SK 20.76 26.32 16.09 15.03 17.36
GCP 15.08 17.89 15.45 23.23 20.91
MG 20.79 23.08 20.69 19.54 25.00
NH 11.96 11.68 17.74 15.24 22.92
The number of DA6.231+ve ECs per millimetre basal keratinocyte
plasma membrane after a standard six week course of UVB
phototherapy.
Number of DA6.231+ve ECs/mm in five separate sections
after UVB irradiation
subject 1 2 3 4 5
MJT 5.40 8.00 14.29 14.95 10.71
JPV 14.29 18.75 8.70 3.91 9.79
EM 25.35 15.85 13.09 15.48 10.45
MJS 11.76 14.52 7.50 5.22 10.77
JAAH 6.98 13.86 19.32 11.34 10.09
SK 6.78 7.25 6.94 8.00 8.45
GCP 10.46 7.22 7.14 10.20 6.00
MG 10.53 10.14 7.41 13.79 11.27
NH 4.52 4.57 6.14 5.64 4.21
Appendix 3c
The number of L243+ve ECs per millimetre basal keratinocyte plasma
membrane.
Number of L243+ve ECs/mm in five separate sections
subject 1 2 3 4 5
MJT 21.93 21.43 24.30 16.66 21.15
JPV 13.31 14.20 13.29 18.46 18.26
EM 16.82 18.91 15.71 15.54 14.79
MJS 16.66 16.53 13.77 20.00 16.28
JAAH 21.26 15.08 21.31 13.25 24.41
SK 18.12 21.58 21.91 18.18 21.25
GCP 15.97 20.15 17.69 15.44 16.39
MG 23.33 21.84 21.11 20.48 14.56
NH 10.69 15.87 11.56 14.03 10.71
The number of L243+ve ECs per millimetre basal keratinocyte plasma
membrane after a standard six week course of phototherapy
Number of L243+ve ECs/mm in five separate sections after
UVB irradiation
subject 1 2 3 ~1 4 5
MJT 5.49 4.86 7.00 9.64 5.80
JPV 6.19 16.35 12.82 5.52 20.59
EM 8.27 7.83 10.85 6.82 7.76
MJS 12.19 4.70 10.07 14.03 7.97
JAAH 9.76 12.05 8.65 10.53 13.11
SK 7.02 8.62 7.89 11.54 13.64
GCP 5.32 5.36 7.32 4.44 10.10
MG 5.88 12.19 9.09 7.37 10.10
NH 7.23 5.96 3.42 4.25 7.34
Appendix 3d
The number of TU22+ve ECs per millimetre basal keratinocyte plasma
membrane.
Number of TU22+ve ECs/mm in five separate sections
subject 1 2 3 4 5
MJT 19.01 13.04 11.96 13.84 8.03
JPV 13.87 12.04 12.54 13.04 13.60
EM o ~~1 0 0 0 0
MJS 5.09 4.92 7.83 4.49 6.25
JAAH 17.42 12.19 13.09 13.29 14.17
SK 0 0 0 0 0
GCP 17.46 8.49 8.08 11.11 11.82
MG 19.05 18.68 13.83 19.54 11.11
NH 4.58 H 3.91 4.54 4.67 4.43
The number of TU22+ve ECs per millimetre basal keratinocyte plasma
membrane after a standard six week course of phototherapy.
Number of TU22+ve ECs/mm in five separate sections
after UVB irradiation
subject 1 2 3 4 5
MJT 4.06 0.87 4.72 5.45 3.96
JPV 8.28 6.21 5.11 8.82 10.28
EM 7.00 4.17 8.25 12.96 12.50
MJS 2.17 4.72 2.25 4.13 4.51
JAAH 1.15 1.07 1.10 0 0
SK 0 0 0 0 0
GCP 2.10 4.54 9.88 6.82 2.74
MG 6.66 2.74 2.44 5.97 4.65
NH 0.91 3.48 2.31 2.46 2.38
Appendix 3e
The number of B721+ve ECs per millimetre basal keratinocyte plasma
membrane.
Number of B721+ve ECs/mm in five separate sections
subject 1 2 3 4 5
MJT 8.51 6.47 10.08 6.76 11.85
JPV 6.42 11.29 16.00 8.04 8.48
EM 6.87 7.72 5.37 9.04 5.17
MJS 5.43 7.59 3.80 7.41 6.45
JAAH 6.83 4.91 6.25 8.33 8.65
SK 8.88 9.21 12.71 14.06 14.47
GCP 5.64 2.40 6.72 8.66 7.26
MG 12.19 13.33 16.45 11.25 11.43
NH 4.54 5.26 5.60 7.30 6.78
The number of B721+ve ECs per millimetre basal keratinocyte plasma
membrane after a standard six week course of phototherapy.
Number of B721+ve ECs/mm in five separate sections after
UVB irradiation
subject 1 2 3 4 5
MJT 2.73 1.80 3.30 0.86 1.92
JPV 5.33 3.55 3.53 2.88 3.51
EM 4.41 7.25 5.80 5.68 7.59
MJS 3.82 2.94 2.84 6.94 7.02
JAAH 5.04 0.94 4.60 1.22 3.09
SK 4.35 3.16 9.09 5.17 10.26
GCP 1.11 3.67 2.35 4.12 2.25
MG 5.38 2.33 5.95 2.41 2.82
NH 1.69 2.87 2.31 2.94 2.96
Appendix 4a
The number of gold particles per pm plasma membrane on five
CDla+ve LCs or ICs.
Number of gold particles per pm on five separate cells
subject 1 2 3 4 5
MJT 0.88 1.59 0.70 0.71 0.60
JPV 0.10 0.35 0.25 0.17 0.37
EM 1.05 0.98 0.46 0.68 0.75
MJS 0.55 1.52 0.75 1.05 0.25
JAAH 0.60 0.74 0.69 1.80 1.31
SK 0.96 0.88 1.20 0.89 1.01
GCP 0.73 0.77 0.48 0.25 0.51
MG 0.15 0.23 0.25 0.45 0.14
NH 1.28 1.46 0.92 1.52 2.38
The number of gold particles per pm plasma membrane on five
CDla+ve LCs after a standard six week course of phototherapy.
Number of gold particles per pm on five separate cells
after UVB irradiation
subject 1 2 3 4 5
MJT 3.90 3.66 3.80 2.43 2.20
JPV 1.09 1.77 1.44 0.36 1.97
EM 1.33 0.93 2.21 2.01 1.56
MJS 1.07 0.57 0.91 2.11 3.46
JAAH 2.81 4.12 1.84 1.09 0.46
SK 0.98 1.00 0.69 0.30 2.04
GCP 0.95 1.55 1.61 1.29 1.31
MG 0.68 0.71 0.12 0.31 0.06
NH 1.01 1.19 1.67 1.39 1.66
Appendix 4b
The number of gold particles per pm plasma membrane on five
DA6.231+ve LCs or ICs.
Number of gold particles per pm on five separa te cells
subject 1 2 3 4 5
MJT 2.90 3.23 3.38 4.80 3.13
JPV 1.63 8.10 3.62 2.41 4.55
EM 6.15 4.77 11.65 5.54 4.87
MJS 5.02 4.11 2.37 3.98 9.67
JAAH 4.69 4.73 3.12 4.26 8.65
SK 5.38 4.95 8.61 4.32 5.97
GCP 5.45 6.84 4.76 6.19 7.41
MG 3.49 3.24 8.28 4.22 4.61
NH 7.97 4.15 6.25 4.03 4.27
The number of gold particles per pm plasma membrane on five
DA6.231+ve LCs after a standard six week course of phototherapy.
Number of gold particles per pm on five separate cells
after UVB irradiation
subject 1 2 3 4 5
MJT 4.12 5.19 4.58 6.53 14.60
JPV 2.10 3.54 2.38 3.29 11.70
EM 8.19 9.86 4.47 13.62 10.21
MJS 7.63 1 8.43 2.86 8.90 5.29
JAAH 10.18 8.85 9.64 12.46 16.92
SK 5.43 8.99 6.25 10.82 11.01
GCP 10.43 3.60 2.91 5.99 4.65
MG 5.22 4.12 17.45 3.69 4.13
NH 5.33 9.83 5.94 5.45 2.00
Appendix 4c
The number of gold particles per pm plasma membrane on five
L243+ve LCs or ICs.
Number of gold particles per pm on five separate cells
subject 1 2 3 4 5
MJT 2.77 0.14 0.41 0.61 6.72
JPV 0.06 0.28 0.08 0.03 0.00
EM 0.25 0.25 0.23 0.29 0.14
MJS 0.15 0.18 0.11 0.03 0.12
JAAH 0.20 0.25 0.19 0.42 0.91
SK 0.03 0.10 0.33 0.01 0.04
GCP 0.84 0.14 0.59 4.04 0.05
MG 0.12 0.32 0.51 0.68 0.11
NH ND ND ND ND ND
The number of gold particles per pm plasma membrane on five
L243+ve LCs after a standard six week course of phototherapy.
Number of gold particles per pm on five separate cells
after UVB irradiation
subject 1 2 3 4 5
MJT 0.44 0.41 0.75 1.85 0.73
JPV 0.16 4.32 0.11 0 0.18
EM 2.79 0.99 2.61 0.84 0.67
MJS 1.74 0.07 0.28 0.16 0.70
JAAH 0.90 3.16 4.97 7.19 3.47
SK ND ND ND ND ND
GCP ND ND ND ND ND
MG ND ND ND ND ND
NH ND ND ND ND ND
Appendix 4d
The number of gold particles per pm plasma membrane on five
TU22+ve LCs or ICs.
Number of gold particles per pm on five separate cells
subject 1 2 3 4 5
MJT 0.53 0.59 0.17 0.46 0.26
JPV 0.00 0.74 0.12 1.07 0.77
EM 0.23 0.22 0.14 0.00 0.22
MJS 0.13 0.39 0.62 0.35 0.09
JAAH 0.26 0.29 0.75 0.92 0.66
SK 0 0 0 0 0
The number of gold particles per pm plasma membrane on five
TU22+ve LCs after a standard six week course of phototherapy.
Number of gold particles per pm on five separate cells
after UVB irradiation
subject 1 2 3 4 5
MJT 0.75 1.63 1.81 0.85 0.26
JPV 0.37 1.38 2.51 1.00 0.59
EM 1.60 0.67 0.09 0.22 3.56
MJS 0.14 1.26 0.96 2.89 0.29
JAAH 3.01 0 2.70 1.57 1.03
Appendix 4e
The number of gold particles per pm plasma membrane on five
B721+ve LCs or ICs.
Number of gold particles per pm on five separate cells
subject 1 2 3 4 5
MJT 0.23 0.31 0.54 0.29 0.07
JPV 0.42 0.29 0.94 0.41 0.21
EM 0.39 1.01 0.54 1.11 0.52
MJS 0.31 0.05 0.12 0.33 0.82
JAAH 0.58 1.01 0.92 1.54 1.19
The number of gold particles per pm plasma membrane on five
B721+ve LCs after a standard six week course of phototherapy.
Number of gold particles per pm on five separate cells
after UVB irradiation
subject 1 2 3 4 5
MJT 0.71 0.40 3.23 6.43 0.32
JPV 0.47 4.09 0.20 0.74 1.03
EM 0.58 1.35 4.21 0.43 2.30
MJS 0.65 0.43 0.80 3.33 1.12
JAAH 3.06 3.20 4.06 0.21 4.89
Appendix 5a
The percentage area of fluorescence label and the number of cells
labelled with FITC-CDla in epidermal sheets viewed 'en face' before
and after a standard six week course of phototherapy.
% labelled area
pre UVB post UVB
number of cells
pre UVB post UVBsubj. field
1 1 6.01 2.56 35 20
2 3.43 2.61 40 17
3 6.79 2.26 47 14
4 6.26 1.86 46 23
5 5.42 2.87 40 18
2 1 4.73 2.10 30 8
2 7.03 1.35 28 6
3 1 1.79 2.89 20 11
4 1.06 3.15 17 4
5 0.33 1.68 11 9
3 1 8.02 2.74 33 21
2 7.54 3.74 32 18
3 5.19 6.11 36 18
4 6.15 4.53 ~1 41 15
5 7.49 5.38 31 18
4 1 2.70 1.15 14 6
2 1.66 0.99 13 7
3~| 1.28 0.91 11 9
4 1.33 1.11 10 12
5 2.84 2.09 13 8
Appendix 5b The morphology of CDla+ve cells in epidermal sheets



















1 1 272 169 118 122 154 47
2 172 282 80 127 92 155
3 205 221 121 159 84 62
4 302 184 135 69 167 115
5 224 132 159 109 65 23
6 319 175 122 133 197 42
7 185 328 92 118 94 210
8 241 234 131 92 110 142
9 189 267 94 221 95 46
10 168 454 112 220 56 234
2 1 260 116 93 60 167 56
2 458 198 136 75 322 123
3 167 228 91 69 76 159
4 336 168 204 107 132 61
5 410 320 162 249 248 71
6 358 347 151 341 207 6
7 484 97 200 85 284 12
8 414 311 179 169 235 142
9 367 183 183 173 184 10
10 467 315 166 254 301 61
3 1 267 120 137 120 130 0
2 416 226 109 93 307 133
3 310 110 232 110 78 0
4 324 336 280 92 44 244
5 282 186 163 74 118 112
6 268 186 171 70 97 146
7 222 221 151 75 70 146
8 279 116 201 62 78 54
9 501 740 94 129 407 611
10 247 165 71 139 176 26
4 1 233 147 82 122 151 25
2 174 217 132 185 41 32
3 179 125 126 125 52 0
4 191 71 153 71 38 0
5 191 161 106 45 85 116
6 211 197 164 120 47 77
7 349 203 143 125 206 77
8 197 117 127 105 70 12
9 190 98 92
10 269 194 75
Appendix 5c
The number of dendrites, the mean length of dendrites and the
dendricity (defined as the perimeter of the whole cell divided by the
perimeter of the putative cell body) of CDla+ve epidermal cells before















1 1 8 4 10.6 9.2 4.9 2.4
2 7 6 7.3 13.4 3.5 4.3
3 3 4 17.2 8.0 2.8 1.8
4 7 9 11.7 7.2 3.8 4.2
5 5 3 8.6 4.8 2.0 1.5
6 5 4 19.6 8.9 5.1 2.0
7 6 4 7.6 8.7 2.7 3.7
8 5 6 14.9 3.8 4.1 3.5
9 2 4 26.7 8.1 4.1 1.9
10 5 3 7.1 32.1 2.0 3.8
2 1 4 7 11.4 3.6 4.0 4.6
2 9 3 10.2 15.6 5.5 3.1
3 4 3 20.8 25.9 4.5 5.1
4 4 2 17.2 24.3 2.9 3.1
5 5 3 22.2 11.5 4.3 1.8
6 3 1 23.2 6.75 3.6 1.1
7 5 2 22.5 3.1 4.4 1.2
8 5 5 14.7 15.5 3.3 2.9
9 5 2 16.8 5.6 3.4 1.3
10 8 3 16.5 9.5 4.9 1.8
3 1 4 0 12.4 0 2.7 1.0
2 6 4 9.44 15.1 5.0 3.2
3 7 0 15.4 0 2.5 2.1
4 7 3 7.6 18.9 1.8 6.3
5 5 6 11.3 12.5 3.5 5.2
6 2 5 28.1 8.9 2.5 3.0
7 3 3 13.7 24.1 2.6 6.2
8 3 4 8.5 8.02 2.0 3.2
9 4 3 10.6 4.7 7.4 9.8
10 2 5 21.4 40.2 4.2 1.7
4 1 8 4 9.3 5.4 5.7 1.5
2 2 3 9.2 6.5 1.9 1.2
3 7 0 5.6 0 2.2 1.0
4 4 0 5.8 0 1.7 1.0
5 6 1 9.4 53.5 2.9 4.9
6 5 2 7.7 9.8 1.7 1.9
7 8 4 11.0 10.5 4.0 2.5
8 3 3 12.2 3.2 2.5 1.2
9 2 12.5 1.9
10 6 8.6 2.1
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